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A randomised controlled trial, cost-effectiveness and process
evaluation of the implementation of self-management for
chronic gastrointestinal disorders in primary care, and linked
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Peter Bower,7* Carolyn Chew-Graham,8 Elaine Harkness9
and Paula Beech10
1Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester,
Manchester, UK
2Institute of Infection and Global Health, University of Liverpool, Liverpool, UK
3National Institute for Health Research Collaboration for Leadership in Applied Health Research
and Care Wessex, University of Southampton, Southampton, UK
4Division of Nursing, Midwifery & Social Work, School of Health Sciences, University of
Manchester, Manchester, UK
5Centre for Health Economics, University of York, York, UK
6Centre for Biostatistics, School of Health Sciences, University of Manchester, Manchester, UK
7Centre for Primary Care, School of Health Sciences, University of Manchester, Manchester, UK
8Research Institute, Primary Care and Health Sciences, Faculty of Medicine and Health Sciences,
Keele University, Keele, UK
9Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK
10Stroke Rehabilitation Unit, Salford Royal Foundation Trust, Salford, UK
*Corresponding author peter.bower@manchester.ac.uk
Background: Chronic gastrointestinal disorders are major burdens in primary care. Although there is some
evidence that enhancing self-management can improve outcomes, it is not known if such models of care
can be implemented at scale in routine NHS settings and whether or not it is possible to develop effective
risk assessment procedures to identify patients who are likely to become chronically ill.
Objectives: What is the clinical effectiveness and cost-effectiveness of an intervention to enhance
self-management support for patients with chronic conditions when translated from research settings into
routine care? What are the barriers and facilitators that affect the implementation of an intervention to
enhance self-management support among patients, clinicians and organisations? Is it possible to develop
methods to identify patients at risk of long-term problems with functional gastrointestinal disorders in
primary care? Data sources included professional and patient interviews, patient self-report measures and
data on service utilisation.
Design: A pragmatic, two-arm, practice-level cluster Phase IV randomised controlled trial evaluating
outcomes and costs associated with the intervention, with associated process evaluation using interviews
and other methods. Four studies around identification and risk assessment: (1) a general practitioner
(GP) database study to describe how clinicians in primary care record consultations with patients who
experience functional lower gastrointestinal symptoms; (2) a validation of a risk assessment tool;
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(3) a qualitative study to explore GPs’ views and experiences; and (4) a second GP database study to
investigate patient profiles in irritable bowel syndrome, inflammatory bowel disease and abdominal pain.
Setting: Salford, UK.
Participants: People with long-term conditions and professionals in primary care.
Interventions: A practice-level intervention to train practitioners to assess patient self-management
capabilities and involve them in a choice of self-management options.
Main outcome measures: Patient self-management, care experience and quality of life, health-care
utilisation and costs.
Results: No statistically significant differences were found between patients attending the trained practices
and those attending control practices on any of the primary or secondary outcomes. The intervention had
little impact on either costs or effects within the time period of the trial. In the practices, self-management
tools failed to be normalised in routine care. Full assessment of the predictive tool was not possible
because of variable case definitions used in practices. There was a lack of perceived clinical benefit
among GPs.
Limitations: The intervention was not implemented fully in practice. Assessment of the risk assessment
tool faced barriers in terms of the quality of codting in GP databases and poor recruitment of patients.
Conclusions: The Whole system Informing Self-management Engagement self-management (WISE) model
did not add value to existing care for any of the long-term conditions studied.
Future work: The active components required for effective self-management support need further study.
The results highlight the challenge of delivering improvements to quality of care for long-term conditions.
There is a need to develop interventions that are feasible to deliver at scale, yet demonstrably clinically
effective and cost-effective. This may have implications for the piloting of interventions and linking
implementation more clearly to local commissioning strategies.
Trial registration: Current Controlled Trial ISRCTN90940049.
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme Grants
for Applied Research programme and will be published in full in Programme Grants for Applied Research;
Vol. 6, No. 1. See the NIHR Journals Library website for further project information.
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Plain English summary
Many patients suffer from what are called gastrointestinal disorders, which can include abdominal painand bloating as well as changing bowel habits.
There is some evidence that people can be helped by ‘self-management support’: engaging patients
more actively in their illnesses, using patient education and self-management and adding psychological
treatments.
Although we know that these methods can work in research settings, we do not know if they can be
rolled out to usual NHS settings.
We did a study to see if a training programme for primary care could help people with irritable bowel
syndrome (IBS), as well as those with diabetes and chronic obstructive pulmonary disease. We also
explored if we could develop ways to identify people who might be at risk of long-term problems.
We divided local practices into two groups and primary care staff were trained to deliver self-management
support.
We found lots of practical difficulties in delivering the changes and were not able to get primary care staff
to implement much self-management support in their routine care of patients. There were no differences
between groups in their health or the costs of their care over time.
We also found that the way that IBS is coded in general practice computer systems varied quite a lot.
General practitioners did not think that a tool to assess the risk of patients having long-term problems
would be very useful.
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Scientific summary
Background
Chronic gastrointestinal disorders are major burdens in primary care. Previous research has suggested that
enhancing self-management (by improving patient information, training health professionals to provide
support and improving access to care) can improve outcomes. However, it is not known if such models of
care can be implemented at scale in routine NHS settings. It is also unclear whether or not it is possible to
develop effective risk assessment procedures to identify patients who are likely to become chronically ill
and could benefit from additional support.
Objectives (list of research questions)
What is the clinical effectiveness and cost-effectiveness of an intervention to enhance self-management
support for patients with chronic conditions when translated from research settings into routine care?
[Phase IV randomised controlled trial (RCT) and economic evaluation.]
What are the barriers and facilitators that affect the implementation of self-management support among
patients, clinicians and organisations? (Process evaluation.)
Is it possible to develop methods to identify patients at risk of long-term problems with functional
gastrointestinal disorders in primary care?
Methods
We conducted a pragmatic, two-arm, practice-level cluster Phase IV RCT evaluating outcomes and costs
associated with an intervention to enhance self-management support.
We trained practitioners to assess patient self-management capabilities and involve patients in a choice of
self-management options, including self-help guidebooks, community resources and a potential ‘step up’
to more intensive patient-focused hypnotherapy or cognitive–behavioural therapy.
We conducted a process evaluation using interviews and other methods to assess the barriers and
facilitators that affect the implementation of the intervention at patient, clinical and organisational levels.
We conducted four studies around identification and risk assessment:
1. a database study was conducted to describe how clinicians in primary care record consultations with
patients who experience functional lower gastrointestinal symptoms
2. a risk assessment study was conducted to validate a risk assessment tool for predicting symptom
distress for irritable bowel syndrome (IBS)
3. a qualitative study was conducted to explore general practitioners’ (GPs’) views and experiences of
defining, diagnosing and managing of functional lower gastrointestinal symptoms in primary care
4. a second database study was conducted to investigate patient profiles in IBS, inflammatory bowel
disease and abdominal pain.
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Results
Project 1
Forty-four practices were randomised and 5599 patients were recruited, representing 43% of the eligible
population on the practice lists. A total of 4533 (81%) patients completed the 6-month follow-up and
4076 (73%) completed the 12-month follow-up.
No statistically significant differences were found between patients attending the trained practices and
those attending control practices on any of the primary or secondary outcomes. All effect size estimates
were below the prespecified threshold of clinically important difference. The intervention had little impact
on either costs or quality of life within the time period of the trial and was unlikely to be cost-effective.
Although some aspects of the intervention were well received and there was significant uptake and
attendance at initial training sessions, we found little evidence of demonstrable impact in terms of
changed clinical practice or patient experience of care.
In the practices, self-management tools failed to be normalised in routine care. Practice nurses viewed
themselves as being patient centred, yet psychosocial and behaviour change support was not generally
incorporated. Nurses had concerns about the burden of providing enhanced self-management support in
terms of both their own workloads and what they felt that their patients could accommodate.
Project 2
Our initial database analyses suggest that it is not yet possible to develop case definitions for primary
care-based studies of patients with IBS using Read Codes.
Full assessment of the planned risk assessment tool was not possible because of the variable case
definitions used in practices and as a result of wide discrepancies in the utilisation of Read Coding.
The number of patients recruited to the risk assessment study was also much lower than anticipated.
However, we were able to calculate sensitivity and specificity based on the sample recruited. The risk
assessment tool appeared to be sensitive in predicting those with severe disease; however, it was not
specific in predicting those without severe disease.
Variability in coding was found to be a function of practitioner preference and low utilisation was also
related to lack of perceived clinical benefit. GPs reported that IBS was not a difficult condition to diagnose
or manage, yet most described reluctance to add the Read Code for IBS to the record. Respondents
acknowledged the link between IBS and psychological distress, but were reluctant to refer for
psychological therapies and did not see the value of a risk assessment tool to predict chronicity.
Conclusion
The self-management intervention did not add value to existing care for any of the long-term conditions
studied. The active components required for effective self-management support need further study. The
results highlight the challenge of delivering improvements to quality of care for long-term conditions that
are feasible to deliver in routine care at scale, yet demonstrably clinically effective and cost-effective.
The active components required for effective self-management support need further study. The results
highlight the challenge of delivering improvements to quality of care for long-term conditions. This may
have implications for the piloting of interventions and linking implementation more clearly to local
commissioning strategies.
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Trial registration
This trial is registered as ISRCTN90940049.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Chapter 1 Introduction to the programme
The programme of research reported here derives from the National Institute for Health Research (NIHR)Programme Grants for Applied Research project number 11/77/82.
The original aims and objectives were:
l project 1 – to take an evidence-based self-management support model [Whole system Informing
Self-management Engagement (WISE)] for established chronic functional gastrointestinal disorder (FGID)
in primary care and to test clinical effectiveness and cost-effectiveness when translated from research
settings into routine care
l project 2 – to determine how well the WISE model prevented patients with new-onset functional
gastrointestinal problems from developing chronic ill-health.
Issues related to the delivery of project 2 were identified following NIHR monitoring visits, which
acknowledged that recruitment and data quality issues rendered the original plan for project 2 unviable.
The focus on project 2 was therefore modified in discussion with the funder to a focus on identification
and risk assessment.
The description of the research actually conducted in relation to project 2 is provided in Chapter 7.
Chronic gastrointestinal disorders, including inflammatory bowel disease (IBD) and FGID, account for
approximately 8% of the general practice workload in the UK, at an estimated cost of £1B per year.1,2
Around 50% of these consultations are for FGID.2,3
Irritable bowel syndrome (IBS), the most prevalent FGID, comprises chronic physical symptoms [abdominal
pain (AP) and bloating, erratic bowel habit], which remain unexplained after medical exploration.4
Improving management of functional gastrointestinal disorder
Over the last decade, members of the research team have developed therapies for these conditions, using
patient education and self-management.5–15 These have been combined with patient-centred psychological
approaches, such as cognitive–behavioural therapy (CBT) and hypnotherapy.16,17
These findings suggested that:
1. information can be improved to incorporate patient experience and expertise alongside medical
information about management and treatment
2. clinician training in patient-centred consultation skills and shared decision-making with patients is
acceptable and appropriate and leads to positive outcomes
3. health systems that are better aligned to self-management are well received
4. an integrated approach leads to reduced health service utilisation and costs without adverse clinical effect
5. defining the boundaries of care in professional support for self-management is necessary for success.
The results of these studies led us to propose a new integrated WISE model. The WISE model is designed
to enhance well-being by improving patient information, drawing on patients’ existing skills in living with
long-term conditions, training health professionals to support self-management and improving access to
further care. The system is applicable to chronic FGID, such as IBS, and commonalities in the management
of conditions suggest that it may be applicable to other long-term conditions.
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Although existing evidence shows that the WISE model was effective, we also identified two key issues
that required further study:
1. Although results have been demonstrated in research trials, there has been no demonstration that the
results could be achieved when translated from research settings into routine care.
2. Psychological ill-health can adversely influence the chronicity and burden of chronic FGID. Psychological
therapies could be added to the original WISE model to increase effectiveness, but their uptake,
acceptability and cost need to be assessed.
Project 1 research questions
l What is the clinical effectiveness and cost-effectiveness of an intervention to enhance self-management
support for patients with chronic conditions when translated from research settings into routine care?
[Phase IV randomised controlled trial (RCT) and economic evaluation.]
l What are the barriers and facilitators that affect the implementation of the WISE model among patients,
clinicians and organisations? (Process evaluation.)
Patient and public involvement
Our patient and public contributors are named in the Acknowledgements. They guided project delivery
through attendance at Study Steering Group meetings and provided particular assistance around the
challenges of recruiting patients to the project.
INTRODUCTION TO THE PROGRAMME
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Chapter 2 The WISE model of self-management
support
Introduction
Long-term conditions are important determinants of quality of life and health-care costs worldwide.18
Increasing focus has been placed on self-management, defined as:
The care taken by individuals towards their own health and well-being: it comprises the actions they
take to lead a healthy lifestyle; to meet their social, emotional and psychological needs; to care for
their long-term condition; and to prevent further illness or accidents.
Clark et al.19 Copyright © 1991, © SAGE Publications
The Wanless report, Securing our Future Health: Taking a Long-term View, suggested that the future costs
of health care were very much dependent on:
How well people become fully engaged with their own health.20
Wanless20 Contains public sector information licensed under the
Open Government License v3.0
However, realising the potential of self-management requires effective ways of encouraging appropriate
behaviour change in patients and professionals. There are a number of factors influencing self-management,
including patient factors (e.g. lay epidemiology and health beliefs, self-efficacy, emotional responses to
long-term conditions, identity and pre-existing adaptations), and wider influences (such as the organisation
of the health-care system and access to material and community resources).21 A number of models of
self-management have been proposed in the literature, including increasing access to health information5 and
deployment of assistive technologies.22 Patient skills training (through the Chronic Disease Self-Management
Program and its derivatives) can be used to encourage patients to enhance their individual self-management
skills.23,24 There is evidence for the effectiveness of the programme on some outcomes,25 but there are
significant limitations. Intervention ‘reach’ is defined as the:
. . . percentage and risk characteristics of persons who receive or are affected by a policy or program.
Glasgow et al.26 © 1999 American Public Health Association
Interventions with limited ‘reach’ are unable to translate the effectiveness of an intervention at the individual
level to that of the wider population. In the case of the Chronic Disease Self-Management Program,
requirements for self-referral or referral from health-care professionals means that levels of uptake can be
low, and biased towards certain patient groups, threatening reach and equity.
Models of self-management support
Health policy in the UK has worked with a model that organises care for long-term conditions around
three tiers: (1) self-management support for low-risk patients, (2) disease management for patients at
some risk and (3) case management for patients with multiple, complex conditions.27 In the UK, the bulk of
disease management is already delivered through primary care. Primary care is generally defined in terms
of attributes such as a gatekeeping function and first contact care,28–30 but other attributes also make it an
excellent platform for self-management support. Primary care offers open access between the health
service and the population, can deliver continuity of care through an extended personal relationship or
through informational continuity,28–30 and has a role in helping patients achieve care that balances
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compliance with clinical guidelines and consistency with patient needs and preferences. Delivering
self-management support through primary care also maximises reach.
However, there are major barriers to achieving effective self-management support in primary care.
Self-management is only one priority among many facing primary care professionals31 and there is
evidence that many primary care professionals do not see self-management as a core part of their
remit.32,33 This is especially true when incentives (financial and otherwise) are focused on specific clinical
tasks and biomedical parameters.34
Achieving the potential of primary care in delivering self-management
support
Our research team has engaged in a programme of research over a number of years that has explored the
barriers to, and facilitators of, effective self-management support. On the basis of this work, we argue that
self-management support requires the following.
1. A whole-systems perspective that involves interventions at the patient, practitioner and service
organisation levels in the delivery of self-management support. Many self-management interventions
have focused on patient behaviour change or professional training only, but we argue that each level
has a different function in encouraging and supporting self-management behaviour, and that effects
are maximised when interventions occur at all levels and include attention to patient actions outside the
context of contacts with the health service.13,14,35
2. Widening the evidence base to acknowledge a range of disciplinary perspectives on the way in which
patients and professionals respond to, and manage, their long-term conditions. Although psychology has
dominated the design of many interventions for self-management support through models such as self-
efficacy theory, there are a wide range of applied social science theories that can inform an understanding
of the way that patients and professionals understand, respond to and manage long-term conditions.36–38
The model has been designed to reflect these findings and provide a feasible and effective model of
self-management support. The model (Figure 1) aims to support patients to receive guidance from trained
practitioners working within a health-care system geared up to be responsive to patient need.
Patient
Aim
Method
Tools
Relevant
information and
support based on:
• Current need
• Personal priorities
• Negotiated plan
• Assessment
• Sharing decisions
• Supporting change
• Self-care support
   options
• Staff training
• Data on local
   resources
• Patient access to
   support
PRISMS
Menu of options
Management plan
Professional
Provide better
self-care support
Make better use of
self-care support
Changed
professional
response:
PRISMS
Menu of options
Management plan
Computer template
Explanatory model
NHS system
Improve access to
self-care support
Improving:
Computer template
Menu of options
Online directory of
support groups
FIGURE 1 The WISE model. PRISMS, Patient Report Informing Self-Management Support.
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Our approach broadly follows the phased development and evaluation framework outlined for complex
interventions by the Medical Research Council (MRC).39,40 We have developed an evidence base for the
elements of the WISE approach using mixed methodology: a combination of RCTs, nested qualitative
studies and economic evaluation. In summary, the evidence shows that:
l information can be effectively improved to incorporate patient experience and expertise alongside
medical information about management and treatment5,7,41
l clinician training in patient-centred consultation skills and shared decision-making with patients to
guide and support self-management is acceptable and appropriate, and leads to positive outcomes5
l health systems that are better aligned to patient practices of self-management are generally
well received.14,35,42
The WISE model as a complex intervention
Complex interventions are defined as those that:
. . . comprise a number of separate elements which seem essential to the proper functioning of the
intervention although the ‘active ingredient’ of the intervention that is effective is difficult to specify.
Craig et al.39 Copyright © 2008, British Medical Journal Publishing Group
The WISE model, as applied to primary care, met this definition. The intervention was designed to impact
on the patient, professional and system levels (see Figure 1). The primary target of the intervention was the
practice. The overall aim of the intervention was to encourage practices to adopt a structured and patient-
centred approach to the routine management of long-term conditions through providing skills, resources
and motivation to make changes to service delivery in line with the principles of the WISE model (Figure 2).
The development, and evaluation, of the training intervention took place prior to this trial, and details have
been published elsewhere.43 The planned approach to training combines evidence-based approaches to
changing professional behaviour with approaches to ‘normalise’ those behaviours in current practice. The
intervention involved the whole practice and there were also ‘system’ links to the local health organisation,
which provided access to additional resources (including a dedicated website of local groups and
organisations providing self-management support).
Assessment
Shared
decision-making
using
PRISMS tool
Accessing
resources
Feedback
and
ongoing
care
Web-based
information
EPP
Information sources 
and guidebooks
Voluntary sector
Stepped-up care
FIGURE 2 Process of care in the WISE model. PRISMS, Patient Report Informing Self-Management Support.
EPP, Expert Patients Programme.
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The components of the WISE training intervention include the following:
l Priority and agenda setting: an intervention, aimed to promote active patient participation in sharing
their priorities and management preferences, was developed from the existing published literature
and refined in a ‘think aloud’ and qualitative interview study.44 The Patient Report Informing
Self-Management Support (PRISMS) tool was based on a combination of patient-reported outcome
measures and a values clarification exercise, intended to encourage patients to clarify and share values
and priorities of personal importance.45,46 The PRISMS tool is intended as a starting point for discussion
of patient priorities.
l Patient-centred information: information can be effective when it incorporates patient experience and
expertise alongside medical information about management and treatment, and when it is given in a
supportive and timely manner.10
l Shared decision-making: shared decision-making about the appropriate type of self-management
support, supported by PRISMS and by the use of appropriate ‘explanatory models’. Patients’
explanations and understanding of a condition often differ from the medical model. Explanatory
models are ways to make sense of problems and encourage discussion about the causes and
consequences of their condition.
l Referral to community groups: to promote a whole-system approach to self-management, it is essential
to engage with relevant community resources. Referral to third-sector providers (i.e. voluntary and
community organisations) from primary care has clinically relevant benefits.47 These groups provide
services that are embedded within local community settings to help normalise health-related activities
into everyday life. Despite the potential benefits of referral to third-sector providers, there remains an
underutilisation of these services by primary care as practitioners report lack of knowledge of the
services available. To promote the system change necessary between primary care and relevant
third-sector providers, an online database of local self-management support options was developed.
Practice-based training sought to teach the following core skills to primary care staff:
1. Assessment of the individual patient’s self-management support needs, in terms of their current
capabilities and current illness trajectory.
2. Shared decision-making about the appropriate type of self-management support based on that
assessment (e.g. support from primary care, written information sources, long-term condition support
groups or condition-specific education), facilitated by the PRISMS tool and the use of explanatory models.
3. Facilitating patient access to support. This may involve signposting patients to various resources depending
on the outcomes of the assessment and shared decision-making processes. These may include access to
the Expert Patients Programme, disease-specific courses (such as pulmonary rehabilitation) or generic
support (such as befriending). The training encompasses ways that health professionals can negotiate
with patients about the more appropriate use of health care.
4. In the case of IBS, this may also involve referral to psychological treatment services (CBT and hypnotherapy)
for eligible patients (so-called ‘stepped-up care’). Patients with IBS were informed of the possibility of
referral to such services through information leaflets.
As part of the training, primary care professionals received specific assistance in development of the core
WISE skills, followed by integration of techniques through role play (with individualised performance
feedback based on that role play).48 The intervention was delivered over two sessions. All relevant staff
within the practice were invited to the first session, including general practitioners (GPs), nurses, practice
managers and reception staff. Clinical staff were invited to the second session (Box 1). A short intermediate
meeting was held between the two main sessions to review progress, and involved the nominated practice
lead only.
THE WISE MODEL OF SELF-MANAGEMENT SUPPORT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
6
A training manual was given to all of those who participated in the training for use within the training
session and to support practice (see Appendix 1). The training was piloted and modified on the basis of
the pilot. The intervention was conducted by trained facilitators working alongside the research team,
rather than the research team itself, to test a model of delivery that would be feasible in routine practice
and wider implementation.
Enhancement of the WISE model with psychological therapies
Our previous studies had identified a residual group (up to 20%) who fail to benefit and who show high
levels of psychological ill-health despite the use of the WISE model.
Evidence demonstrates that physical and psychological factors have an impact on symptom chronicity in
patients with chronic gastrointestinal disorders, not only in patients with FGID49 but also in patients with
IBD.50 Such psychological components, particularly anxiety and depression, are important determinants of
clinical outcome and health resource use. Although there are limited studies investigating effectiveness of
BOX 1 Training sessions
Session 1
The first session is delivered to the whole practice by two trainers employed by the PCT who are familiar
with primary care. The session involves clinicians, the practice manager and administrative staff and has the
following structure:
l brief introduction to the WISE model
l team-building exercise
l exercise on care pathways for patients with long-term conditions
l WISE tools – PRISMS, explanatory models and menu of local support
l interactive discussion
l nomination of practice member to lead on implementation.
Intermediate meeting
This session is a short meeting between the trainers and the nominated practice lead to discuss progress with
the WISE approach since session 1.
Session 2
This session is delivered by two trainers to all clinicians in the practice team. Through the use of role play and
clinical discussion, the training focuses on embedding the three core skills: (1) assessment of self-management
needs and capabilities, (2) shared decision-making and (3) facilitating patient access to support into primary
care consultations. The session has the following structure:
l introduction and provision of manual
l reflection on competencies
l demonstration of skills to support self-management
l skills practice
l discussion on how to ensure sustainability of the WISE model.
PCT, primary care trust.
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psychological interventions for all FGID, the most common of these disorders (IBS) has been subject to a
number of trials. In a systematic review and meta-analysis of the efficacy of psychological treatment for IBS,
there was a 50% reduction in symptoms.51 Our own studies have shown that psychological treatments are
of value in chronic gastrointestinal problems.52 Given the clear evidence of the clinical efficacy of CBT in
common mental health problems,53 current best evidence would suggest that either CBT or hypnotherapy
would be of utility. We therefore offered both in addition to treatment by the GP.
Cognitive–behavioural therapy
We developed a 12-week CBT intervention comprising an initial assessment of between 60 and 90 minutes,
followed by up to 11 weekly, individual, face-to-face sessions of between 45 and 60 minutes. Session 1
consisted of a patient-centred assessment for problem identification, risk assessment and development of a
shared problem formulation. The following sessions involved education about the condition and specific
CBT techniques (pacing, behavioural activation, diary keeping, identifying and challenging negative and
unhelpful thinking patterns, and the development of a longer-term management plan). Participants received
a self-management manual with information about IBS, CBT and ‘patient stories’ typical of people’s
experience of IBS and how to manage their symptoms.
Hypnotherapy
Gut-focused hypnotherapy consists of giving patients ideas about how the gastrointestinal system works
and then using hypnosis to try and control abnormalities of gut function as well as dealing with any other
factors that might exacerbate their condition. All sessions last 45–60 minutes on a weekly basis for up to
12 weeks, with the first consisting of an assessment of the patient and their symptom profile, followed by
an ‘educational’ tutorial on simple gut physiology and how it might be controlled. Subsequent sessions
involve the introduction of relaxation and hypnosis in general, followed by progressively more emphasis
being placed on control of gut symptoms by the use of imagery or tactile techniques. All patients are given
a compact disc to practise on a regular, preferably daily, basis.
The CBT therapist was an experienced and accredited therapist with the British Association for Behavioural
& Cognitive Psychotherapies. A 2-day training workshop, provided by the trial team, consisted of a range
of presentations about IBS and applying CBT interventions for people with IBS, with a focus on skills
practice. The training was accompanied by a training handbook. The hypnotherapist had been previously
fully trained and had been working for 2 years in the local hypnotherapy unit. CBT supervision was
provided to the therapist on a fortnightly basis by applicant Karina Lovell (an experienced and accredited
CBT therapist). Supervision for the hypnotherapist was provided on a regular basis by applicant Peter
Whorwell (an experienced hypnotherapist).
Procedure
Initial and follow-up sessions
Following GP referral, the therapist contacted the participant to arrange the initial session at a convenient
time. Each potential patient was given an information sheet prior to the first meeting, and those who
agreed to take part signed a consent form to allow access to the self-reported measures (Patient Health
Questionnaire-9 and Generalised Anxiety Disorder-7). Treatment sessions were delivered in a range of
primary care settings, including practices.
The low-intensity aspects of WISE were rolled out from April 2009 and patients with a history of IBS who
did not benefit from the WISE low-intensity intervention after 3 months were then given information
about different step-up options by their GP or practice nurse. Following discussion with their GP, patients
were directly referred to a therapy.
THE WISE MODEL OF SELF-MANAGEMENT SUPPORT
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Recruitment
At the start of the project, both therapists identified the need to introduce themselves to the practices
that could potentially refer to step-up, and, when possible, this took place. The aim of these meetings
was to educate the practice team about the CBT and hypnotherapy treatments and to reiterate the
referral protocol.
However, as a result of the low uptake of step-up via this route, alternative recruitment strategies were
developed. This included building a relationship with the local primary care mental health teams in Salford
that sought to promote the step-up with the relevant GP practices and facilitated a number of referrals.
In addition, an individual letter to every GP in a WISE-trained practice was sent in March 2010, advising
GPs about the availability of step-up for their IBS patients. In May 2010, in recognition that the referral
rate to step-up remained very low, a leaflet describing the CBT/hypnotherapy options was produced in
conjunction with NHS Salford Primary Care Trust (PCT); > 200 leaflets were then directly mailed to patients
known to the trial. The step-up treatments were regularly advertised in WISE communications (e-mails and
newsletters), and a poster advertising the availability of CBT or hypnotherapy for IBS sufferers was also
displayed in patient waiting areas in WISE-trained surgeries.
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Chapter 3 Design of the randomised
controlled trial
The research question was:
What is the clinical effectiveness and cost-effectiveness of an intervention to enhance self-management
support for patients with chronic conditions when translated from research settings into routine care?
(Phase IV RCT and economic evaluation.)
The initial iteration of the MRC framework for the development of complex interventions suggested five
phases: preclinical and Phases I–IV. Phase III involves comparing ‘a fully defined intervention with an
appropriate alternative’ in the context of an appropriately powered RCT. The RCTs completed in the
development and initial testing of the WISE model can be considered to be Phase III.
Phase IV has received the least attention of all aspects of the framework.54 The initial guidance suggested
that it concerns replication of Phase III outcomes ‘in uncontrolled settings’. Recent exploration of the
differences between Phase III and IV studies suggest other important differences, including:
l Phase IV RCTs being based on Phase III evidence
l broad patient inclusion criteria based on those for the clinical service
l randomisation at the service level
l outcomes often collected using routine data
l uptake of the intervention is a crucial variable
l the implementation of the service is an important part of reporting.
Many of these were present in the study, although not all. For example, measures of self-management and
health-related quality of life (HRQoL) are not available in routine data and had to be collected.
Methods
The trial was a pragmatic, two-arm, practice-level cluster Phase IV RCT evaluating outcomes and costs
associated with the WISE model (Figure 3). The study was approved by the Salford and Trafford local
Research Ethics Committee (reference number 09/H1004/6). We include a summary of the main outcomes
of the RCT in this report. A full publication is available elsewhere.55 The Consolidated Standards of
Reporting Trials (CONSORT) checklist is provided in Appendix 2.
Research question
What is the clinical effectiveness and cost-effectiveness of an intervention to enhance self-management
support for patients with chronic conditions when translated from research settings into routine care?
(Phase IV RCT and economic evaluation.)
Population
The general practice was the cluster and, in line with the Phase IV study design, we aimed to involve all
practices in a local ‘health economy’ in the UK. The context was a PCT in Salford, in north-west England.
The organisation had a strong commitment to supporting self-management, viewing this as part of a
strategic approach to improving the health and well-being of the population. This study took place
between 2009 and 2012.
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The WISE model is designed to be robust and adaptable enough to use with the vast majority of patients
with a long-term condition. We recruited patients with three long-term conditions: diabetes, chronic
obstructive pulmonary disease (COPD) and IBS. The particular conditions to be included were chosen
on the basis of a number of theoretical, policy and practical criteria, and they have important similarities
and differences. Each condition is amenable to self-management interventions, and there is already a
significant evidence base that will facilitate comparison of the effects of the WISE model with alternatives.
The conditions are also of sufficiently high prevalence within practices to meet the sample size needs
of the proposed trial. The conditions also have important differences in symptoms, experience and
management. IBS is a more ‘contested’ condition with greater disagreement about diagnosis and
appropriate management. The management of both diabetes and COPD is also incentivised in the UK
under the Quality and Outcomes Framework (QOF), whereas IBS is not.
As a Phase IV RCT, the inclusion criteria were simple and broad to enhance the external validity of
the study.
l Patients had a clinical diagnosis of COPD, diabetes or IBS, identified from existing primary care systems
using appropriate clinical registers (for COPD and diabetes) and Read Codes (for IBS), and verified by
primary care professionals.
l Patients also had to demonstrate sufficient English to be able to complete questionnaires.
l The practice had to agree that the patient was appropriate for research assessment.
Exclusion criteria included patients in the palliative care stage of condition or the presence of mental health
problems that reduced capacity to consent and participate.
Recruitment of practice pair
Randomisation of practice pair
Identification of existing COPD,
diabetes and IBS patients
Baseline assessment of existing
patients 
Intervention group
Training of practice
Usual care
Training of practice
Delivery of WISE to
existing patients
6- and 12-month
assessments 
6- and 12-month
assessments 
FIGURE 3 Planned trial design. COPD, chronic obstructive pulmonary disease.
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Patients who had two or more of our index conditions, or a single index condition and another long-term
condition, were still included in the trial. Where a patient was identified as having two or more of the
three conditions, clinical staff in the practice were asked to determine the main condition, in order to assist
with appropriate outcome measurement (see Outcomes).
Intervention
The intervention was described in detail in Chapter 2.
Intervention practices received training as soon as possible after baseline data collection and subsequent
allocation; control practices received training 1 year later. Training was undertaken in two sessions,
with the second session approximately 1 month after the first. Practices were asked to select two WISE
champions (a health-care professional and a member of the administration team) to help embed the WISE
approach in the practice (a short mid-training session for them with the trainers was made available).
Outcomes
All outcomes were at the level of the individual patient. Each practice sent eligible patients a questionnaire
at baseline, to be returned directly to the research team. Follow-up questionnaires were sent at 6 and
12 months.
The primary end point was the 12-month follow-up of patient health outcomes and costs.
The trial had three primary outcomes, all at 12 months:
1. shared decision-making (short-form Health Care Climate Questionnaire)56
2. self-efficacy (confidence to undertake chronic disease management)57
3. generic HRQoL [EuroQol-5 Dimensions (EQ-5D)].58,59
These outcomes represent core measures along the ‘causal pathway’ from intervention to
health outcomes.
The study also collected a number of secondary outcomes, including disease-specific quality of life,
self-management behaviours, service utilisation, empowerment, general health, social/role limitations,
well-being and vitality. These are all detailed at URL: www.bmj.com/content/bmj/suppl/2013/05/13/
bmj.f2882.DC1/kena009790.ww2_default.pdf (accessed 26 October 2017).
There was no blinding of patients or outcome assessors, although all outcomes were self-report.
The analyst remained blind to allocation.
Design
The study was a pragmatic cluster RCT using a waiting list control (see Figure 3). The intervention was
designed to impact on all primary care staff in a practice, thus randomisation was at the level of the
practice to avoid contamination.
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Practice recruitment and randomisation
Practices were recruited via practice visits and asked to identify their preferred time during the year
for training. Practices were paired as closely as possible according to their preferred times, and using a
minimisation procedure, one practice in each pair was allocated to training in the first year, with the
other practice allocated to training at the same time the following year. Research staff recruiting practices
were unaware of the next allocation in the sequence at the time of recruitment. Baseline (and subsequent
follow-up) data collection then took place at both practices in a pair at the same time. This ensured a
balance between the intervention and control groups, to avoid potential bias from changes to care delivery
outside the trial context (e.g. new government policy or local system changes on the management of
long-term conditions).
The practice (cluster) pairs were allocated – one to the intervention group and the other to the control
group – using a minimisation algorithm by the trial statistician. Minimisation variables were practice size,
practice deprivation [as measured by the Index of Multiple Deprivation (IMD)] and practice contractual
arrangements (i.e. general medical services or personal medical services). This ensured that, barring
attrition, the two arms of the trial would have equal numbers of practices and be balanced on the
minimisation variables and data collection timeline.
After practice pairing and allocation, potentially eligible patients at each intervention and control group
practice were identified from the computer systems and checked for eligibility to be contacted by practice
clinical staff.
Sample size
Sample size calculations were made on the basis of data collected from the national evaluation of the
Expert Patients Programme. Although all three patient groups were combined in the primary analysis
(see Analysis), we powered the trial to detect a fairly small effect of the intervention on diabetes, COPD
and IBS separately. Data on outcomes from the national evaluation of the Expert Patients Programme had
a range of intraclass correlation coefficients from 0.01 to 0.07. For the power calculations, we assumed
an intraclass correlation coefficient of 0.05. Baseline follow-up correlations were taken to be 0.6, that is,
towards the lower end of those found in the Expert Patients Programme. On these assumptions, each arm
of the trial required 18 practices and 36 patients per condition per practice, to achieve 80% power to
detect an effect size of 0.21 per condition. To allow for attrition of practices (estimated to be around
10%), we aimed to recruit 20 practices into each arm of the trial. Questionnaires were to be sent to
80 patients per practice with each condition. For each of the three conditions, this aimed to provide, on
average, 48 patients per practice at baseline, reducing to 36 patients at 12 months. We recognised that
smaller practices might not have 80 patients with COPD, in which case we compensated by recruiting
additional patients from larger practices. On the basis of the above, we aimed to recruit totals of
1728 patients with diabetes, 1728 with COPD and 1728 with IBS.
Analysis
Analysis followed a prespecified analysis plan. Each outcome was subjected to analysis of covariance
within a multilevel (patients within practices) regression framework, following intention-to-treat principles
and with the analyst (applicant DR) blind to practice allocation. Although we powered the study to detect
effects for separate conditions, we maximised power and minimised multiple testing in the analysis by
testing for a treatment effect across all three condition groups combined, and for an interaction between
trial arm and condition group (controlled for the main effects of condition group). This analysis also
controlled for baseline values of each outcome, design factors (practice list size, deprivation and contractual
type), and additional covariates (see Process evaluation).
DESIGN OF THE RANDOMISED CONTROLLED TRIAL
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In the case of a statistically non-significant (p > 0.05) interaction between trial arm and condition group,
no further condition-specific analyses would be conducted; if the interaction term were significant, this
would imply that the effect varied by condition and further analyses would be conducted for each separate
condition group.
We applied multiple imputation (five imputed data sets) to baseline variables with missing values (all < 5%),
using chained equations and all variables in the model. We did not impute missing follow-up data, but used
multivariate logistic regression to identify baseline covariates predictive of missing data and included these
(disease condition, age, general health, deprivation index and home ownership) as covariates. Additional
prespecified covariates included gender, comorbid conditions count, education and primary care visits
6 months prior to baseline.
Sensitivity analyses assessed the stability of the results to the model specification. All analyses used
Stata® v12 (StataCorp LP, College Station, TX, USA) and an alpha value of 5%. For outcome variables with
skewness or kurtosis values of ≥ 1.0, confidence intervals (CIs) and p-values were derived using standard
errors based on 100 bootstrapped samples.
The trial included an economic analysis to compare the costs and outcomes for the trial arms (see Chapter 5
for details of the health economic analysis).
Process evaluation
A process evaluation was designed to complement and provide additional information concerning the
trial.60 Details about the process evaluation and accompanying qualitative study are included in Chapter 6.
Changes to original protocol
The size and complexity of the evaluation meant that it was extremely challenging to implement, and
initial delivery of the intervention and research components faced a number of barriers that led to a
number of minor changes to the original protocol. We detail these changes and their potential threats to
internal and external validity in the following sections.
Single health economy
Our aim was to deliver the proposed intervention across all practices in a single PCT to assess an
intervention effect across a complete health economy. Although we were able to recruit 32 practices
in Salford (73% response rate), this did not give us the desired level of statistical power. We therefore
spread our recruitment to a neighbouring PCT (Bury). This area has a similar socioeconomic profile
and the overall spread of IMD scores across practices is quite similar to Salford (4.5–65.5 compared with
6.6–77.2). In addition, the two trusts shared the same chief executive and both are part of a north-west
self-management initiative.
However, some aspects of the whole-system intervention detailed previously were not available, such as
existence of a dedicated self-management education team and availability of certain community-based
support schemes. Differences in the financial arrangements between trusts also meant that we were
unable to offer the intervention to control group practices in Bury PCT after 12 months.
Selection of patients before practice allocation
One of the threats to the validity of a cluster randomised trial is recruitment bias, where professionals
allocated to different trial arms recruit differently depending on their allocation, leading to selection
bias and baseline incomparability.61 It is preferable in these cases to recruit patients prior to allocation.
Although this was our intention, in the event we found that practices required adequate advance notice of
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their training date; hence it became necessary to inform them of their group allocation prior to patient
selection. This does raise the possibility of bias, but we are confident that such bias was small. Initial
patient selection was via existing disease registers and Read Codes; therefore, the only way practices could
influence recruitment was to request exclusion of a patient after they had been identified through these
methods. These exclusions represented a relatively small proportion of patients (11% control and 15%
intervention with COPD, 10% and 11%, respectively, for diabetes and 18% and 11%, respectively,
for IBS).
Baseline sampling and assessment
Response rates from patients at the practices first to enter the trial were considerably lower than originally
expected. In view of this, we made a number of adjustments to improve response. To ensure the patient
numbers required for our target level of statistical power, we increased the number of patients surveyed to
include all eligible patients at each practice, up to a maximum of 200 per condition (selected at random
where this applied). Very few practices had > 200 patients for any condition; hence the study became, in
effect, a total population survey. In addition, we introduced a financial incentive to patients for returning a
completed questionnaire. We also took the decision to change the baseline questionnaire to focus on a
smaller number of core variables. The main effect on the trial of the shortened baseline questionnaire is to
reduce our scope for analysis of baseline moderators of treatment effect. However, such analyses are
always secondary to the primary intention-to-treat analysis.
Long-term follow-up
Although the original protocol planned for implementation of the model in usual-care practices and a
further follow-up at 24 months to assess long-term effects, delays to the project and the lack of effect
demonstrated (see Chapter 4) meant that a longer-term follow-up was not possible or appropriate.
DESIGN OF THE RANDOMISED CONTROLLED TRIAL
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Chapter 4 Results
F igure 4 presents the trial CONSORT flow diagram. Practice recruitment from the main PCT(32 practices) fell short of the 40 required to ensure full power. We therefore included additional
practices from an adjoining PCT with a very similar demographic profile, resulting in a final total of
44 practices randomised. Three practices randomised to the intervention group withdrew prior to data
collection, leaving 19 intervention and 22 control practices.
Baseline characteristics of the study participants
A total of 5599 patients (n = 2546 diabetes, n = 1634 COPD and n = 1419 IBS) were recruited, representing
43% of the eligible population. Just over half the sample were female (53.5%) and around half (50.8%)
were aged ≥ 65 years (Table 1). Very few (3.4%) were non-white. The great majority (72.5%) had more than
one long-term condition, and 23% had visited their GP five times or more in the 6 months prior to the study.
Enrolment
Practices 
(n = 51)
  Excluded:
  • Not eligible due to involvement 
     in pilot, n = 2
  • Not eligible due to shared staff 
     or patient list, n = 6
  • Practices declined, n = 11
• Practices to control, n = 22
• Practices provided patients, n = 22 
• Invited (diabetes, COPD and IBS), n = 7475 
• Consented to baseline, n = 3304; 44.2% 
• Practices intervention, n = 22
• Practices withdrew prior to training 
   and provided no patients, n = 3
• Invited (diabetes, COPD and IBS), n = 5578 
• Consented to baseline, n = 2295; 41.1%
6 months: patients, n = 1844 (80.3%)
12 months: patients, n = 1649 (71.9%)
6 months: patients, n = 2689 (81.4%)
12 months: patients, n = 2427 (73.5%)
Allocation
Analysis
Responses at 12-month follow-up:
Responded, n = 1649; 71.9% 
Follow-up
6 months
Follow-up
12 months
Responses at 6-month follow-up:
Responded, n = 2689; 81.4% 
Responses at 12-month follow-up:
Responded, n = 2427; 73.5% 
Responses at 6-month follow-up:
Responded, n = 1844; 80.3% 
Additionally recruited:
• Practices, n = 12
Practices randomised
(n = 44) 
Practices (n = 22, n = 2295 patients) Practices (n = 22, n = 3304 patients)
Mean cluster size = 151; range = 24 – 296Mean cluster size = 121; range = 8 – 259
FIGURE 4 The CONSORT flow diagram for the trial.
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TABLE 1 Baseline characteristics of participants
Characteristic
Trial arm
Total (N= 5599)Usual care (N= 3304) WISE model (N= 2295)
Main chronic condition, n (%)
Diabetes 1486 (45.0) 1060 (46.2) 2546 (45.5)
COPD 1009 (30.5) 625 (27.2) 1634 (29.2)
IBS 809 (24.5) 610 (26.6) 1419 (25.3)
Gender, n (%)
Female 1728 (52.4) 1262 (55.1) 2990 (53.5)
Male 1573 (47.7) 1030 (44.9) 2603 (46.5)
Age group (years), n (%)
< 50 540 (16.4) 431 (18.9) 971 (17.5)
50–64 1039 (31.6) 730 (32.0) 1769 (31.8)
65–74 948 (28.9) 627 (27.5) 1575 (28.3)
≥ 75 757 (23.1) 492 (21.6) 1249 (22.5)
Number of chronic conditions, n (%)
None or one 909 (27.5) 628 (27.4) 1537 (27.5)
Two 999 (30.3) 709 (30.9) 1708 (30.5)
Three 780 (23.6) 532 (23.2) 1312 (23.4)
Four or more 615 (18.6) 426 (18.6) 1041 (18.6)
Accommodation, n (%)
Owner–occupier 2164 (66.2) 1498 (66.2) 3662 (66.2)
Renting 1106 (33.8) 765 (33.8) 1871 (33.8)
Education, n (%)
No qualifications 1044 (31.6) 699 (30.5) 1743 (31.1)
School-level qualifications 362 (11.0) 250 (11.0) 612 (10.9)
Professional or vocational 949 (28.7) 649 (28.3) 1598 (28.5)
Bachelor’s degree or higher 198 (6.0) 157 (6.84) 355 (6.3)
Missing 751 (22.7) 540 (23.5) 1291 (23.1)
IMD, mean± SD 30.7 ± 20.0 28.9 ± 18.1 30.0± 19.3
GP visits in prior 6 months, n (%)
None 407 (12.9) 265 (12.1) 672 (12.6)
1 or 2 1215 (38.4) 881 (40.3) 2096 (39.2)
3 or 4 808 (25.5) 545 (24.9) 1353 (25.3)
5 or 6 448 (14.2) 264 (12.1) 712 (13.3)
≥ 7 287 (9.1) 233 (10.7) 520 (9.7)
Ethnicity, n (%)
White 3167 (96.4) 2207 (97.0) 5374 (96.7)
Not white 117 (3.6) 69 (3.0) 186 (3.4)
RESULTS
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The two trial arms were well balanced on all variables at the patient level, although practices in the
intervention group were, on average, slightly smaller (mean list size of n = 4003 patients compared
with n = 4528).
Engagement with training
Practice staff attendance rates at the training sessions were generally high: 90% of eligible staff attended
session 1 (n = 179) and 82% (n = 85) attended session 2. Training was rated positively (mean score of
> 2.5 on a 5-point scale) by 76% of session 1 participants and by 89% of session 2 participants.
Implementation of training
This is detailed in Chapter 6.
Implementation of step-up therapies
Generally, implementation was limited. In total, 94 referrals were received for step-up therapies,
36 referrals for CBT and 58 referrals for hypnotherapy.
Analysis
With one exception, no statistically significant differences were found between patients attending
WISE-trained practices and those attending control practices on any primary or secondary outcome
(Table 2). The exception was shared decision-making at the 6-month follow-up (p = 0.05), and the
difference favoured the control group.
TABLE 1 Baseline characteristics of participants (continued )
Characteristic
Trial arm
Total (N= 5599)Usual care (N= 3304) WISE model (N= 2295)
Shared decision-making, mean ± SD 76.7± 24.0 75.7 ± 24.4 76.3± 24.1
Self-efficacy score, mean± SD 71.1± 23.0 70.5 ± 23.5 70.8± 23.2
HRQoL, mean ± SD 0.6 ± 0.3 0.6 ± 0.3 0.6 ± 0.3
General health, mean± SD 41.4± 23.7 41.2 ± 24.2 41.3± 23.9
Practice variables
Number of practices 22 19 41
Practice list size, mean± SD 4528 ± 2591 4003 ± 2211 4285± 2407
Practice IMD, mean ± SD 37.9± 21.9 40.6 ± 19.6 39.1± 20.6
Contract type, n (%)
General medical services 14 (63.6) 11 (57.9) 25 (61.0)
Personal medical services 8 (36.4) 8 (42.1) 16 (39.0)
SD, standard deviation.
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All effect size estimates were very small with narrow 95% CIs and well below the minimally important
difference of 0.2 that the trial was powered to detect (Figure 5). The lack of effect applied equally to the
intermediate outcomes of shared decision-making, self-efficacy, enablement and self-care activity – which
might reasonably be expected to be most directly affected by increased support for self-management – as
it did to health-related outcomes. Furthermore, none of the interactions between intervention group and
condition group was significant; therefore, we conducted no condition-specific analyses in accordance with
the analytic plan. Sensitivity analyses provided no evidence that the results were substantively influenced by
model assumptions.
TABLE 2 Summary of analyses of covariance
Outcomea
Trial arm, unadjusted
analyses (mean± SD; n) Adjusted mean
difference
(95% CI)b
Effect size
(95% CI)c p-value
p-value for
interaction
with condition
groupdUsual care WISE model
Primary outcomes
Shared
decision-making
69.1± 26.3;
2379
67.7 ± 27.7;
1626
–0.47
(–2.55 to 1.61)
–0.02
(–0.11 to 0.07)
0.657 0.696
Self-efficacy score 71.2± 22.5;
2394
70.4 ± 22.8;
1611
–0.35
(–1.42 to 0.71)
–0.02
(–0.06 to 0.03)
0.519 0.205
HRQoL 0.6 ± 0.3;
2382
0.6 ± 0.3;
1609
–0.00
(–0.02 to 0.01)
–0.01
(–0.05 to 0.04)
0.724 0.305
Secondary outcomes
General health 41.7± 24.8;
2413
42.2 ± 25.8;
1643
0.28
(–1.37 to 0.82)
0.01
(–0.03 to 0.06)
0.621 0.884
Social/role
limitations
63.3± 31.1;
2408
62.8 ± 32.3;
1638
–0.49
(–1.95 to 0.96)
–0.02
(–0.06 to 0.03)
0.505e 0.436e
Energy/vitality 46.8± 20.9;
2411
46.2 ± 21.8;
1638
–0.42
(–1.53 to 0.69)
–0.02
(–0.07 to 0.03)
0.456 0.332
Self-care activity 42.4± 14.6;
2382
42.5 ± 14.9;
1613
0.01
(–0.95 to 0.97)
0.00
(–0.06 to 0.07)
0.977 0.960
Psychological
well-being
64.7± 21.9;
2412
64.7 ± 22.2;
1640
0.49
(–0.75 to 1.73)
0.02
(–0.03 to 0.08)
0.436 0.303
Enablement 78.6± 28.8;
2365
80.7 ± 28.3;
1624
0.85
(–1.36 to 3.06)
0.03
(–0.05 to 0.11)
0.450e 0.948e
Shared
decision-making
(6 months)
70.3± 26.1;
2658
68.3 ± 27.3;
1818
–1.77
(–3.53 to 0.0)
–0.07
(–0.15 to 0.0)
0.050f 0.065
g
Self-efficacy
(6 months)
71.1± 22.5;
2659
70.4 ± 23.1;
1816
–0.70
(–1.69 to 0.29)
–0.03
(–0.07 to 0.01)
0.168 0.316
HRQoL (6 months) 0.6 ± 0.3;
2646
0.6 ± 0.3;
1803
0.00
(–0.01 to 0.01)
0.00
(–0.04 to 0.05)
0.862 0.824
Self-care activity
(6 months)
42.5± 14.6;
2645
42.7 ± 15.0;
1813
0.03
(–0.88 to 0.93)
0.00
(–0.06 to 0.06)
0.955 0.776
SD, standard deviation.
a Outcome at 12 months unless otherwise stated.
b Difference in group means after adjustment for model factors and covariates.
c Adjusted group difference divided by the within-practice SD.
d p-value for test of whether or not the intervention effect varies by disease condition group (intervention by condition
group interaction).
e p-value based on boot-strapped variance estimates.
f Non-significant (p= 0.1) in analysis of sensitivity to exposure.
g Significant in analysis of sensitivity to covariates (p= 0.04) and sensitivity to exposure (p = 0.018).
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We repeated the analysis for the IBS sample of 1419 patients, of whom 1119 (79%) completed 6-month
follow-up and 1004 (71%) completed 12-month follow-up. Table 3 gives the baseline characteristics for
the IBS participants. The analysis, again, found no statistically significant differences between groups on
any primary or secondary outcome (Table 4).
– 0.30 – 0.20 – 0.10 0.00 0.10 0.20
Usual care better Effect WISE model better
0.30
Self-care activity at 6 months
HRQoL at 6 months
Self-efficacy at 6 months
Shared decision-making at 6 months
Enablement
Well-being
Self-care activity
Energy/vitality
Social/role limitations
General health
HRQoL
Self-efficacy
Shared decision-making
FIGURE 5 Forest plot of standardised effect sizes (vertical bars indicate minimally important differences).
TABLE 3 Baseline characteristics of IBS participants
Characteristic
Trial arm
Total (N= 1419)Usual care (N= 809) WISE model (N= 610)
Gender, n (%)
Female 626 (77.4) 478 (78.5) 1104 (77.9)
Male 183 (22.6) 131 (21.5) 314 (22.1)
Age group (years), n (%)
< 50 333 (41.2) 295 (48.6) 628 (44.4)
50–64 264 (32.7) 195 (32.1) 459 (32.4)
65–74 years 130 (16.1) 81 (13.3) 211 (14.9)
≥ 75 81 (10.0) 36 (5.9) 117 (8.3)
Number of chronic conditions, n (%)
None or one 323 (39.9) 251 (41.2) 574 (40.5)
Two 237 (29.3) 198 (32.5) 435 (30.7)
Three 164 (20.3) 93 (15.3) 257 (18.1)
Four or more 85 (10.5) 68 (11.2) 153 (10.8)
continued
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TABLE 3 Baseline characteristics of IBS participants (continued )
Characteristic
Trial arm
Total (N= 1419)Usual care (N= 809) WISE model (N= 610)
Accommodation, n (%)
Owner–occupier 561 (69.6) 456 (75.9) 1017 (72.3)
Renting 245 (30.4) 145 (24.1) 390 (27.7)
Education, n (%)
No qualifications 142 (17.6) 99 (16.2) 241 (17.0)
School-level qualifications 115 (14.2) 99 (16.2) 214 (15.1)
Professional or vocational 276 (34.1) 208 (34.1) 484 (34.1)
Bachelor’s degree or higher 86 (10.6) 65 (10.7) 151 (10.6)
Missing 190 (23.5) 139 (22.8) 329 (23.2)
IMD, mean± SD 27.7± 19.2 25.3± 16.1 26.7 ± 17.9
GP visits in prior 6 months, n (%)
None 91 (11.7) 81 (13.8) 172 (12.6)
1 or 2 303 (38.9) 237 (40.4) 540 (39.6)
3 or 4 217 (27.9) 134 (22.9) 351 (25.7)
5 or 6 98 (12.6) 77 (13.1) 175 (12.8)
≥ 7 70 (9.0) 57 (9.7) 127 (9.3)
Ethnicity, n (%)
White 776 (96.4) 593 (97.9) 1369 (97.0)
Not white 29 (3.6) 13 (2.2) 42 (3.0)
Shared decision-making, mean± SD 71.9± 25.9 71.9± 24.6 71.9 ± 25.3
Self-efficacy score, mean± SD 70.2± 22.8 70.8± 22.3 70.4 ± 22.6
HRQoL, mean ± SD 0.7 ± 0.3 0.7± 0.3 0.7 ± 0.3
General health, mean± SD 3.0 ± 1.0 3.0± 0.9 3.0 ± 1.0
Practice variables
Number of practices 21 19 40
Practice list size, mean± SD 4654 ± 2586 4003± 2211 4345 ± 2407
Practice IMD, mean ± SD 36.1± 20.7 40.6± 19.6 38.2 ± 20.1
Contract type, n (%)
General medical services 14 (66.7) 11 (57.9) 25 (62.5)
Personal medical services 7 (33.3) 8 (42.1) 15 (37.5)
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TABLE 4 Summary of analyses of covariance, IBS participants only
Outcomea
Trial arm, unadjusted analyses
(mean± SD; n)
Adjusted
mean
difference
(95% CI)b
Effect size
(95% CI)c p-valueUsual care WISE model
Primary outcomes
Shared decision-making 66.0± 27.7; 560 64.5± 27.7; 431 0.60
(–3.17 to 4.38)
0.03
(–0.13 to 0.19)
0.755
Self-efficacy score 70.6± 20.9; 563 71.9± 21.0; 420 0.96
(–0.88 to 2.80)
0.04
(–0.04 to 0.12)
0.305
HRQoL 0.7± 0.3; 564 0.7 ± 0.3; 423 0.01
(–0.02 to 0.04)
0.03
(–0.06 to 0.12)
0.521
Secondary outcomes
IBS-specific quality of life 80.3± 22.4; 536 81.8± 21.9; 403 2.07
(–0.46 to 4.59)
0.07
(–0.02 to 0.16)
0.109d
General health 3.0± 1.0; 570 3.0 ± 1.0; 432 0.02
(–0.06 to 0.11)
0.02
(–0.06 to 0.11)
0.588
Social/role limitations 68.1± 29.6; 569 69.2± 29.7; 428 1.14
(–1.76 to 4.04)
0.04
(–0.06 to 0.13)
0.441d
Energy/vitality 47.6± 20.0; 568 47.3± 21.5; 431 0.40
(–1.73 to 2.53)
0.02
(–0.08 to 0.12)
0.714
Self-care activity 42.4± 15.8; 558 42.1± 16.1; 423 0.02
(–1.97 to 2.02)
0.00
(–0.13 to 0.14)
0.983
Psychological well-being 61.1± 22.4; 569 61.3± 22.0; 432 1.21
(–1.22 to 3.65)
0.06
(–0.06 to 0.17)
0.329
Enablement 81.0± 28.2; 556 82.8± 26.4; 426 1.06
(–2.23 to 4.36)
0.04
(–0.08 to 0.15)
0.528d
IBS-specific quality of life
(6 months)
80.7± 22.4; 598 82.3± 22.5; 454 1.66
(–0.61 to 3.93)
0.06
(–0.02 to 0.14)
0.151d
HRQoL (6 months) 0.7± 0.3; 626 0.7 ± 0.3; 476 0.00
(–0.03 to 0.02)
–0.01
(–0.08 to 0.07)
0.871
Shared decision-making
(6 months)
68.3± 26.4; 634 64.5± 27.4; 479 –2.87
(–5.81 to 0.06)
–0.12
(–0.25 to 0.00)
0.055e
Self-efficacy (6 months) 72.4± 20.6; 627 70.8± 22.2; 477 –1.89
(–3.66 to –0.12)
–0.08
(–0.16 to –0.01)
0.036f
Self-care activity
(6 months)
42.4± 15.8; 624 41.7± 16.1; 478 –0.37
(–2.25 to 1.50)
–0.03
(–0.15 to 0.10)
0.697
SD, standard deviation.
a Outcome at 12 months unless otherwise stated.
b Difference in group means after adjustment for model factors and covariates.
c Adjusted group difference divided by the within-practice SD.
d p-value based on boot-strapped variance estimates.
e Significant in analysis of sensitivity to covariates (p = 0.034) and sensitivity to exposure (p= 0.042).
f Non-significant (p= 0.11) in analysis of sensitivity to exposure.
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Discussion
This chapter reports one of the largest trials of self-management support in primary care. The WISE model
had no significant effects on patient outcomes or on service use. This chapter focuses on trial results, but a
separate process evaluation will explore barriers to implementation (see Chapter 6).
Strengths of the study included a very large practice and patient sample size, an intervention based on
previous published trials and delivered at an intensity feasible in primary care. A patient recruitment rate of
43% is relatively high for a community-based trial in UK primary care and we achieved excellent levels of
follow-up. We also achieved high levels of practice participation. Although it might be argued that effects
may have been demonstrated in different long-term conditions or outcomes, our inclusion of a range of
conditions and our comprehensive outcome assessment gives us confidence that the lack of effect is robust.
The key threat to trial validity is recruitment bias, which occurs when professionals recruit differently
depending on the trial arm to which they are allocated.61 We intended to recruit patients prior to
allocation, but this proved logistically impracticable. Recruitment was via electronic health records rather
than professional invitation, but practitioners could exclude patients after identification.62
A common complaint in health services research is that effective interventions are often not feasible, and
feasible interventions are often not effective. Many published self-management trials are conducted in
atypical contexts with selected, volunteer samples. Our study took proven components of self-management
support and tested whether or not we could implement these as a comprehensive package in routine primary
care practice using existing educational structures and applied to an entire local health economy. We sought
to sensitise our intervention to the particular nature of primary care, providing a structure and tools to allow
practitioners to introduce self-management support into time-limited consultations, to enhance partnerships
with patients, and to encourage behaviour change.
The local context included indicators of institutional commitment from the host organisation. This was
reflected in the relatively high level of practice engagement. Data from practice staff (see Chapter 6) suggest
that training facilitation was successful in parts, with relatively high levels of attendance and acceptability.
Limited time was available for training. However, time provided for training was based on our pilot studies
and negotiations with practices, and was judged the maximum acceptable to clinical staff, given time
demands and the high costs of providing staff cover. Staff self-report data suggest that implementation was
variable. We allowed practices flexibility in how they implemented self-management support at the practice
level and flexibility can lead to attenuated outcomes. Although a more standardised approach may have
enhanced effectiveness, this may have equally jeopardised recruitment and engagement.
In addition, despite our best efforts and the full support of the PCT, no practice was prepared to free up
further staff time for reinforcement sessions or fuller engagement of the ‘WISE champions,’ and only one
practice allowed access for fidelity checks.
A fuller discussion of the results of the RCT will be presented following the economic analyses and the
results of the process evaluation.
RESULTS
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Chapter 5 Health economic analysis
In this chapter we assess the cost-effectiveness of the WISE approach to provide useful information fordecision-makers. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist is
provided in Appendix 3.
Methods
Design
The trial was a two-arm, practice-level cluster RCT evaluating outcomes and costs associated with adoption
of the WISE approach in primary care to manage three conditions. The intervention and comparator have
been described in Chapter 3, as has the trial design.
Decision problem
To assess the cost-effectiveness of the WISE model in the management of long-term conditions, compared
with routine primary care services, and to assess the cost-effectiveness of the model in IBS separately.
Parameter estimates
The following parameter estimates were generated as part of the RCT.
Health-related quality of life
Health-related quality of life was measured in the trial using quality-adjusted life-years (QALYs). QALYs
were generated as the product of the health state of each individual and the time spent in that state.
The health state of each individual in the study was assessed at entry to the trial (baseline), and at 6- and
12-month follow-up using the EQ-5D descriptive system.
Quality-adjusted life-years were estimated using the area under the curve approach,63 with linear
interpolation between EQ-5D scores at each follow-up point. The QALY estimates are presented adjusted
for baseline EQ-5D score,64 but also without the adjustment.
Resource use and unit costs
At each follow-up (6 and 12 months post randomisation), patients were asked to recall their use in the last
6 months of hospital services (including inpatient stays and outpatient attendances), visits to GP surgery
(GP or practice nurse), home visits (from GP, physiotherapist, or occupational therapist) and other health/
social sector resource use.
The unit costs of health services, for example the cost of a visit to a GP, were estimated using the
published literature and are presented in Table 5. The unit costs were then applied to the appropriate
resource use item.
Missing data
All data were available at baseline. There were missing data when follow-up questionnaires were
incomplete or patients missed one or more follow-up interviews. In the main analysis missing data were
imputed by multiple imputation. Complete-case analysis was conducted as a sensitivity analysis to assess
the robustness of results to imputation assumptions.
Where data were missing, the relevant item (e.g. EQ-5D index and/or health-care costs) was imputed by
multiple imputation with the Stata v11 program. The ‘mi impute chained (pmm)’ command was employed
to generate values for missing data at each follow-up using a predictive mean matching method. Multiple
imputation generates several (in this instance, five) data sets rather than a single imputed data set. Each
data set contains different imputed values and analysis is then conducted on each of the imputed data
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sets. The multiple analyses are then combined to yield a single set of results. The major advantage of multiple
imputation over single imputation is that it produces standard errors that reflect the degree of uncertainty as
a result of the imputation of missing values. In general, multiple imputation techniques require that missing
observations are missing at random. This means that, given the observed data, the reason for the observation
being missing does not depend on the unobserved data. So, for example, a missing HRQoL observation might
be predicted by previous HRQoL, but does not depend on current HRQoL.
EuroQol-5 Dimensions index scores were imputed rather than missing responses to individual EQ-5D
domains. Thus, an individual who responded to three of the five EQ-5D domains would have an index
score imputed that would reflect their age, gender and other characteristics, but not their responses to the
non-missing EQ-5D domains. However, EQ-5D index scores from other time periods were included in the
predictive mean matching imputation.
Similarly, because of the complexity of imputing missing resource use by each item, costs were aggregated
to levels of primary care, secondary care and community care. Missing data were then imputed at these
levels (i.e. primary care costs, secondary care costs or community care costs).
Sensitivity analyses were carried out by excluding patients with missing data. Although complete case can
be a useful sensitivity analysis, only a small proportion of individuals completed every question at every
follow-up. Therefore, available case data are presented as a sensitivity analysis. The difference between
groups was then assessed on this subset of available data.
TABLE 5 Unit costs of health-care services
Description Mean (£) Source
Cost per elective bed-day 341.00 Unit Costs of Health and Social Care 2010/1165,66
Outpatient attendance 105.00 Unit Costs of Health and Social Care 2010/1165,66
A&E 119.00 Unit Costs of Health and Social Care 2010/1165,66
Physiotherapist 47.00 Unit Costs of Health and Social Care 2010/1165,66
Occupational therapist 74.00 Unit Costs of Health and Social Care 2010/1165,66
District nurse 38.00 Unit Costs of Health and Social Care 2010/1165,66
GP 25.00 Unit Costs of Health and Social Care 2010/1165,66
Practice nurse 11.00 Unit Costs of Health and Social Care 2010/1165,66
GP home visit 82.00 Unit Costs of Health and Social Care 2010/1165,66
Nurse specialist (community) 44.00 Unit Costs of Health and Social Care 2010/1165,66
NHS Direct 25.00 Unit Costs of Health and Social Care 2010/1165,66
NHS walk-in centre 99.00 Salford Royal NHS Foundation Trust
Home help 9.00 Unit Costs of Health and Social Care 2010/1165,66
Meals on Wheels 3.50 Variable
Respite care 500.00 PSSRU 199867 (inflated to 2010/11)
Counsellor 60.00 Unit Costs of Health and Social Care 2010/1165,66
Other 9.00 Unit Costs of Health and Social Care 2010/1165,66
A&E, accident and emergency; PSSRU, Personal Social Services Research Unit.
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Cost-effectiveness analysis
A NHS and Personal Social Services perspective was considered. All costs and outcomes fell within a
12-month period and, therefore, discounting was not conducted. The analysis presented is a ‘within-trial’
analysis. Thus, only costs and effects observed within the period of the trial were analysed and presented.
Where any substantial differences were demonstrated between groups, we intended to investigate the
consequences of extending the period of analysis to a longer, more appropriate time horizon.
The mean cost and mean QALYs per patient were calculated for both groups over the period of the
trial. The difference in mean costs and mean effects between groups was estimated, and incremental
cost-effectiveness ratios (ICERs) were calculated where appropriate. Currently, NHS treatments in England
are considered cost-effective by the National Institute for Health and Care Excellence (NICE) if the ICER is
< £20,000 per QALY. For interventions that are associated with an ICER between £20,000 and £30,000
per QALY gained, there needs to be evidence that the intervention is innovative and/or that HRQoL is not
captured adequately and/or that there is considerable uncertainty around the ICER. As the ICER goes
above £30,000 per QALY gained, this evidence needs to be stronger.
Cost-effectiveness analysis is conducted under uncertainty. Uncertainty around the adoption decision is
presented graphically using cost-effectiveness acceptability curves.68,69 Uncertainty in the choice of analysis
(e.g. the form of imputation) is addressed using sensitivity analysis.
Results
The results are presented initially for the three conditions combined. The subsequent analysis considers the
cost-effectiveness of the WISE model in individuals whose primary condition was IBS only.
The unit costs of the health-related resource use in the trial are presented in Table 5.
The resource use for each item recorded is presented, by trial group, in Table 6. These figures are based
on the available cases and will therefore differ from those presented in later tables, which are based on
imputed values.
Table 6 shows that there are few substantial and/or statistically significant differences in resource use
between the two trial groups. Although the analysis above describes available cases, these results are
completely consistent with the complete-case analysis.
Health-related quality of life
Table 7 shows the percentage of each patient group in each EQ-5D domain by follow-up for those who
completed the EQ-5D at the relevant follow-up time point. An examination of the table indicates that
there was very little movement between dimensions for either the WISE model or the usual-care group
over the 12-month period.
Imputation of missing data
There were a considerable number of missing resource use data at each follow-up point, although the
response rate was > 70% for each resource use variable and > 80% for inpatient stays at 6 months.
Thus, the analysis based on multiple imputation is considered as the primary analysis, with the available
and complete cases conducted as secondary/sensitivity analyses.
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TABLE 7 Percentage of patients in each EQ-5D dimension by group at baseline and each follow-up
Intervention and EQ-5D dimension
Time point, % of patients in health state at
Baseline 6 months 12 months
1 2 3 1 2 3 1 2 3
WISE model
Mobility 47.2 52.3 0.4 46.6 53.1 0.2 46.9 52.6 0.5
Self-care 76.9 22.1 1.1 76.1 22.9 1.1 76.8 22.3 1.0
Usual activities 46.1 46.3 7.6 46.9 46.5 6.7 46.4 46.9 6.7
Pain/discomfort 28.8 56.3 15.0 27.2 59.0 13.9 28.4 56.9 14.7
Anxiety/depression 55.0 39.2 5.8 54.0 39.8 6.1 54.7 38.8 6.5
Usual care
Mobility 45.0 54.8 0.2 43.8 55.9 0.3 44.7 55.0 0.3
Self-care 77.7 21.6 0.7 76.9 22.2 0.9 78.3 20.7 1.0
Usual activities 44.8 48.8 6.4 44.9 48.8 6.3 45.6 47.6 6.8
Pain/discomfort 27.5 59.6 12.9 26.9 59.9 13.3 28.0 59.2 12.8
Anxiety/depression 56.3 37.9 5.7 54.9 39.6 5.5 55.8 38.7 5.5
TABLE 6 Available casea resource use
Resource use
Trial arm, mean resource use
Difference in mean (95% CI)WISE model Usual care
Length of stay 1.589 1.322 0.268 (–0.343 to 0.879)
Outpatient attendances 2.912 2.887 0.024 (–0.366 to 0.415)
A&E attendances 0.298 0.290 0.009 (–0.050 to 0.068)
GP surgery visits 4.429 4.505 –0.077 (–0.371 to 0.218)
GP home visits 0.155 0.227 –0.072 (–0.009 to –0.135)
GP other 0.208 0.280 –0.072 (–0.157 to 0.012)
Practice nurse visits 2.783 2.893 –0.110 (–0.307 to 0.086)
Community nurse visits 1.141 0.615 0.525 (0.129 to 0.922)
OT visits 0.136 0.081 0.055 (–0.057 to 0.166)
Home care worker 1.156 2.290 –1.133 (–4.405 to 2.139)
Meals on Wheels 0.028 0.181 –0.153 (–0.402 to 0.095)
Physiotherapist 0.104 0.090 0.014 (–0.041 to 0.070)
NHS Direct 0.172 0.136 0.036 (–0.030 to 0.101)
Walk-in centre 0.534 0.357 0.178 (0.034 to 0.321)
Respite care 0.077 0.039 0.038 (–0.031 to 0.107)
Counsellor 0.252 0.281 –0.029 (–0.156 to 0.098)
Other 0.865 0.528 0.337 (0.045 to 0.630)
A&E, accident and emergency; OT, occupational therapist.
a Available cases are those that provided data for that variable at each follow-up, for example if visits to the GP at 6 months
and 12 months were both recorded, then the total number of GP visits over the duration of trial has been calculated for
that individual.
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Cost-effectiveness
The mean QALYs for both the WISE model and usual care group are presented in Table 8, together with
the CIs around the difference. Unadjusted QALY differences are presented, followed by the adjustment
for EQ-5D baseline score, as recommended in the literature.64 Whether the adjusted or unadjusted analysis
is considered, the QALY differences are not substantial. The change in direction of effect that occurs
after allowing for baseline differences in EQ-5D score is attributable to the small absolute difference in
effectiveness. The mean costs by group are presented in Table 9 and are based on the imputed data.
The difference in cost between the two trial arms is, again, insubstantial. Combining the difference in costs
and effects generates the ICER. This statistic is presented in Table 10 with and without adjustment for
baseline EQ-5D scores (although the latter is the preferred statistic).
There is a considerable amount of uncertainty around the adoption decision, driven by uncertainty in
whether the intervention is less or more effective, and less or more costly. This is reflected in the
cost-effectiveness acceptability curve (Figure 6), which shows that, at commonly used threshold
values of a QALY, we are unsure whether or not the intervention is cost-effective. For example, at a
cost-effectiveness threshold of £20,000, there is approximately 30% chance that the WISE model is
cost-effective, whereas at £30,000 this rises to almost 50%. The ICER of around £33,000 would not be
considered cost-effective at commonly used thresholds. Therefore, the choice of analysis does not affect
the adoption decision and the WISE model would not be implemented based on these data.
TABLE 8 Unadjusted and adjusted mean QALYs per patient over the 12-month period
Group Mean QALY Difference (95% CI)
Difference allowing for
baseline characteristics
(95% CI)
WISE model 0.6871 –0.0029 (–0.0176 to 0.0117) 0.0044 (–0.0052 to 0.01385)
Usual care 0.6900
TABLE 9 Total costs per patient over the 12-month period
Group Mean total cost (£) Difference in mean total cost (£) (95% CI)
WISE model 1264 144 (–99 to 387)
Usual care 1120
TABLE 10 Incremental cost-effectiveness ratio for the WISE model with and without adjustment for baseline
EQ-5D scores
Cost difference (£)
(95% CI)
QALY ICER (£)
Difference (95% CI)
Difference allowing for
baseline characteristics
(95% CI) Unadjusted QALY Adjusted QALY
144 (–98.9 to 386.7) –0.0029
(–0.0176 to 0.0117)
0.0044
(–0.0052 to 0.01385)
Dominated 32,695 per QALY
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Sensitivity analysis
To test the robustness of the multiple imputation assumption, costs and effects were estimated for the
groups based on the responses received at each follow-up and including the adjustments for zero values
described earlier. The results are very similar in magnitude, and direction, for all estimates, thereby adding
weight to the conclusion that the WISE model has little impact on either costs or effects on these patient
groups (Table 11).
Subgroup analysis of irritable bowel syndrome patients
Costs
Based on imputed data for those individuals whose primary condition was IBS, the WISE model was
associated with an increased cost of £387 per patient over the duration of the trial. Although this may
appear substantial, it would not be considered statistically significant, with a 95% CI of –£133 to £907.
Health-related quality of life
Again, based on imputed data for IBS patients, the WISE model was associated with a small increase in
HRQoL. This difference of 0.0015 QALYs is not statistically significant (95% CI –0.0163 to 0.0193 QALYs).
Cost-effectiveness
In the IBS population, the WISE model was associated with small increases in HRQoL observed together
with some increases in cost. Thus, it is appropriate to generate an ICER. With an ICER of > £260,000
per QALY for IBS patients, the WISE model would not be considered cost-effective at commonly
considered thresholds.
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FIGURE 6 Cost-effectiveness acceptability curve, controlling for baseline utility.
TABLE 11 Available case analysis
Cost difference (£) (95% CI)
QALY ICER (£)
Difference (95% CI)
Difference allowing for
baseline characteristics
(95% CI)
Unadjusted
QALY Adjusted QALY
172 (–27.5 to 372.1) –0.0025
(–0.0175 to 0.0125)
0.0050
(–0.0046 to 0.01499)
Dominated 34,400 per QALY
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Comparison with other conditions in trial
The three conditions combined yielded a very small improvement in QALYs at an increased cost. The analysis
of IBS patients generates very similar results, suggesting that the conclusion that the WISE model has little
impact on costs or QALYs over the duration of the trial in any of the conditions considered.
Discussion
The WISE model had little impact on either costs or effects within the time period of the trial. In addition,
there is no evidence to suggest that there were any longer-term implications that may not have been
captured within the time period of the trial. The results were robust to alternative assumptions about missing
data and did not differ between conditions included in the trial. The results of the cost-effectiveness analysis
are therefore consistent with the results of the effectiveness analyses.
The strengths of this study are clearly that it is a large RCT so that any demonstration of a treatment effect
on costs or outcomes is likely to be reliable. The variety of sensitivity analyses performed also suggests that
this result is robust.
A potential weakness of the economic analysis is the time horizon. This assumes that there are no
differences between groups after the end of the trial. However, given the lack of movement within EQ-5D
dimensions (and single index scores) over the trial period, it is considered a justifiable assumption. Similarly,
the trajectory of the EQ-5D scores between follow-up periods is unknown. We have assumed a linear
interpolation in the absence of evidence to the contrary. It is feasible that if EQ-5D scores were collected
more frequently, differences may have been observed. However, again because of the lack of movement
in individuals across dimensions, this is considered unlikely.
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Chapter 6 Process evaluation
Sections of this chapter have been reproduced from Kennedy et al.
70 Copyright © 2013 The Authors.
Published by Elsevier Ltd.
Primary care potentially provides ready access and continuity of care for patients and, therefore, an
appropriate location for guideline-based disease management programmes for patients and, more
recently, as a key provider of self-management support.14 In UK primary care, long-term condition
management operates through an increasingly biomedical framework, partly as a result of the QOF,
a system of payment to practices for activities done and outcomes achieved.
The organisation of care for people with long-term conditions is in transition and self-management
support policies are seen as important to enhance peoples’ self-management capabilities and thus improve
health outcomes and reduce the fiscal burden on health-care systems.71
There are gaps in our knowledge about the implementation of a ‘whole-systems’ approach. A significant
degree of complexity was anticipated given the need to incorporate different elements of a relatively
‘open’ system of primary care (compared with secondary care). Thus, there is a need to capture this
complexity in understanding how a comprehensive approach to self-management reconfigures
existing relationships, communication and practices and how (and if) the principles of a whole-systems
patient-centred approach to self-management can become embedded and integrated into routine
practice.72 The latter is particularly salient in a context where the labour of primary care professionals
has ostensibly become more biomedical and bureaucratic as a result of the pressures and demands
of governance arrangements linked to QOF and pay for performance,34 but at a time when the
empowerment and engagement of patients in their own care is also being advocated.
All primary care health professionals are relevant to the implementation of self-management. The role
of the practice nurses in long-term condition management grew as a result of the delegation of work
associated with QOF.73 For nurses, two aspects of self-management have been identified as being
particularly relevant: using education, techniques and tools to help patients improve their self-management
abilities; and a more demanding requirement to transform the patient–caregiver relationship into a
collaborative partnership.74–76
Process evaluation
A process evaluation was designed to complement the RCT (see Chapter 4). Recent MRC guidance defined
process evaluation as:
A study which aims to understand the functioning of an intervention, by examining implementation,
mechanisms of impact, and contextual factors. Process evaluation is complementary to, but not a
substitute for, high quality outcomes evaluation.
Moore et al.60 Copyright © 2015, British Medical Journal Publishing Group
The success (or failure) of interventions is predicated on the potential for embedding new interventions
within normal ‘everyday’ practices. In this context, normalisation process theory (NPT)77 has utility as a
conceptual framework for understanding the incorporation or rejection of the WISE model from a patient
and professional perspective.
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Process evaluation question
What are the barriers and facilitators that affect the implementation of the WISE model at patient,
clinical and organisational levels?
Normalisation process theory provides the conceptual framework for the process evaluation. NPT is
designed for the study of implementation processes – to explain how new technologies, ways of acting
and working become routinely embedded in everyday practice. Thus, NPT is well orientated to describe
and explain the way in which the new practices associated with the WISE model are operationalised in
health care. In order to understand the embedding of a practice we must look at what people actually do
and how they work.
The theory is concerned with three core problems:
1. implementation – the social organisation of bringing a practice or practices into action
2. embedding – the processes through which practices do or fail to become routinely incorporated in
everyday work
3. integration – in which we mean the processes by which a practice or practices are reproduced and
sustained among the social matrices of an organisation or institution.
According to NPT, practices become routinely embedded – or normalised – in social contexts as the
result of people working, individually and collectively, to enact them. The work of enacting a practice is
promoted or inhibited through the operation of generative mechanisms (coherence, cognitive participation,
collective action, reflexive monitoring) through which human agency is expressed.
Implementation was explored at three levels: (1) organisational (PCT), (2) practice and professionals
and (3) patients.
At the organisational level, the process evaluation investigated how far the knowledge of the intervention
had been diffused, taken up, adapted locally and embedded at the level of the PCT and the consequences
of any such diffusion.
At the practice and professional level, the key issues were the implementation of the training in the WISE
model provided to practices and the implementation of WISE practices and tools (e.g. the use of
PRISMS forms).
At the patient level, the process evaluation explored patient perspectives about existing services, their
engagement with those services and attitudes to engagement with the new self-management arrangements.
When the results of a RCT are positive, a process evaluation is needed to identify ‘active ingredients’, to
aid generalisability (or transferability in qualitative research terms) and to facilitate learning and translation
into everyday practice. Similarly, when the results of a RCT are negative or inconclusive, evidence is
needed to identify reasons for the lack of effect, which may be found in cultural, organisational or
behavioural factors.
Methods
A process evaluation was carried out, in parallel to the RCT, using the following methods.
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Organisational level
l Organisational context: baseline face-to-face interviews with a purposive sample of relevant members
of a practice-based consortium and PCT governance bodies.
l Recruitment of practices: methods to assess this process included contemporaneous researcher notes,
e-mails from practices and minutes from meetings.
l Interviews with relevant individuals who were key to the roll-out of the WISE model.
Practice and professional level
l Post-training evaluation questionnaire.
l Collation of documents generated by the training, including patient journey maps created during
training; reflections on what the practice does well and on challenges and problems to achieve change;
action plans and steps to change identified by the practices; and logos designed by each practice as an
ice-breaking task.
l Training notes (written by the trainers after each training session).
l The post-training evaluation questionnaires (distributed to all staff who attended each of the training
sessions) were collected immediately after each session ended.
l The survey questionnaires were posted out to the practices.
l At 3–6 months following the training, all trained practices within Salford PCT were invited to take part
in interviews and interviews continued until a broad representation of practice types (based on practice
size, population served and number of GPs) was reached. Practice staff interviewed included GPs,
nursing staff, the practice manager and a member of the administrative staff. Both trainers were
interviewed.
l Questionnaire to survey the use of tools was conducted 6 months post training.
l Face-to-face in-depth interviews with practice staff. An interview schedule was used to ask staff
about their involvement in supporting patients’ self-management of diabetes, COPD and IBS, their
impressions of PRISMS and the guidebooks, and attempts to integrate the tools within their daily
routines. The interviews were recorded using digital audio equipment. Field notes summarising the
interviews and highlighting key issues were written up soon after each interview.
Patient level
l Patient experience of the current service arrangements and the WISE model. Face-to-face in-depth
interviews with a purposefully selected sample of patients who took part in the trial and a longitudinal
study of patients recruited during the exploratory study and early piloting of the WISE model.78
l Thirty patients were selected for interview using maximum variation sampling based on the following
factors: condition, length of time diagnosed, number of contacts with the GP, self-efficacy scores,
help and support from family, choices ever offered by GP, age and gender. For the longitudinal study,
participants were recruited for interview when attending two general practices in Salford. Participants
were purposefully sampled to have at least one of three conditions in the RCT. We also sampled to
include a range of ages and length of time since diagnosis.
l Analysis: verbatim transcriptions of the audio-recorded interviews were discussed over the course of
data collection, enabling an iterative approach to data collection and discussion of emerging codes.
The content of the interviews was considered case by case and comparisons drawn across cases to
identify similarities and differences in the understanding and values attached to the tools and
individuals’ attempts to integrate them in everyday practice. The NPT framework allowed a systematic
evaluation of the factors influencing the work required to implement and embed the WISE model.
Questions relating to each component within each of the four core constructs were generated.
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Results
Organisational level
Seven key individuals were interviewed at the start of the roll-out of the WISE model across Salford.
These included the PCT chief executive, two senior PCT managers, the NIHR programme grant principal
investigator, the NIHR programme grant project manager and the two WISE model trainers (one
of whom had a dual role as a PCT self-care development manager). Interviews took place at baseline.
However, as a result of the rapidly changing structure of health management systems and the dismantling
of the PCT during the period of the study, follow-up interviews were not conducted.
Findings
Set-up of project
l Respondents reported that Salford operates as a health economy with close geographical and local
networks. It is a PCT with a strong local identity and a reputation for innovation. These factors were
seen to have been key in facilitating PCT ‘buy-in’ to the WISE project.
l The cost of GPs’ time was not included in the budget and so an amount of around £100,000 had to
be underwritten by the PCT. This created difficulties because it delayed the start of recruitment of
practices and was also a source of anxiety for the project manager.
l Although there was no risk of the PCT withdrawing support, the processes of getting finances
authorised was slow, especially as the project coincided with the introduction of a financial recovery
scheme to make savings to prepare for anticipated financial stringencies.
Recruitment of general practices
l Respondents reported that estimates of buy-in by practices were overstated and did not take account
of variation: some practices were keen and motivated to adopt the WISE model but others less so.
The WISE model was not viewed as critical to practice business and did not fit with QOF targets,
enhanced service or training, development or appraisal targets.
l This meant that the recruitment process was slower than anticipated, which delayed the start of the
training programme.
l Further practices were recruited from Bury to make up numbers caused by the low recruitment of
practices. The chief executive of Salford had oversight of Bury PCT during this period, which facilitated
their buy-in to the project.
l Some interviewees suggested that, in retrospect, the recruitment process could have been improved by
getting more key stakeholders engaged earlier on in the project (e.g. GP cluster leads), who could have
raised the profile of the WISE model ahead of the implementation process.
The WISE model and the primary care trust
l During the early stages there were tensions arising from the way in which the PCT involvement in the
project had been disseminated from executive level to middle managers. The PCT at an executive level
were keen and committed and one of the senior managers interviewed was the executive responsible
for the WISE model and a member of the Study Steering Committee. However, their role as Director of
Clinical Professional Leadership meant that the WISE model was established in the Clinical Professional
Directorate rather than the Commissioning Directorate. This made it more difficult to get engagement
from the commissioning managers and also for the WISE model to be integrated with the PCT annual
planning cycle. In part, this also seems to relate to the status of the WISE model as a pilot rather than
an mature strategy.
l Respondents reported that the lack of an appropriate ‘home’ for the WISE model or a champion
working at managerial level seems to have had considerable consequences on the profile of the WISE
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intervention across the PCT. There is evidence that the WISE model provided a model to support
another initiative around diabetes, but this seem to have happened more by chance than by planning.
l The status of the WISE model as a research project also meant that PCT managers were uncertain as to
its future, which made them less keen to engage fully. One senior manager said she believed it would
be useful to have evaluative feedback as soon as possible to give them a sense of whether or not the
model was successful enough to be adopted across long-term conditions commissioning.
l The WISE model was also impacted by turnover of PCT managers. The commissioning manager for
long-term conditions was offered an interview, but then left the PCT. The WISE model was then
allocated to the commissioning manager for long-term conditions and public health. However, she did
not seem to demonstrate ‘ownership’ of the WISE model, although she was keen to receive evaluative
feedback as soon as possible.
Training
l Those attending the first few training sessions did not seem to have a clear idea of the purpose of the
session, the project, its funding and its relationship to the PCT. The trainers therefore introduced an
overview of the WISE model to the beginning of the training session to address these problems.
l There were some conflicts around trainers’ responsibilities for the WISE model and other PCT priorities.
One trainer in particular stated that she had to ensure that she did not have to take on extra
responsibilities for PCT work.
l The trainers were keen to identify ‘WISE champions’ and introduce follow-up sessions to the training as
a way of improving uptake, but had difficulty in engaging practices beyond the initial training.
Communication
l The appointment of a project manager for the NIHR programme with experience in managing
projects in Salford PCT seems to have been key to resolving the initial difficulties. The project manager
identified the communication problems between executive and manager level and worked to ensure
that all involved were appropriately briefed. The interviews generated positive comments about the
project manager’s support.
l Very positive comments were received about accessibility of the research team and their willingness to
support the training scheme.
Summary of organisational-level interviews
Overall, the implementation seems to have progressed well, although more slowly than had been anticipated.
The initial problems relating to communication, extra funding for GP time and recruitment of practices appear
to have been resolved. However, there was a consistent view that the WISE model had not developed a high
enough profile within the PCT. This seems to have arisen because of the tensions created by placing the
WISE model outside the Commissioning Directorate. Thus, commissioning managers did not develop much
knowledge of the aims of the WISE model. In addition, there is a sense that the fact that it was perceived as a
pilot may have contributed to the lack of buy-in at managerial level.
Recruitment of practices
The project started with a list of 56 practices. Practices were not eligible if they shared clinicians or
administrative staff with other practices or if they served a very specific population (e.g. drug users, the
homeless or young patients). Forty-four practices in the Salford PCT were identified as potentially eligible
for the study, and all were contacted. Of these, 32 initially agreed to participate in the trial and were
randomised, and three subsequently withdrew from the study before data were collected from 29 practices.
To ensure that sufficient power for the study was maintained, we recruited 12 practices from Bury
(a neighbouring PCT serving a similar population to Salford).
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Salford has a large number of single-handed practices, and 17 were identified as eligible for the trial:
14 of the early sign-ups were from single-handed practices and two of the ineligible practices were
single-handers. High sign-up from single-handed practices may reflect the fact that it proved easier to
negotiate times of meeting and set dates for training when only one GP was involved.
From the start, practices had different reactions to the introduction of the WISE model training. Reactions
ranged from interest and enthusiasm to complete lack of interest and hostility. Few perceived that training
in self-management support was needed, so the approach to engaging practices involved the use of
incentives (costs of attending training to be met by the PCT), as well as targeting practices known to be well
disposed to involvement in research early on and using this to encourage more reluctant GPs to join the
programme. The involvement in a research project was deliberately downplayed because of the known
difficulties of getting GPs to engage with research. Barriers to engagement included:
l Practical problems such as staff sickness, arranging time out of the practice to undertake the training
and the implications for practice finances (although the PCT provided funding for locum and
out-of-hours cover to allow participation in training).
l Practices faced with incorporating other changes, at the same time, to practice and management.
l Self-management not being seen as a priority for the practice and a lack of belief that supporting
self-management would be effective.
l A perception of the WISE model as providing nothing new. Staff claimed that they were already
providing good care for patients with systems and strategies for long-term conditions in place.
Furthermore, they could see no need to change practice and no potential benefit for patients in their
attending training.
l A perception among some practices that patients were unlikely to take-up, or benefit from,
a self-management approach.
l Training being considered by some to be inappropriate for support staff.
l Signing up to the training and the link to research meaning that clinicians would be expected to invest
additional time with patients providing self-management support (i.e. there was concern that using the
WISE model approach would generate more work).
l Negativity towards the inclusion of IBS as one of the chronic conditions being included.
Practice and professional level
Training impact
Evaluation forms were completed by staff at the end of each training session. The scores indicated high
satisfaction with the training (Tables 12 and 13).
Questionnaire survey of the use of the WISE model tools
The questionnaire was sent to 302 staff at the 31 practices where training took place (25 in Salford and six
in Bury), including 163 administrative staff and 139 clinicians. There was an overall response rate of 48%
(88 administration staff and 67 clinicians) (Table 14).
Face-to-face in-depth interviews with practice staff
The analysis presented here is based on interviews with 11 practice nurses and one assistant practitioner;
all were female with between 2 and 21 years of experience of working in general practice. Interviews
with other staff, documents and notes collected during the study and the training sessions and the
observations carried out in the development stage of the WISE model helped to provide context for
the analysis.
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Findings
Table 15 provides a summary of how the systematic identification of work undertaken by nurses mapped
on to the NPT framework. The analysis focused on the ways nurses spoke about the work of managing
patients with long-term conditions and how using the WISE model tools changed their everyday
self-management practices. Some elements of the WISE model were reported to work well (such as
distribution of the guidebooks), but other elements (such as using the PRISMS tool to help address patient
needs and priorities) were rarely taken up. A number of themes emerged. Illustrative data are presented
and labelled with the respondent identifier.
TABLE 13 Staff satisfaction with training: session 2 (GPs and nurses)
Satisfaction question n Minimum Maximum Mean SD
Did you find the training useful? 123 1 4 3.21 0.668
Did you like the structure? 124 1 4 3.18 0.663
Did you learn from others? 124 0 4 3.19 0.779
Was the DVD useful? 120 1 4 2.93 0.796
Did you find role play helpful? 108 0 4 3.06 0.818
Were the discussions of benefit? 124 1 4 3.35 0.665
Will you be able to use the skills? 116 1 4 3.26 0.674
DVD, digital versatile disc; SD, standard deviation.
Notes
124 participants ranging from one to seven per practice.
Score range: 0= not at all, 4= very much.
TABLE 12 Staff satisfaction with training: session 1
Satisfaction question n Minimum Maximum Mean SD
Did you find the training useful? 265 1 4 3.05 0.820
Did you like the structure? 264 1 4 3.05 0.766
Did you learn from others? 264 0 4 3.08 0.751
Was the patient pathway useful? 263 0 4 2.99 0.803
Was creating opportunities helpful? 255 0 4 2.91 0.791
Were the discussions of benefit? 263 0 4 3.11 0.784
How actively involved were you? 262 1 4 2.96 0.772
Will the practice use PRISMS? 255 0 4 2.80 1.007
How likely is system change? 252 0 4 2.50 0.815
SD, standard deviation.
Notes
Number of practices = 31 (18 intervention and 13 control).
265 participants ranging from 4 to 16 per practice.
Score range: 0= not at all, 4= very much.
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TABLE 14 Self-reported use of the WISE model tools
Use of WISE tools % reporting use
Guidebooks (GPs) 54% ‘regularly’
Guidebooks (nurses) 50% ‘regularly’
Guidebooks (administration) 32% ‘regularly’
PRISMS (GPs) 11% ‘regularly’
PRISMS (nurses) 15%, ‘regularly’
PRISMS (administration) 7% ‘regularly’
Explanatory models (GPs) 36% ‘regularly’
Explanatory models (nurses) 19% ‘regularly’
Salford web directory (GPs) 17% ‘regularly’
Salford web directory (nurses) 22% ‘regularly’
Salford web directory (administration) 13% ‘regularly’
TABLE 15 Processes influencing uptake of WISE tools
NPT construct Component Questions to consider Findings
Coherence:
sense-making
work
Differentiation Does the participant recognise how
the WISE model tools and techniques
are different from their existing ways
of working?
There was difficulty differentiating WISE
principles from those underpinning
existing SMS practice, which undermined
the embedding of the intervention
Does the participant understand the
purpose of the tools and techniques?
Communal
specification
Does the participant recognise the
steps she/he needs to take as part of
the practice team to assist in the
integration of the tools?
Limited communication within practices
post training stifled discussion surrounding
the WISE model and its potential benefits
Individual
specification
Does the participant identify their
personal role and responsibilities with
the use of the tools?
Marked variation existed in nurses’ opinion
as to the fit of the WISE model tools in
their current practice. Nurses reported
that the guidebooks fitted well and
PRISMS did not
Internalisation Does the participant identify any
benefit in adopting the WISE model
tools, and for whom?
Familiarity with information and services
provided by long-established, reputable
sources undermined efforts to identify
the benefits and value of the WISE
model guidebooks. One nurse saw the
WISE model as improving patient care
and relationships
Cognitive
participation:
relational work
Initiation To what extent does the participant
appear to have been a supporter of
the process to integrate the tools?
Failure to engage in a practice-wide
strategy discouraged individual
commitment to adopt the WISE model
Enrolment Has the participant made any
adaptations to their personal routine
or assisted in the reorganisation
process leading to implementation?
In most cases, no adaptations were made,
but nurses who saw themselves as having
autonomy were able to take up the WISE
model tools in individual practice
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TABLE 15 Processes influencing uptake of WISE tools (continued )
NPT construct Component Questions to consider Findings
Legitimation Does the participant believe that it is
appropriate for them to be involved in
integrating the tools?
Health-care assistants and newly
qualified nurses did not perceive that
their roles required adoption of the WISE
model approach
Activation Has the participant taken steps to
sustain the use of the tools?
Assessment and review of the processes
involving the tools to sustain their use
was afforded little priority. Nurses
reported that QOF remained the
over-riding practice priority
Collective action:
operational work
Interactional
workability
What work does the participant
describe as having taken place to
operationalise the use of the tools?
Difficulty engaging patients in
self-management practices limited
enthusiasm to invest effort in new ways
of working. PRISMS was used (rarely) to
widen the content of the consultation,
but not in supporting behaviour change
Relational
integration
To what extent does the integration
of the tools and resources help or
impede people’s work within the
practice?
The convenience of and ready access
to information in hard-copy format
encouraged use of the guidebooks,
but PRISMS got in the way of existing
tasks and priorities
Skill-set
workability
Who does the participant view as
being best placed to make use of the
tools?
Nurses were delegated responsibility for
SMS by the GPs. Responsibilities as
health educators promoted nurses’ role
as implementers of the approach of the
WISE modelHow compatible are the tools with
their current tasks?
Contextual
integration
Does the integration of the tools fit
with the objectives of the practice?
QOF is the priority of the practice. Nurses
were generally happy to do the QOF
tasks, but there were tensions with the
skills they see themselves as having that
are disregarded by the QOF process. QOF
priorities means that there is little space
for SMS work. The practice systems were
not able to integrate PRISMS forms –
so ‘not to hand’
Reflexive
monitoring:
appraisal work
Systematisation Has the participant taken practical
steps to measure the influence of
adopting the new techniques?
Limited, informal gathering of feedback
from patients regarding the accessibility
and utility of the WISE model guidebooks
was recorded, suggesting some use
of this resource as a prompt when
responding to patient concerns
Communal
appraisal
Has the practice come together
to appraise the impact of
implementation?
This was generally limited, as few
practitioners recorded engaging
colleagues in discussion of their
experience of using the tools
Individual
appraisal
Does the participant reflect personally
on the impact of the WISE model
tools on his/her routine?
The limited take-up of the tools and
resources was reflected in the prevalent
view that the training had produced
little change in practice. In contrast,
supporters of PRISMS noted the positive
impact on patient engagement
Reconfiguration Has the participant made attempts to
modify the way the WISE model tools
are used as a result of experience?
For adopters of PRISMS, identifying how
the process of using it could be adapted
to fit in with existing practice (such as by
focusing on the most-pressing concern
rather than a range of issues) was
important to the sustainability of the tool
SMS, self-management support.
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Theme 1: the work associated with self-management support is not a priority
for practices
Although all the practices involved had signed up to the RCT and participated in the training, the WISE
model approach did not emerge as a priority and failed to ‘disrupt’ the existing work of the nurses.
Practice nurses generally work to a set of tasks and do so in a way that is dictated by practice priorities.
One priority is to ensure QOF targets are reached – which involves setting up and carrying out review
appointments with patients on the practice disease register. In these appointments, nurses monitor
and record vital signs, such blood pressure, blood sugars and lung capacity, as required by QOF. This
prioritisation marginalises other non-incentivised work, such as self-management support. GPs, however,
viewed nurses as having the specific skills, time and opportunity to do self-management support work
with patients and delegated this without necessarily knowing, or being interested in, how this was
actually achieved.
So I tend to fiddle with their blood pressure pills and the diabetic pills and their insulin doses and cope
with crises when they come along . . . The lifestyle type things, which I know are important, tend to get
delegated to the nursing staff to do . . . you know, beyond me being very basic and saying to them
well, you need to try and lose weight or you need to try and eat more healthily or you need to do more
exercise, that’s almost as much as I can do, really, because of time limitations. Nurses do have more
time and they have longer appointments, I would say. So the lifestyle side of things, the nurses are
more involved with, that’s my belief anyway.
Dr X, practice 22
This attitude meant that, for nurses, the work of providing self-management support had to be fitted
between other, more structured, tasks. This led to cognitive and practical tensions for nurses who were at
pains to convey their ability to provide holistic care for their patients, while servicing the QOF agenda for
which they had been tasked.
Well now. The thing is I’ve always been taught to focus on the patient and you’ve got to tick . . . you
know you’ve got to fulfil your QOF criteria and stuff so . . . It’s COPD, looking if there are any changes
in their condition over a period of 12 months. If there is anything they can’t do, if it’s impacting on
their lifestyle, are they more breathless, are they getting more exacerbations. You are looking at
depression and how it’s impacting on that kind of thing generally.
Nurse E, practice 12
Nurses identify patient education as key to self-management support, but the need to fulfil QOF criteria
leads to a didactic approach to dealing with patients in consultations. Handing out written information
while instructing patients what to do is the easiest and quickest way to undertake the task.
. . . have loads of literature, yeah. That’s it. We have a raft of information for diabetes. So I do give out
information. And I think COPD . . . diabetes, I’m the same. With the diabetic ones we manage them
and we sort of tell them. It sounds awful tell them. We don’t tell anybody but we do sort of tell them,
‘You need to do this. You need to do that. You need to do the other’.
Nurse N, practice 28
Handing out the WISE model guidebooks fitted readily into this way of working, and the guidebooks
were seen as filling in the missing ‘patient-centredness’ of their practice. In this respect guidebooks were
minimally disruptive so were easily normalised.40
We give them the WISE book. And we just ask them to read that and if they have any concerns, that
there’s a little problem thing at the back they can always talk to us about it when they next come . . .
I think it’s made people more aware of how to manage their own condition. The information is in the
book. They know they can look at that any time. If there is something there they don’t understand or
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whatever, I think the information is all in there, you know, and we go through it with them when they
come, and we tell them, ‘If you’re ever stuck or worried, please look at the book. Please read and see
where you can make these changes if you need it’.
Nurse F, practice 3
Theme 2: the responsibility for self-management is passed ‘down’ from general
practitioner to nurse to patient
The demarcation of roles within the practice impacted on how nurses viewed and dealt with self-management
support. GPs delegate self-management support to nurses and, in their turn, nurses delegate responsibility to
patients. In both cases, this was not necessarily an empowering process based on a partnership and shared
decision-making approach: little was shared with patients and work outside the testing for biomedical
markers of disease was not considered a central element of consultations. Nurses viewed GPs as having little
understanding of the work they did:
They tend to leave us to our own devices, I know it sounds awful, but, to our own devices, because,
they don’t really know what we do, in the clinics.
Nurse M, practice 19
The general lack of interest in nurses’ work within the practice was given as justification for why the WISE
model approach was not taken up by nurses.
It’s all right being a pilot and stuff, but you’ve got to want to do it and if they’re not . . . Why should
one person do it on their own?
Nurse E, practice 12
A few nurses who did make use of the tools to change their practice found that the WISE model provided
a structured approach to self-help and brought a more patient-centred focus to consultations previously
‘driven by targets and guidelines’. Patients were felt to need time to understand what they had to do and
the work of self-management support could be done in a gradual and shared way.
It sort of has changed my practice quite a lot, but what I mean, I think, is I didn’t necessarily say to the
patient, what do you want to talk about today? Whereas maybe I do now, because they’ve gone
away with the booklet and they’ve come back with . . . they’ve highlighted what it is that’s really
worth talking about.
Nurse B, practice 22
Theme 3: autonomous working practices provide space for optimal self-management
support discussions
Some nurses recognised that, although they had certain core tasks to perform, they did have autonomy in
planning their work. A few nurses built in elements of the WISE model approach and were enabled to do
this by being seen to be efficient managers of QOF work. The recognition and respect they garnered as a
result meant that they were left with autonomy to create space for working in other spheres.
I’ve done this job for 21 years now, I’ve been here a long time, so we do have a very good
understanding of each other’s roles and I certainly know where my limits are and I don’t overstep that.
But within my sphere of expertise I do all the respiratory care, I do all the diabetes care, the CHD
[coronary heart disease] stuff, . . . I’m really left to it because my, it’s obvious what I’m doing, it’s in
there, it’s all auditable, it’s easy to see. So you know and the QOF has been good for that.
Nurse B, practice 22
This nurse went on to talk about how she had been able to use the PRISMS tool in her consultations and
how it had helped to open up the conversation and focus on the priorities of patients rather than the
priorities of the practice.
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Basically what it does, it enables me to talk about the things that are worrying them, and things like,
for example, sexual health. Unless you ask the question they are never, ever, ever going to bring
it up in a consultation in a million years. So having something like that does help focus on the
whole shebang, really. But I think it just enables the patient to feel that they’re bringing something,
it’s not just about me yappy, yacky, yapping on at them, it’s about them sharing more and having,
[whispering] (because I do talk a lot at times) . . . you know it’s allowing them to have a little bit of
time to . . . for me to shut up.
Nurse B, practice 22
For others, having autonomy allowed nurses to identify with acting in a patient-centred manner through
establishing relationships with patients. Relationality is seen as a central part of their work.25,41 However,
in practice, most nurses were not able to use their existing style of relating to engage patients in in-depth
conversations concerning self-management support. This was because they gave more priority to building
and maintaining comfortable interpersonal relationships over the more negative and hard work of
challenging ‘problem’ behaviours.
Yeah. It just depends, because, a lot of the time, you can get them chatting when you’re doing other
things, as well.
Nurse M, practice 19
Theme 4: self-management support is not perceived as different enough to warrant
investment of time and effort
In terms of making sense of the new innovation, there appeared to be little differentiation made between
the WISE model approach and normal self-management support practice. Self-management support was
viewed in terms of being patient centred, addressing lifestyle and behaviours and effecting change, and
having time to listen – all of which were considered to be ‘normal practice’. This sense of there being
nothing new translated into the view that there was no need for change. Indeed, to the following
respondent, the time constraints of practice meant that thought of adopting new ways of managing
was ridiculous.
I know it sounds awful, it was, like, it was teaching us to suck eggs! . . . Because, we’ve all been
clinicians for a long time, I know it gives you another way of looking at things, but, it’s, like, we
already know what the patients are going through, we’ve all been experienced clinicians, it’s not, like,
we’re new to the post and the fact that, it’s, like, we have a limited amount of time, in a consultation,
we’ve not got an hour, per patient, I wish we did, . . . we have 10 minutes and you try and get
everything done in them 10 minutes and, then, somebody is coming along and telling you, oh, this is
what you should be doing and this is this and this and this and it’s, like, and where are we supposed
to fit everything in, in 10 minutes.
Nurse M, practice 19
Theme 5: perceptions of feasibility of changing patient behaviour are low
Changing people’s behaviour is seen as difficult, a view that receives some support from the literature on
behavioural change. There was little or no talk about how health professionals could change people’s
behaviour in everyday practice. Giving patients information and instructions was seen as easy and routine,
but examples of how to motivate and engage people with new practices and behaviours were missing from
the narratives of respondents. The PRISMS tool was supposed to assist this process, but the few nurses who
reported using the PRISMS tool did not get much further than using it to open the consultation to patient
needs and had well-formulated views borne out of previous experience of working with patients shown in
the metaphors used to describe non-behaviour change.
We can point . . . take a horse to water but I can’t make him drink. I can give them all these things,
but I can’t make them access them. But I can do my best and . . . that’s all.
Nurse E, practice 12
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Nurses suggested that their patients were not suitable candidates for a self-management approach, for
example because their lives were too chaotic or they had too many other problems. They found it hard to
engage patients with lifestyle change and a patient-centred approach was thought to be at odds with
providing self-management support in which the shifting of responsibility is a longer-term aim. This has the
effect that self-management support work is deferred.
I think COPD, I mean, the main lifestyle is you have to address there is obviously smoking and I will go
straight in and say do you smoke, have you thought about stopping . . . If they don’t want to address
it, if they’re not interested then I just leave it because it’s pointless trying to force somebody to do
something that they’re not prepared to do. And I’ll just leave it open.
Nurse D, practice 12
Theme 6: it is easy to dismiss or under acknowledge the needs of patients
The PRISMS tool was easy to dismiss for several reasons: lack of time, the potential to open up too many
complex issues in time-limited consultations, practice systems were not geared up to support it and the
cost to the practice.
The happy, smiley face-y thing. We didn’t use it. We primarily, I’ll be honest and say I didn’t use it
because I didn’t have the time because there’s only me and I only work part-time. And I think it was
another tool, you know what I mean? And I’d love to be able to sit here and have half an hour
consultation about patients’ priorities and I’m going to say that I do but in a more roundabout way,
and you know. But I didn’t have the time really to be fair.
Nurse N, practice 28
I am doing it, but not quite in the same form as they thought. I’m not doing the PRISMS because
nobody has given the forms out. You see we don’t send letters out for appointments because it’s too
expensive. If we could send letters we could send the PRISM forms and they could bring it in when
they come for an appointment.
Nurse E, practice 12
Theme 7: self-management support resources need to be readily accessible and trustworthy
Nurses work within a structured primary care team. However, their day-to-day work can be distant from
other practice staff. Thus, in terms of tools and technologies, they will use what is readily to hand and
draw on resources that they trust. The guidebooks were seen as a positive benefit to patients, a nice ‘gift’
for nurses to hand out and superior to computer printouts. So long as the supplies were on the office
shelf, they were easy to work with.
Say I have a new diabetic that’s the . . . usually the time that I would introduce the booklet because
I find the information is very easy to understand. So and they can take away that is a form it’s not just
an A4 piece of paper because we tend to use an awful lot of the patient.co.uk stuff which is excellent,
but it’s only a scrap of paper, isn’t it. Whereas the booklet I think [whispering] you know, and they go
away with a nice little booklet and it’s nice, but it’s also very pertinent information, it’s easy to read,
it has pictures that are coloured in, and I think that helps the eye, and all of that.
Nurse B, practice 22
For some, their use of resources was determined by the trust they had in the organisation that produced
the information, rather than any engagement with the content.
I mean the British Lung Foundation is a well-recognised organisation, so they’re the ones that I tend to
use. There are also some other booklets which, to be honest with you, I don’t remember where
they’re from but they’re . . . they will be from a recognised organisation.
Nurse D, practice 12
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Forms such as PRISMS were more troublesome to deal with because more thought was needed into how
and when they are utilised in the consultations and integrated into practice systems. The logistics of
distributing forms to patients was viewed as problematic. A number of options were considered, including
sending them out with patient reminders to attend review appointments. However, practices either lacked
the impetus to consider change, or immediately dismissed the possibility of engaging in the work
necessary to co-ordinate the adjustments to staff routines.
I’ve got to be 100% and tell you the truth, I don’t know out there because I’m in here [in the
consulting room] from 8 o’clock in the morning ‘til half 4. I don’t really go out to be honest. So I’ve
got me hand on heart and say I don’t really know.
Nurse G, practice 2
One practice did embrace the WISE model and was able to integrate the forms into its systems, although
sustaining the approach is feasible only if there is continual reflection and reappraisal of the benefit of the
PRISMS tool at all levels of the practice.
Yes, we have them out in reception for them to complete. Well the reception staff know who’s
diabetic or who’s COPD or whatever, the long-standing condition, and they will give them the form at
reception when they come in, if they can please fill this form in before you see the nurse.
Nurse F, practice 3
Patient experience and participation with self-management arrangements
Twenty-four participants with an index condition of either COPD (n = 5), diabetes (n = 9) or IBS (n = 10)
were interviewed during the process evaluation. Thirty participants from the exploratory trial were also
interviewed as part of an embedded longitudinal qualitative study: diabetes (n = 15), IBS (n = 8) and
COPD (n = 7).43
One of the aims of the patient interviews was to explore patient attitudes to engagement with any of the
new self-management arrangements. It was apparent from the interviews that patients had not experienced
any changes in the nature of their care as a result of the intervention and the interviews explored their views on
the tools developed for the WISE model and on their experiences and expectations of self-management
support. In order to do this, these instruments were introduced to patients during the interviews.
Meaning and use of the PRISMS tool
The majority of participants in both studies had not used the PRISMS form. When shown the form there
was a range of responses about its utility. The participants who did consider it something they could use
primarily saw it as a memory prompt and mechanism of introducing relevant issues into the consultation
which otherwise would be forgotten or not raised (e.g. if it was a sensitive issue or something that
was considered embarrassing, this provided an opportunity that might not occur naturally during the
consultation). Of most concern was the receptivity of the GPs to patient-initiated prompts and thus the
feasibility of making this work in practice. In this respect patients were rehearsing the needs of professionals
and conscious of the problems of disrupting consultation practices established over time.
I haven’t used it. But, it’s um, it is a good idea actually because if you’re like me, you keep forgetting,
you can go through it, tick it all off and then just hand it in to your GP when you go. Yeah that’s a
good idea that actually . . . Yeah, yeah, that’d be better that, fill it in at your leisure and then when you
go down there you can just hand it in. And then they’d know what, rather than trying to remember
what you were going to say when you get there . . . it’s a good idea. But, whether the GPs would like it
you don’t know, they should do, they can just, alright then, write you a prescription and give it you and
you’re away aren’t you?
ID 43309, female, index condition COPD
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The perceived usefulness of the PRISMS tool by patients was influenced by the participants’ relationship with
their GP and the expected response. One participant who had used the PRISMS form during a primary care
consultation reported that this had enabled her to raise ongoing health problems that were not condition
specific (i.e. increasing tiredness), and to be referred to appropriate services (Box 2). Use of the PRISMS tool was
considered by respondents with reference to previous consultations and encounters with their GP or practice
nurse. Participants’ perceived relationship with their GP ranged from good to poor. When participants reported
a good relationship with their GP, they described being able to raise concerns easily. However, for the majority
of participants, their relationship ranged from ambivalent to negative and this seemingly influenced the
perceived acceptability of introducing the PRISMS form. In addition, some participants who considered their
conditions to be stable did not feel that the PRISMS tool was applicable to them at that time but might be in
BOX 2 A case study of PRISMS as a potential ‘tipping’ point
Lyn was a participant in the longitudinal study who had used the PRISMS form. Over the course of the year-long
study her health had deteriorated, indicated to her by the number of medications she was taking (seven tablets
daily at the outset and 14 tablets daily at the time to the final interview). The way in which she had framed her
condition and her well-being had changed for the better. In the final interview, as a result of a number of
infections, Lyn’s health had deteriorated. However, she described increasing family support and the valued role
of the GP in referring her to a nutritionist. The nutritionist was perceived to have improved her quality of life
through dietary changes and the respondent reported being more engaged with managing her conditions,
although she did not see any objective improvements in her health. In the final interview the participant recalled
using the PRISMS tool, which had reportedly helped her to address ongoing generic health problems, such as
increased tiredness, a state which had become normalised over several years. The introduction of this form
coincided with the participant being so tired and lacking energy that she believed she was going to die and this
critical realisation acted as a tipping point to seeking help.
Answer: . . . I filled in what I could . . . like sleep problems, well I always have, I’ve always had big sleep
problems . . . support from the family, yeah I get, I get plenty of support . . .
Question: And for the things that it was a problem did this help you sort of start talk, bringing up things
with the doctor?
Answer: Yeah this is when I said to him I’m going to get myself motivated . . . get myself cracking, I don’t,
I, I kept saying I’ll die in the chair if I carry on that cause that’s what I’m saying.
Question: So this sort of helped . . .
Answer: Yeah because that’s what he said, that’s what he’s doin’ tests for cause this tiredness but it can
be due to the cal-, the calories that I’m burning away . . . that makes you, that can make you tired and all.
Question: Oh OK so this sort of prompted that discussion.
Answer: Yeah.
COPD and IBS, Female, age 57
The PRISMS form acted as an initial prompt to the discussion with her GP about how these general symptoms
of tiredness were restricting her quality of life. The recommendations made by the GP and nutritionist were
then maintained by the ongoing presence of family support, which reinforced personal motivation and
engagement with management practices, which in turn continued to improve her sense of well-being and
reduction in her symptoms.
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the future. This points to the need for tools to be sensitive to patient trajectories and changing needs and
circumstances.
Question: The PRISMS form. Do you think that’s useful?
Answer: Not to me.
Question: How come? . . .
Answer: Most of this is not applicable . . . Maybe because of my age, maybe because it’s diet
controlled diabetes . . . It might be more applicable later on.
ID 12188, index condition: diabetes, male
The Salford online self-care support guide
None of the participants reported using the self-care guide or being referred to it by their GP or practice nurse.
Condition guidebooks
Participants in the longitudinal study had not received the guidebooks; however, five participants provided
feedback on the content in the final interview (Box 3). The majority of participants in the process
BOX 3 Opinions on the guidebooks from participants in the longitudinal study
Participant ID 130a (index condition: IBS)
A very useful book to be given when first diagnosed as it gives other people’s experiences, which may be
the same as your own. Also helpful as you can see how other people manage and control the condition
and also how some people are not able to do so.
The second chapter is particularly useful as a lot of information in it is not always explained and gone in to
in any detail when the condition is being discussed with health-care workers.
Participant ID 110a (index condition: IBS)
I read all of this book and found it really easy to read and understand.
Very informative.
If you are a new patient to IBS you will find this a valuable book so you can refer to it anytime you want
to, or maybe you forget sometimes what is inside.
A great book for everybody with problems no matter what you are, male or female.
Participant ID 100a (index condition: diabetes)
I found the guidebook very helpful and I seem to have learned a lot from it. I am sticking more to a
healthy diet and trying to do more exercise. I shall keep reading it because it’s useful and interesting.
Participant ID 500s (index condition: COPD)
It is very thorough but rather ‘wordy’ and does rather labour the point about stopping smoking – which
does not apply to all patients with these problems.
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evaluation of the main trial did not recollect being sent the guidebooks through the post or being given
them during a consultation. However, in dialogue with the interviewer, the following participant had
received the guidebook and found it useful.
Yeah I sat down and read them. I did sit down, that one [guidebook], that yeah. Yeah you read them
and if there’s anything that catches the eye, what I’ll do, yeah I do take notice of what people say and
what advice . . . Yeah, they’re good. They are, they are useful.
ID 43309, female, index condition COPD
Stepped-up care
The stepped-up care option was available to IBS participants in the process evaluation only (n = 10)
and none had been referred to stepped-up care.
Patient expectations of self-management support
Patients’ expectations of help with self-management were shaped by previous experiences with their GP
and expectations of support available. There were generally low expectations of support based on poor
previous experiences, and difficult and unhelpful relationships.
. . . but when your doctor says something that really doesn’t help, you know, and I have had her say
‘well you just need to control what you put in your bloody mouth’.
ID 62153, female, diabetes patient
Such events resulted in people avoiding going to their GPs because of their low opinions of the help they
would get.
. . . she’s no good as a doctor basically . . . I’d rather suffer than have to go and see her. I only go if
I really need to go.
ID 63325, female, IBS patient
The restrictions imposed by the way in which primary care is organised militates against meaningful and
supportive discussions and adds to the lack of confidence in obtaining support.
Well, first time I went to her was Thursday morning and apparently you’ve got 10 minutes, but it’s
like 2 weeks to get in to see her. So I had a little list, because my memory’s not very good with this
fibromyalgia. Sometimes I’m alright, other times I can’t remember things. And I wanted advice on my
IBS, seeing if she could come up with something different while I was in the process of suffering as
well as this fibromyalgia, as well as menopause, things like that, but she said right, start with the
most important, and then when my 10 minutes was up she said would you like to make another
appointment please. I thought right, I’ve got another 2 weeks to wait. So I’m not pleased. Not when
the person in front of me was in more than 10 minutes.
ID 33304, female, IBS patient
In order to get support that they felt was appropriate, patients often had to work hard to persuade the
doctor and the build-up of negative experiences contributed to the low expectations of help.
I had to go to [Town] to a pharmacy that does the programme there . . . you can only purchase it
through a pharmacy. And they weigh you every week, they advise you, but they will only let you do
the programme with the agreement of the doctor. So they approached my doctor, she was reluctant
to do it at first, and it took a month to get her agreement for me to do it.
ID 62153, female, diabetes patient
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The examples of positive support occurred when existing relationships were good and when the doctor or
nurse was perceived to have genuinely listened; this appeared most likely in nurse consultations.
I usually ask if I can make an appointment with the nurse, and obviously they ask me why. She’s
very good. The nurse at my GP centre is very good. They will sit and listen. Listening makes a big
difference, while a doctor’s looking at you and looking right through you. You’re just sat there and
you’re making me money.
ID 61015, female, COPD patient
Self-management in patients with multiple conditions
One of the objectives of the longitudinal study was to examine self-management priorities for individuals
with multiple long-term conditions over time.78 The study demonstrated the impact of multiple conditions
on many aspects of people’s illness management and highlighted the complexities of self-management.
Narratives illuminated how individuals’ priorities changed at pivotal points and altered their engagement
with self-management practices. This was influenced by contact with health professionals and how people
framed illness and lifestyle changes. Medication management was a central point in which individuals took
control of their conditions.
Managing additional conditions
Additional conditions were more readily accommodated if people established cognitive links between
existing management practices. Thus, multiple conditions were not inevitably experienced as an increasing
burden but subject to considerable flux and change. Prioritising one condition over another at a particular
time together with a transfer and amalgamation of practices appears to facilitate accommodation of
multiple conditions. Clinicians might usefully engage with patients’ understanding to reduce complexity,
and enhance engagement of condition management.
However, patients who developed additional long-term conditions could experience that as disruptive.
I don’t know whether it’s I am carrying too much weight or I’m having too much sugar . . . but I’m
trying to find out . . . and all I get from [GP], it is your diabetics, they give it a different name all
together, I forget, I can’t get my bloody tongue round it and yeah, that’s one main thing and the
other is, I have had my eyes done cataract done and that, that were all right but um, it’s just niggly.
ID 0900 (diabetes, knee problems and kidney problems, male, age unknown)
I have, yeah just get on with it. It’s a chronic condition, there’s not a lot I can do about it other than,
except I’d like to take more exercise, walking, but at the moment as I say because of my feet problems
I can’t, so it’s a double whammy as they say.
ID 110s (COPD, oesophageal problems, feet problems, male, age 69 years)
Conversely, accommodation of further conditions could occur as there was a flow of existing management
practices reducing the impact of further conditions on the daily management.
I have to sort of eat regularly for the epilepsy, eat regularly, not get over tired, not drink too much
alcohol . . . don’t skip meals, so that is what I do for me epilepsy anyway, so that’s what helps with
the diabetes as well.
ID170a (diabetes and epilepsy, female, age 55 years)
Practices that learned and adapted from the management of one condition allowed some respondents to
accommodate new conditions if new routines were congruent with existing routines. This contrasts with
a view that multimorbidity by definition requires more complex clinical management accompanied by a
new set of practices for each ‘new’ condition. Of greatest salience to our respondents was a process of
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continuation and flow of actions, reactions and self-preservation of strategies that are deemed to work for
one condition applied to another.
Answer: Well she talked about diet and um, yes, really it was diet really you know, just be careful
what I eat.
Question: And has that been a big change?
Answer: No not really ‘cos I was already on quite a healthy diet . . . You know, before that I’d um,
I’d decided to lose a bit of weight if I could because with having MS it’s better not to carry a lot of
weight with it.
ID 100a (diabetes, multiple sclerosis, underactive thyroid and high cholesterol, female, age 66 years)
The dynamic prioritisation of conditions
Shifting prioritisation between conditions was key to the way management was framed and the process
of prioritisation over time required renegotiation of available resources. Although for a few participants
there was little description of change where one condition remained routinely prioritised, the majority of
descriptions were of changing prioritisation of conditions.
But it’s hard (to lose weight) I don’t know. So I put it down me personally to the tablets, whether
that’s putting weight on I don’t know . . . just watching what I eat now you know with diabetes really
more than anything like . . . But this breathing, this COPD that’s what will affect me in another few
weeks when it starts getting cold; it’s the cold that affects me.
ID 600s (diabetes, COPD, high blood pressure, high cholesterol, male, age 65 years)
Interactions with health professionals
Most respondents described a dynamic and variable process of self-management with little separation
between conditions. Respondents’ accounts of management practices were viewed across conditions with
links in practices and tensions that required active choices between options. This suggests a difference
between health professional accounts and patient approaches to multimorbidity, given that participants
talked about seeking information and management strategies across conditions and were given little or
no information.
The degree of congruence or conflict between views of health professionals and patients regarding
management priorities impacted on subsequent management practices and therapeutic relationships.
For participants who described similar management goals to their health professionals, contact reinforced
and maintained priorities.
Question: What’s kind of, your main priority at the moment with [GP]? . . .
Answer: Probably blood pressure, probably and cholesterol . . . so I’m more worried about those
because they are more serious things. IBS didn’t kill anybody, you know, but blood pressure is serious
and cholesterol is serious so IBS has gone into the background, you know.
ID 110a (IBS and high blood pressure, female, age 57 years)
However, for participants whose illness management priorities conflicted with health professionals,
established relationships were challenged. One participant with diabetes and chronic depression described
being ‘upset’ and ‘angry’ when her GP told her that she ‘just had to have willpower’ to control her diet for
diabetes. However, the respondent’s priority was depression, which she recognised affected her diabetes
control, and it was something she had actively tried to change over a number of years but was a complex
problem. When she tried to obtain information about managing both conditions ‘they couldn’t offer any
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help’. The GP’s response conflicted with her priorities and had a negative impact on what she would
engage with in managing her health.
I mean, I’ve got to say, when the doctor, when the GP said it to me, I actually came home and felt, er,
why should I stick to this diet, because I was depressed I felt, I’ve nothing to live for anyway, the
diabetes will kill me anyway.
ID 300s (diabetes, chronic depression, female, age 50 years)
Tipping points
To manage the complexity of multiple conditions, most participants reacted to changes in a process of
prioritisation and reprioritisation over time. This involved an interaction of factors such as timing between
diagnoses, prior experiences, recommended self-management activities, bereavement, contact with health
services and flare-up of conditions.
. . . there’s been a lot of things going on, because I started with epilepsy in 2000 and it’s like I was,
I had like a cluster and then they settled down . . . and then out of the blue I started with another
cluster, but I think it’s hormonal because that started up, I started with diabetes and blood pressure
you know, it seemed just, and I had gone through a period of depression because of [losing] my dad.
ID 170a (diabetes, epilepsy, female, age 55 years)
Prioritisation and reprioritisation occurred around key transition points when the relative importance of
different management practices shifted, having either negative or positive effects. These ‘tipping points’
particularly arose around issues of medication management, lifestyle changes and understanding
of conditions.
Medication management
Participants’ accounts of medications were framed in one of two ways: as an external event that was
‘being done to them’ and over which they had little control or, conversely, as an internal process whereby
they gained control of their illness management by establishing routines for taking tablets and personalising
their medication management. For participants whose narratives emphasised taking control, the presence of
multiple long-term conditions played a minor role in everyday life.
I am quite vigilant about taking my medication um, and if I’ve missed it I do know that I do start
feeling tired um, so I am quite compliant with me medication, but I have to take my epilepsy
medication anyway so yeah, I take me medication morning and take my medication at night, like I say
I am quite compliant about that.
ID 170a (diabetes and epilepsy, female, age 55 years)
However, other accounts of medicines portray a sense of an ever-increasing burden of tablets and
resistance to further tablets. These accounts depicted medicines as objects and a process which they are
subject to but have little direction over.
. . . for different ailments and that like and I’ve got bags of tablets there and now I’ve got that many
tablets and I don’t know you know, swapping and changing tablets, getting tablets from the hospital
and I don’t know where I’m up to with them like, you know.
ID 600s (diabetes, high blood pressure, high cholesterol, male, age 65 years)
Medications were also a point through which change could be negotiated. Some respondents described
seeking additional sources of information and verification around medicines to those provided by GPs or
specialists, as they did not feel confident that the latter were aware of all medicines being taken or their
interactions. The main sources of verification were from the internet, pharmacist and others with similar
conditions. These acted as legitimation points through which participants could change their routines as
they were able to engage in focused discussions with health professionals to take control and direct illness
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management. Narratives depicted a change to becoming active self-managers and taking control by
seeking out enough information to enable them to make decisions about medications.
I asked the pharmacy yesterday, I rang them up, ‘cos I’m taking so many different drugs, you’ve gotta
be careful. And they were saying, I was saying could you take them at the same time, ‘cos you’re
supposed to take these with food but you can’t take ‘em all with food . . . there’s one or two more,
but . . . you’ve gotta keep a track.
ID 0700 (diabetes, rheumatoid arthritis, high blood pressure, male, age 82 years)
I take a lot of tablets now, every time I go and see him, ‘Don’t give me another tablet.’ . . . He tries me
on different things and what you know doesn’t agree with me, he doesn’t give me . . ., he knows
that, you know what I mean. Same as painkillers, I won’t take painkillers, I only take paracetamol.
ID 120a (COPD and IBS, female, age 57 years)
Information use in patient self-management
Existing knowledge and direct experience of conditions from other sources played a role in illness prioritisation
and interpretation of information. Information was often viewed as contradictory or too general with
insufficient information about interactions across conditions. Participants described integrating information
from a number of sources. This led respondents either to feel confused or to actively monitor the suitability
of information provided by practitioners. Information and advice had to be reinterpreted and verified for it
to be useable and allow development of pragmatic routines.
Again, if you start to research it you come across dietary and nutrition, so that one kills all the sugars
off and that kills all the fat off and the two of them just clash all the way down . . . You end up with
you would be eating absolutely nothing except fruit and the odd slice of bread.
ID 150a (diabetes, high cholesterol, male, age 52 years)
Exercise as part of self-management
Exercise was considered important but also unrealistic because of functional limitations. When conditions
placed a physical limitation on an individual, this was often talked about as having the greatest impact
on their lives. It caused a tension between which self-management activities they should prioritise and
restricted daily activities. Restrictions could accumulate and produce further problems, which influenced
what could be attempted and the prioritisation of management practices.
Breathing. Um, only that I can’t do the things I used to, but whether that’s breathing or whether
that’s old age I’m not sure. In truth, I suppose I used to walk up to [town centre], now I get a taxi . . .
Or somebody takes me, but 70% of that is because of my feet, maybe 30% [because of COPD].
If my feet were fine, I’d still walk up to [town].
ID110s (COPD, oesophageal problems and feet problems, male, age 69 years)
Food and diet as part of self-management support
Dietary information was described as conflicting by many respondents and was not necessarily translatable
across conditions, resulting in the accommodation of new practices within pre-existing regimes. Advice
was often considered to be too generic and insufficiently individualised. Health-care professionals were not
seen as always addressing the impact of other conditions and respondents were left to navigate through
conflicting information to find the most appropriate course of action or seek further information.
Well she [practice nurse] gave me, um, information on diet which you could read in any woman’s
magazine, there was nothing specific. I did say to her that my problem was binge eating and she had
nothing to offer at all. She could not comment you know she knew nothing about it, so she wasn’t
able to help. So as I say it was a complete and utter waste of time.
ID 300s (diabetes and chronic depression, female, age 50 years)
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Social networks and self-management support
Interviews conducted as part of the longitudinal study with patients also revealed something of the wider
relationships influencing self-management support. Analysis reinforced evidence that who is in the network,
and the types of relationships that are present, influence how management practices are framed and the
extent of engagement.79 Resources available to an individual through the network can support or undermine
engagement, and these change over time. Networks included family, friends, GP, nurses and companion
animals. The amalgamation of different relationships that constituted the social networks were characterised
by three network typologies. The three types of networks are characterised by differing combinations of
features that influence priorities for health, the various roles that network members occupy and the degree
to which the network might support and facilitate the normalisation of illness management into everyday
life. Networks can be categorised as a family-focused network, a friend-focused network or a health-care
professional-focused network.
In the family-focused network, the main source of support and information is provided by multiple family
members with various roles in supporting the individual. There are usually multiple ties between network
members. For networks that can be defined as family-focused networks, health-care professionals are
viewed as important but are not so regularly seen. In a friend-focused network, there is greater variance in
the types of relationships present; friends appear to have a more significant role for the individual than
members of either the family-focused network or the health-care professional-focused network. For younger
participants with a friend-focused network, parents and partners are also important, yet their role is subject
to change (e.g. becoming more restricted because of specific events which have altered their relationship).
For the participants whose social networks are characterised as friend focused and who are older, family
members are less relevant. For these first two types of networks, management is normalised into existing
practices and routines through negotiation and discussion with other network members, but, despite
multiple conditions, participants in this study identified only a single GP or nurse as significant. The networks
described in these first two categories frame health management within existing dimensions of everyday life
that are not separate but integrated as routines and practices in daily life. The friend-focused network seems
to emerge when there is an absence or loss of adequate family support and alternative lay support is
sought instead.
The third type of network, the health-care professional-focused network, represents a network in which
health is considered to be something managed more separately from the wider social network. Health
and its management are framed as private, which can be a burden to others, and so seeking support is
avoided, or limited as much as possible.
Discussion
In the practices, self-management tools failed to be normalised in routine care, apart from handing out
the guidebooks. This may explain the lack of change experienced by patients. The WISE model was
intended to encourage reassessment of work practices while introducing new elements that fitted with
existing work and improved patient care. The long-term condition management work delegated to
nurses was a routinised process of monitoring and recording necessary for QOF. Practice nurses viewed
themselves as being patient centred and holistic, yet psychosocial and behaviour change support is not
generally incorporated, with our respondents reporting use of didactic information giving. Nurses had
concerns about the burden of providing enhanced self-management support in terms both of their own
workloads and what they felt their patients could accommodate. Provision of the guidebooks was the
one element that could be considered minimally disruptive work, fulfilling their need to provide good
information while enhancing their ability to be patient centred.
The challenges of changing professional behaviour and attitudes in order to implement self-management
support are widely reported.73 The WISE model approach aimed to pragmatically address existing evidence
and recommendations, and provided tools and training in skills to assist self-management support in the
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context of an organisation geared up to provide appropriate resources. Using NPT allowed us to focus on
the everyday work of nurses and to explain why the WISE model did not embed: self-management support
was not a practice priority as it was not part of QOF; it was not seen as different enough to existing work
to value yet considered too disruptive and time-consuming; and there was lack of communication or
support within the practice.
In showing reluctance to engage in behavioural change discussions with patients, nurses demonstrated
an awareness that, for patients, self-management involves a complex, embodied, practical knowledge
that clashes with the abstract, rationalised models assumed both in biomedical approaches to long-term
condition management and in programmes such as the Expert Patients Programme. The claim by nurses to
integrate patients’ lived experience and priorities into clinical encounters is not new, but for the most part
this is treated as an addition or as something to fit into the tasks of monitoring and testing in a way which
represents only marginal movement towards patient needs and knowledge concerning self-management
support. In this respect, nurses were not able to deploy the principles of WISE that fitted with patients’
agendas, needs or experience of managing a condition in their daily lives. Rather, they could not adopt
and embed a new system at odds with their protocol-based system, which ensures the financial income of
the practices which employ them.
The rare occasions when aspects of self-management support were incorporated involved nurses
experienced and confident enough to disrupt the prevailing system. Such nurses were prepared to
overcome the hidden nature of self-management support and the lack of recognition for providing it.
In other words, those individuals were willing to try different approaches and able to reflect on the
benefits they saw for their patients. Even so, they were not able to report moving beyond opening up
the consultation to address patient priorities – lifestyle change is not readily doable in primary care and
falls more within the day-to-day world of the patient.
DOI: 10.3310/pgfar06010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2018 VOL. 6 NO. 1
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Thompson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
55
Chapter 7 Project 2: identification and risk
assessment
Some patients with IBS have symptoms that are difficult to control and suffer considerable ill health,whereas other patients have symptoms that are well controlled and they cope well. Approximately
30% of patients who consult their GP with FGIDs go on to develop chronic symptoms.80 Previous studies
have shown that an intervention with self-management tools reduces distressing symptoms for hospital
outpatients, consequently reducing health-care utilisation. Provision of a self-help guidebook reduced
primary care consultations for IBS by 60%.15
The medical management of functional lower gastrointestinal symptoms usually involves antispasmodics,
antidiarrhoeals or laxatives, as appropriate, and antidepressants, particularly low-dose tricyclic
antidepressants. Unfortunately, for some patients medical management yields far from satisfactory results.
For patients with intractable symptoms, which are resistant to conventional medical therapy, current
guidelines recommend referral for psychological intervention to CBT or hypnotherapy.81
It has been shown that within primary care it might be possible to predict those patients at risk of having
persistent symptoms: 87% of patients exposed to a small number of factors at the time of initial
consultation were found to have persistent gastrointestinal symptoms at 6 months.82 It may be possible to
use a screening tool to identify patients at risk of persistent symptoms.82
This study aimed to test this finding prospectively on a larger scale. If this finding was validated it might
be possible to identify those patients at risk of poor outcomes and fast-track them to therapies that are
known to be effective, such as CBT or hypnotherapy. This should lead to less distress and lower health-care
utilisation for these patients in the long run.
One of the difficulties encountered in previous work on IBS within primary care is the identification of
patients. GPs use a variety of Read Codes to describe patients presenting with IBS and, to our knowledge,
the range of Read Codes used has not previously been investigated. This would enable future studies to
evaluate the ‘true’ burden of IBS in primary care. The work on the use of Read Codes used by GPs to
describe functional lower gastrointestinal symptoms is supplemented further by conducting qualitative
face-to-face semistructured interviews with GPs to explore their attitudes and approaches to diagnosis and
management of functional gastrointestinal symptoms.
Project 2 therefore comprised the following four separate studies.
1. The first study consisted of a GP database study (GP database study 1) to describe how clinicians in
primary care record consultations with patients who experience functional lower gastrointestinal
symptoms.
To meet this aim we used a computational mapping approach using data from NorthWest EHealth,
a health data repository.
2. The second study was a risk assessment study. The aim of the study was to validate a risk assessment
tool for predicting symptom distress for IBS.
We used a 12-month prospective case–cohort study in which patients consulting their GP with IBS were
recruited prospectively in order to validate a risk assessment questionnaire.
3. The third study was a qualitative study to explore GPs’ views and experiences of defining, diagnosing
and managing of functional lower gastrointestinal symptoms in primary care.
4. The fourth study was a further GP database study (GP database study 2) to investigate patient profiles
in IBS, IBD and AP, and to explore whether or not GPs follow NICE guidelines81 for patients with IBS.
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General practitioner database study (study 1)
Consultations in general practice are recorded and coded using a clinical diagnostic coding system, known
as Read Codes. Consultations tend to be coded either by symptom presentation or by problem title, and
the current computerised systems for clinical coding seem to promote diversity rather than consistency.83
GPs tend to make a positive diagnosis of IBS when the risk profile of the patient for that condition is high
(and their characteristics fit the profile for functional disease) and the risk of serious bowel disease is low.84
This approach is recommended in current NICE guidelines81 to help practitioners identify patients with
IBS more easily and make a ‘positive diagnosis’ for the condition. This method is distinct from applying
diagnostic criteria to the patient’s symptoms, such as Rome III criteria,85 to define IBS. Thus, there might
be considerable variation in the way that consultations for patients with IBS are coded. This might be
compounded by the fact that IBS is not one of the chronic conditions contained in the QOF – a system
of paying GPs for achieving clinical targets. Variations in coding practice, and exclusion of IBS from the
QOF, may militate against quickly and reliably identifying IBS patients who might benefit from therapeutic
interventions.
Aim
The aim of GP database study 1 was to determine the extent to which there was a recognisable and
reliable phenotype for IBS patients presenting to general practice. This was deemed important so that
we could identify a range of Read Codes used by GPs serving the study population to denote patients
with IBS.
Methods
Setting
The setting for this study was the city of Salford, in north-west England, with an estimated population of
228,992 in 2010.
Sampling frame
The sampling frame comprised all patients registered with the 52 general practices in Salford PCT.
Data collection and coding
The Salford Integrated Record (SIR) is a local patient-sharing record system that integrates primary care,
community care and secondary care information into one continuous electronic health record per patient.
An anonymised data set is made available for research through NorthWest EHealth. Patients may opt out
of the SIR; however, the proportion who do so is relatively small.
We obtained electronic clinical records from the SIR for January 2003 to December 2009. The data set
comprises anonymised patient identifiers, anonymised general practice identifiers and the set of Read
Codes used to code clinical consultations. In total, the data set contained > 136 million Read Codes
derived from 34,200 distinct codes. Two gastroenterologists independently identified all Read Codes
potentially relating to gastrointestinal disorders or IBS.
Ethics permission for this study was granted by the NorthWest EHealth Board.
Analysis
The analysis was conducted in two parts. First, we conducted analyses of patients with gastrointestinal
symptoms. Second, we refined this analysis to consider only those patients with IBS.
Gastrointestinal symptom space
First, we selected patients with evidence of at least one Read Code for gastrointestinal disorders in 2009,
which generated 19,869 patient records. The records for these patients were then searched for those with
at least one diagnosis of IBS (Read Code J521) at any time since 2003. For each of these patients we
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collected together all the Read Codes from their records in general practice in 2009. Each patient was
therefore represented by their set of Read Codes from 2009. To investigate the importance of gastrointestinal
symptoms we then generated a second data set, which included only the Read Codes for gastrointestinal
symptoms for these patients.
These data sets were then mapped onto a two-dimensional plane using a methodology that calculates the
Resnik similarity between the concepts. It then maps these data from similarity space to the appropriate
vector space and uses principal components analysis (PCA) to represent the data on a plane.
Each patient was therefore represented as a point on the plane and patients with similar symptoms
occupied similar positions on the plot. These plots were then presented according to particular sets of
Read Codes contained within the records.
The total data set available for analysis in diagnosis space was too large to make an analysis computationally
tractable. We therefore examined 16,584 patient records from the three GP surgeries with the highest
number of patient records with a diagnosis of IBS. All diagnosis codes for all these patients were collected
and projected into diagnosis space using the same computational strategies discussed above.
Results
Representation of patient records in gastrointestinal symptom space
Patient records were represented in the space of gastrointestinal symptoms. Figure 7 shows the results
obtained by taking just the gastrointestinal symptoms from the 2009 Salford data set, and performing the
semantic similarity analysis and PCA for dimensionality reduction.
The gastrointestinal symptoms recorded by GPs were separated on the basis of two predominant
symptoms, diarrhoea and gastrointestinal tract (GIT) pain. Patient records marked in light blue do not have
any record of diarrhoea or GIT pain. The region highlighted in light green represents the patient records
that are positive in recording of diarrhoea symptoms and negative GIT pain. Therefore, the largest source
of variation within the data set concerns diarrhoea and GIT pain. Furthermore, patients with particular sets
of symptoms occupy particular regions of gastrointestinal diagnosis space.
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FIGURE 7 Principal component analysis plot of gastrointestinal symptom data. Each dot represents a particular set
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records, as indicated in the figure legend. GIT, gastrointestinal tract.
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We considered next how other symptoms are distributed in symptom space. In Figure 8 we present
several common gastrointestinal problems in this space: heartburn, flatulence, abdominal distension and
indigestion. These symptoms are scattered across most of the diagnosis space without being clustered in
any particular area.
Representation of irritable bowel syndrome patient records in gastrointestinal
symptom space
Figures 7 and 8 provided some insights into symptom space and the ways in which the patients are
distributed. Next, we examined whether or not there was any clustering of patients diagnosed with IBS in
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FIGURE 8 Common gastrointestinal problems mapped into symptom space. Shown in green are patients who
have been given a diagnosis of IBS. (a) Heartburn; (b) flatulence/wind; (c) abdominal distension symptom; and
(d) indigestion. (continued )
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this space by looking for the IBS diagnosis code in all patient records from 2003 to 2009 and highlighted
whether or not the IBS code was present. These records were then mapped onto gastrointestinal symptom
space from 2009, as previously calculated (Figure 9).
The IBS patients were scattered across all of symptom space. There was no evidence that IBS patients
cluster in any part of this space.
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FIGURE 8 Common gastrointestinal problems mapped into symptom space. Shown in green are patients who
have been given a diagnosis of IBS. (a) Heartburn; (b) flatulence/wind; (c) abdominal distension symptom; and
(d) indigestion.
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Irritable bowel syndrome patients in diagnosis space
Figure 10 shows the results of the PCA applied to all the diagnosis data from all the patients from the
three general practices in Salford that had the most patients with an IBS diagnosis. Patient records were
classified in different regions of vector space in terms of three different groups of diseases: ‘nervous system
and sense organ diseases’; ‘genitourinary system diseases’; and ‘infectious and parasitic diseases’. The
light-green area belongs to the patients who were recorded to have ‘infectious and parasitic diseases’ but
not ‘nervous system and sense organ diseases’, or ‘genitourinary system diseases’. The light-blue area
encompasses those patients who have none of the diseases. The area in black represents the patients who
were recorded to have ‘nervous system and sense organ diseases’ but not ‘genitourinary system diseases’.
The dark-green region contains the patients who were recorded as having ‘genitourinary system diseases’
but not ‘nervous system and sense organ diseases’. Finally, the dark-blue area belongs to patients who
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FIGURE 9 A representation of patients in gastrointestinal symptom space.
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were recorded as having both ‘nervous system and sense organ diseases’ and ‘genitourinary system
diseases’. The various diagnoses do cluster very effectively in the plot.
Figure 11 Shows this same data, but this time with patients labelled either by the presence of a
gastrointestinal symptom code in their data (see Figure 11a), or by a diagnosis of IBS (see Figure 11b).
Comparing Figures 10 and 11 provides an insight into the areas of diagnosis space in which patients with
gastrointestinal symptoms and a diagnosis of IBS fall. It is clear that gastrointestinal symptoms are found in
patients across all of this space. The picture for patients with IBS is more informative. There is a cluster of
IBS patients in the area associated with infectious disease, another in the area associated with nervous
system and sense organ disease and a third area clustering in genitourinary system disease.
Discussion
In this study we attempted a novel analysis of data regarding the diagnosis and description of patients
with IBS from data coded in GP electronic patient records from Salford. Using this approach we were
unable to reliably identify a phenotype for IBS patients in primary care.
A major advantage of the SIR is the complete linkage between primary care, community care and secondary care
data sets, providing a continuous electronic record for each patient in contact with health services in Salford.
However, there were certain limitations in using these data to try to identify patients with IBS in our study.
First, a variety of computerised systems are available for capturing clinical consultation data in primary care.
Furthermore, there are several different versions of the various operating systems in use so that there
might be slight variations at computer operating system level that would have impeded our research.
Second, the Read Codes used to code a consultation are at the discretion of the individual clinician,
which means that there can be considerable variation in their use to describe the same set of symptoms
in practice. However, research requires a disciplined approach to data entry and retrieval,86 so that
inconsistency in coding potentially presents an important source of information bias.
A further challenge was validating the data set. Although two clinicians generated the list of Read Codes
used in the study, independently of each other, we were unable to validate the GP diagnoses. Ideally we
would have created a cohort of IBS patients from SIR and validated the diagnosis by asking their GPs,87 but
this was not possible as the SIR for research is anonymised at both the patient and GP level. Our analysis
of IBS patients in diagnosis space was confined to data from three practices in Salford. This was because of
limitations in computational power. However, it is possible that the diagnostic coding behaviour of GPs in
those practices with more IBS patients was not typical of the diagnostic coding behaviour of other GPs in
Salford. Finally, there are idiosyncrasies in the Read Code taxonomy, in particular the fact that codes for a
lack of existence of a symptom can occur as leaf nodes describing that symptom. This type of structure in
the codes breaks the semantic relationship between ‘parent’ and ‘child’ nodes in the taxonomy; a ‘child’
does not inherit properties from the parent. However, it seems that GPs might be reluctant to document
patients using such negated child node Read Codes as none was found in the data set we used.
Despite these limitations, our analyses generated some useful insights. We first looked at symptoms
associated with IBS to investigate whether or not there were any particular gastrointestinal symptom data
that could be used to identify IBS patients. However, there was no such clustering of IBS symptoms – the
symptoms associated with patient records containing a diagnosis of IBS were distributed throughout this
space. This accords with evidence that approximately two-thirds of the symptoms presented by patients in
primary care remain unexplained.88 It is clear from the scattering pattern of IBS in the gastrointestinal
symptom space that these symptoms are not unique to, or characteristic of, IBS and probably reflect the
relatively subjective criteria used for establishing an IBS diagnosis. Therefore, it would be difficult to find
any linear combination of gastrointestinal symptoms as recorded in the GP data in Salford that could be
used to reliably identify IBS patients. Cases with diagnosis of any kind of digestive system diseases showed
a similarly fragmented pattern.
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FIGURE 11 A representation of all diagnosis information collected in 2009 for patients from three GP surgeries in
Salford. (a) any patients showing gastrointestinal symptoms are shown in green and (b) patients with a diagnosis
of IBS are shown in green.
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We looked next in diagnosis space to determine if IBS patients clustered in any way in this space. Here the
findings were less clear cut. There was no unique cluster of IBS patients. However, this is unsurprising, as
patients with IBS are known to display a range of other symptomatologies. There were concentrations of
IBS patients associated with infectious disease, genitourinary problems and nervous system disease. The
links with infectious disease and nervous system disease have been highlighted previously,89 and it is
reassuring that we found these associations using this novel methodology. There is less literature about a
link between IBS and genitourinary disease. However, this work suggests that this is an area that might be
worth exploring further.
In epidemiological studies, case definitions are paramount for describing patients for inclusion in a study
systematically. Our analyses of data from the SIR, in particular our inability to define an IBS phenotype,
suggest that it is not yet possible to develop case definitions for primary care-based research studies of
IBS patients using Read Codes. To do so would require a more rigorous, standardised approach to
implementing Read diagnostic coding in primary care.
Risk assessment study (study 2)
It has been reported that over half of patients with IBS have consulted their GP within the past 6 months.90
A significant proportion (approximately 30%) of patients consulting their GP with FGID go on to develop
chronic symptoms.80 However, it might be possible to predict those at risk of having persistent symptoms
in patients with gastrointestinal symptoms in primary care.82
A previous study found that 87% of patients exposed to a small number of factors at the time of initial
consultation had persistent gastrointestinal symptoms at 6 months. These factors included higher levels of
psychological distress, no change in diet, symptom duration, no recent gastroenteritis and interrupted
activities as a result of bowel problems. Consequently, it may be possible to use a simple screening tool to
identify patients at risk of persistent symptoms in the future.82
The current study aimed to test this finding prospectively in a larger-scale study. If the finding was
replicated it might be possible to stratify patients into those at low and high risk of persistent symptoms
and to fast-track those at risk of doing worse to therapies that are known to be effective, such as CBT or
hypnotherapy. In turn, this should lead to less distress and lower health-care utilisation for these patients in
the longer term.
Aim
The aim of this study was to test the validity of the risk assessment questionnaire for predicting symptom
distress in patients with IBS.
Methods
Design
The risk assessment study was a 12-month prospective case–cohort study in which patients consulting their
GP with newly identified (incident) or existing (prevalent) IBS were recruited prospectively in order to
validate the risk assessment questionnaire.
Setting
Initially we approached those practices that had a service-level agreement with the Greater Manchester
Comprehensive Local Research Network. We then took a staged approach to roll the study out to general
practices within Greater Manchester.
Study population
Patients consulting their GP for existing (prevalent) or new episodes (incident) of IBS.
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Sample size calculation
The sample size calculation was based on separate samples of newly diagnosed and prevalent (i.e. existing)
patients. Assuming an intracluster correlation coefficient of 0.05, 320 patients would be required to
provide a 95% CI of ± 10 points or less for true sensitivity of ≥ 70%. The CI for an equivalent level of
specificity is considerably smaller (± 6%). Assuming a dropout rate of approximately 25%, 420 newly
diagnosed and 420 prevalent (i.e. existing) participants would be required.
Recruitment method: via consultation
General practitioners were asked to invite potential participants to take part in the study during their
consultation for IBS and forwarded a permission to contact slip for those participants who expressed an
interest in taking part to the study team.
During the consultation, GPs were asked to recruit patients with new or prevalent cases using the
following definitions.
1. New diagnoses of functional lower gastrointestinal symptoms were defined clinically as a patient
reporting symptoms for at least 3 months but less than 1 year by using Read Codes for:
i. IBS
ii. bloating
iii. AP
iv. diarrhoea
v. constipation
vi. change in bowel habit.
2. Prevalent episodes were defined clinically as patients with an onset of functional lower gastrointestinal
symptoms/IBS more than 1 year ago for:
i. IBS
ii. bloating
iii. AP
iv. diarrhoea
v. constipation
vi. change in bowel habit.
In addition, patients had to meet the following inclusion criteria:
l adults aged > 18 years
l must have consulted the health-care team in the past 3 months for functional lower gastrointestinal
symptoms/IBS as defined at (1) and (2) above.
Exclusion criteria
The following are exclusion criteria for both new and prevalent episodes:
l patients with a terminal illness
l patients who do not speak English and for whom a suitable interpreter is not available
l patients with severe mental incapacity
l patients with known chronic gastrointestinal disorders:
¢ IBD (Crohn’s disease and ulcerative colitis)
¢ coeliac disease
¢ cystic fibrosis
¢ surgical obstruction
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l patients with NICE ‘red flag’ indicators:
¢ unintentional and unexplained weight loss
¢ rectal bleeding
¢ a family history of bowel or ovarian cancer
¢ a change in bowel habit to looser and/or more frequent stools persisting for > 6 weeks in a person
aged > 60 years
¢ anaemia
¢ abdominal masses
¢ rectal masses
¢ raised inflammatory markers.
Recruitment method: Read Code searches
Owing to the difficulties recruiting patients via consultation, GPs were asked to conduct a Read Code
search to identify participants. Initially we focused on those practices that had not referred any patients
and assistance from the Primary Care Research Network (PCRN) was offered. GPs were asked to screen
participants to ensure their suitability for the study.
For the Read Code searches in practices, the inclusion criteria differed slightly from those for GPs who
recruited patients via the consultation. Practices were asked to recruit patients on the basis of the IBS Read
Code, by identifying those who had received this code within the last 10 years, but patients must have
consulted their GP within the past 3 months for functional lower gastrointestinal symptoms (e.g. bloating,
AP, diarrhoea, constipation or change in bowel habit). By restricting the search to those who had received
the IBS label within the last 10 years and who had consulted recently for lower functional gastrointestinal
symptoms, it was felt that this would produce a more manageable number of patients and, therefore,
reduce the burden on practices.
Potential participants were sent a study pack containing an invitation letter (either from the GP or the
research team), study information sheet, questionnaire and consent form. Those participants who wished
to take part in the study were asked to complete the consent form and return it with the questionnaire
to the research team. Those who did not wish to participate were asked to return a blank copy of the
questionnaire. One reminder was sent to non-responders after approximately 2 weeks. Participants were
followed up at 3, 6 and 12 months. One reminder was sent to non-responders after approximately
2 weeks.
Questionnaires
Practice questionnaire
Practices that agreed to take part in study 2 were asked to complete a short questionnaire about the
characteristics of their practice. This included details on the number of male and female partners,
assistants, retainers, salaried GPs and practice nurses working full or part time; numbers of patients on the
practice list; and the number of sites that the practice operated from. Practices were also asked to describe
the type of location of their practice (rural, semi-rural, suburban, town/city or inner city), as well as the type
of practice population (deprived, mixed – poor, average, mixed – well off or affluent). Finally, they were
asked about their contract: General Medical Services, Personal Medical Services, Alternative Provider
Medical Services or other; and whether or not the practice was a teaching/training practice.
Patient questionnaire
This consisted of the risk assessment questionnaire, the General Health Questionnaire (GHQ), IBS Symptom
Severity Scale, Irritable Bowel Syndrome Quality of Life Questionnaire (IBS-QOL) and the EuroQol-5 Dimensions,
three-level version (EQ-5D-3L), as well as patient demographics (see Appendix 4).
DOI: 10.3310/pgfar06010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2018 VOL. 6 NO. 1
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Thompson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
67
The risk assessment questionnaire consisted of the following questions:
l When your symptoms occurred how long did they last? (≤ 2 hours or less, > 2 hour)
l When your symptoms occurred had you changed your diet? (yes, no)
l Did you (i) have gastroenteritis or food poisoning (yes, no) or (ii) have contact with anyone with
diarrhoea and vomiting? (yes, no)
l Have your activities (e.g. work or social activities) been interrupted in the last year because of problems
with your bowels? (yes, no)
Participants were asked to answer the questions thinking about the symptoms they consulted their GP
with most recently.
Participants were also asked to complete the 12-item GHQ.91 The GHQ is a self-administered questionnaire
aimed at detecting psychological distress. It consists of 12 questions in relation to symptoms or behaviours,
which participants are asked to score from four categories ranging from ‘not at all’ to ‘much more than
usual’. Scores are then summed for each of the 12 items to produce a total score out of 12, with higher
scores representing increasing levels of distress.
The scoring for the risk assessment tool was based on participants’ responses to the above questions
(see Appendix 5).82 In addition, those who scored ≥ 3 on the GHQ were scored an additional point on
the risk assessment tool. Thus, participants were given a total score (0–5).
The IBS Symptom Severity Scale92 is a four-item questionnaire. Participants are asked to score on individual
visual analogue scales the severity of their AP and distension, satisfaction with bowel habit and interference
with life in general. They are also asked how many days out of the last 10 days they had AP. They are
given a total score up to a maximum of 500. Those with a score of < 75 are considered healthy patients,
75–174 indicates mild IBS, 175–299 moderate IBS and ≥ 300 severe IBS.
The IBS-QOL93 is a 34-item questionnaire that asks participants to provide responses to statements about
their bowel problems over the last 30 days. Responses range from ‘not at all’ to ‘extremely’. The IBS-QOL
produces an overall score and eight subscales, including dysphoria, interference with activity, body image,
health worry, food avoidance, social reaction, sexual and relationships. Scores are transformed to a
0–100 scale ranging from poor quality of life (0) to maximum quality of life (100).
The EQ-5D-3L58,59 is a self-administered standardised measure of health status. It consists of five
dimensions: mobility, self-care, usual activities, pain/discomfort, anxiety/depression. Participants are asked
to rate each of these dimensions as having no problems, some problems, extreme problems. Participants
are also asked to indicate their own health state today by completing a visual analogue scale from worst
(0) to best imaginable health (100).59
The questionnaire also contained questions in relation to age, gender, postcode (as a measure for
socioeconomic status), ethnicity, occupation and employment status. Follow-up questionnaires at 3, 6 and
12 months consisted of the IBS Symptom Severity Scale, GHQ, IBS-QOL and EQ-5D-3L.
Data cleaning and validation
Questionnaires were entered into the study database; data were double entered and checked. This process
did not reveal any systematic data entry discrepancies. Frequencies and cross-tabulations were run to check
for out-of-range values and data inconsistencies.
Analysis
Responders versus non-responders
Where possible, anonymised data were collected on non-responders, to provide comparison between
participants and non-respondents. These data included age, gender and postcode sector. IMD scores were
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derived using GeoConvert (UK Data Service Census Support, Colchester, UK),94 which provides an IMD
score for individual postcodes. For those non-responders identified via Read Code searches, we had
information only on postcode sector rather than full postcode. To ensure comparability between responders
and non-responders, we used postcode sector for both groups. For each postcode sector GeoConvert was
used to obtain a list of postcodes within that postcode sector and assigned an IMD score based on the
weighted mean of the postcodes within that postcode sector.
Referrals and response rates
Referrals and response rates were reported for those recruited via the consultation and Read
Code searches.
Sensitivity and specificity
Receiver operating characteristic curve analysis was used to examine the ability of the risk assessment
questionnaire to predict patients classified as having severe IBS according to the irritable bowel severity
scoring system 3, 6 and 12 months later. Sensitivity and specificity were calculated for a range of cut-off
points on the questionnaire, from which it was determined whether or not a cut-off point existed that
yielded adequately high levels of both sensitivity and specificity. Positive predictive values were used to
assess the extent to which those patients rated as high risk by the risk assessment tool went on to have
high symptom distress.
Comparison of participants at baseline, 3 and 6 months
Symptom distress, IBS quality of life and EQ-5D scores were presented for all participants at baseline
(unmatched), as well as for those who completed the questionnaire at baseline and at 3 and 6 months
(matched). We do not report changes at 12 months because responses were not collected from
all participants.
Results
Referrals
A total of 58 individual practices were recruited. Table 16 gives further details of practices recruited to
the study.
The majority of practices recruited described their location as suburban (48%) or town/city (35%). The
population type was described as average by 43% of practices, deprived or mixed (poor) by 33% and
mixed (well off) or affluent by 24% of the practices. The majority of practices worked under a General
Medical Services contract (62%) and were training practices (69%). The mean list size was 7166 patients,
ranging from 1344 to 16,583 patients. The median number of full- and part-time GP partners was two
and the median number of full- and part-time nurses was zero and one, respectively.
Of the 58 practices recruited to the study, 34 referred patients to the study either via permission to contact
slips or through the use of Read Code searches. In total, there were 606 referrals to the study, of which
just over half (n = 325, 54%) were referred via practices using permission to contact slips (Table 17).
The remaining 281 (46%) referrals were made through the use of Read Code searches at the practice.
The mean number of referrals from all practices was 10 and ranged from zero referrals to 207 referrals
from one practice.
Response rates
Of those referred to the study, 257 patients from 30 different practices agreed to take part (the overall
response rate was 42%). The response rate was higher among those patients who were identified via the
consultation (47%) than among those who were identified via Read Code searches (37%). For those
practices that recruited patients to the study, the mean number of patients recruited was nine, the mode
was one and the number of patients recruited ranged from 1 to 94 from one practice.
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Completed responses at 3, 6 and 12 months were received from 188 (73%), 161 (63%) and 73 (28%)
participants, respectively. Owing to time constraints, complete 12-month data were not available for all
participants; of those who posted a 12-month questionnaire, the response rate was 60% (73/121). Of
those who returned the initial questionnaire, 54 (21%) completed the initial questionnaire only, 38 (15%)
completed the initial and 3-month questionnaires, 82 (32%) completed the initial, 3- and 6-month
questionnaires and 65 (25%) completed the initial, 3-, 6- and 12-month questionnaires. A further 18 (7%)
participants completed the initial questionnaire but missed one or more follow-up questionnaires.
Table 18 shows the patient characteristics for those recruited to the study. The majority of participants
were female (80%) and white (88%). The mean age was 41 years and the mean IMD score was 23.65.
TABLE 16 Practice demographics (N= 58)
Practice demographic variable Number of practices % of practices
Location
Rural/semi-rural 4 7
Suburban 28 48
Town/city 20 35
Inner city 6 10
Population type
Deprived 8 14
Mixed: poor 11 19
Average 25 43
Mixed: well off 12 21
Affluent 2 3
Type of contract
General Medical Services 36 62
Personal Medical Services 20 35
Alternative Provider Medical Services 2 3
Teaching practice
Yes 40 69
No 18 31
Practice list size (mean) 7166
TABLE 17 Referrals and response rates by method of recruitment
Referral method Referrals, n Responders, n (%)
Via consultation 325 153 (47)
Via record search 281 104 (37)
Total 606 257 (42)
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Responders versus non-responders
Demographic data were available for 81% of non-responders (281/345). Males were less likely to respond
(56%) than females (52%), and non-responders tended to be slightly younger (39.8 years) than responders
(41.3 years). These differences were not statistically significant. There was also no significant difference in
the mean IMD scores for responders and non-responders based on the postcode sector analysis (24.9
vs. 26.5, respectively).
Sensitivity, specificity and positive predictive values
Table 19 shows the number and percentage of participants by symptom severity and risk assessment score
at baseline, and at 3, 6 and 12 months. At baseline, one-quarter of participants were classified as having
severe symptom distress; this proportion fell to about 15% at each of the follow-up periods. The majority
of participants scored 4 or 5 on the risk assessment tool at each time point.
Table 20 shows the results from the receiver operating characteristic curve analysis. A score of ≥ 4 on
the risk assessment tool yielded the best cut-off point to predict severe symptom severity at follow-up;
however, the number of participants included in the analysis was much lower than that proposed in
the original sample size calculation and included both those with prevalent and incident IBS. At 3 and
6 months, sensitivity (the probability that the score on the risk assessment tool was high when symptom
severity was severe) was > 80%, but specificity (the probability that the score on the risk assessment
tool was low when symptom severity was not severe) was low (36% and 42% at 3 and 6 months,
respectively). Positive predictive values (the probability that symptom severity was severe when the score
on the risk assessment tool was high) was poor (approximately 20%) at all three time points.
TABLE 18 Patient characteristics
Patient demographic variable Participants, n (%)
Gender
Female 206 (80)
Male 51 (20)
Age group (years)
16–24 56 (22)
25–34 63 (25)
35–44 34 (13)
45–54 37 (14)
55–64 29 (11)
≥ 65 37 (14)
Age (years), mean (SD) 41.3 (17.9)
Ethnic origin
White 225 (88)
Mixed 5 (2)
Asian or Asian British 14 (5)
Black or black British 7 (3)
Other 4 (2)
Missing 2 (1)
IMD score, mean (SD) 23.65 (13.95)
SD, standard deviation.
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Comparison of participants at baseline and at 3 and 6 months
Of those who completed the baseline questionnaire, 147 (57%) participants also went on to complete
questionnaires at 3 and 6 months.
Figure 12 shows the IBS-QOL subscales and overall score for those participants who completed the baseline
questionnaire and did not have matched data for 3 and 6 months’ follow-up (baseline unmatched) and
those with matched data for baseline, 3 and 6 months. Those with unmatched data tended to have lower
scores on all subscales and on the overall IBS-QOL scale. At all time points the lowest scores were reported
on the food avoidance subscale and were highest on the relationship subscale. The data also suggest that
there were small improvements in most HRQoL subscales over time.
TABLE 19 Number and per cent of participants by symptom severity and risk assessment score
Risk assessment score
Symptom severity scale
Severe (300–500) Not severe (0–299)
n % n %
Baseline
4 or 5 50 32.1 106 67.9
1–3 11 12.6 76 87.4
Total 61 25.1 182 74.9
3 months
4 or 5 23 19.3 96 80.7
1–3 4 7.0 53 93.0
Total 27 15.3 149 84.7
6 months
4 or 5 20 21.5 73 78.5
1–3 4 7.1 52 92.9
Total 24 16.1 125 83.9
12 months
4 or 5 8 19.0 34 81.0
1–3 3 10.0 27 90.0
Total 11 15.3 61 84.7
TABLE 20 Sensitivity, specificity and positive predictive values for the risk assessment tool at 3, 6 and 12 months
ROC curve analysis value
Time point, n
3 months 6 months 12 months
n 176 149 72
Area under the curve 68 62 70
Sensitivity 85 83 73
Specificity 36 42 44
Positive predictive value 19 22 19
ROC, receiver operating characteristic.
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Likewise, Figure 13 shows the data for participants according to their symptom severity classification.
The proportion of patients within each category was similar for both matched and unmatched participants
at baseline, with the majority being classified as having moderate disease. The proportion of those with
moderate and severe disease fell at 3 and 6 months, as more participants reported disease remission or
mild disease.
Figure 14 shows the proportion of patients reporting problems (some or extreme problems) on the
individual EQ-5D scales. The majority of patients reported no problems on the mobility and self-care scales,
about one-third reported problems with their usual activities and a much larger proportion reported
problems with pain and/or discomfort or with anxiety and/or depression. The chart suggests that there was
a small improvement in the usual activities, pain/discomfort and anxiety/depression scales at 3 months’
follow-up, but this was less obvious at 6 months’ follow-up.
Discussion
Summary of findings
The number of patients recruited to the study was much lower than anticipated. However, we were able
to calculate sensitivity and specificity based on the sample recruited. The risk assessment tool appeared to
be sensitive in predicting those participants with severe disease; however, it was not specific in predicting
those without severe disease. Patients reported reduced quality of life; however, the data suggested that
there were modest improvements over time.
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FIGURE 12 Irritable Bowel Syndrome Quality of Life Questionnaire subscales. Higher values indicate better HRQoL.
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Strengths and limitations of the study
The main strength of this study was the large number of practices that agreed to take part. Practices were
recruited from across Greater Manchester and, therefore, covered a wide geographical area. However,
despite the large number of participating practices, the number of referrals to the study was disappointing.
Initially, GPs were asked to recruit patients during the consultation and we therefore relied on GPs to
remember about the study during the consultation. For a small number of practices this method worked
well, but the majority of practices did not refer any patients via this method. This recruitment strategy was
later supplemented with Read Code searches at a number of practices. As a result, recruitment to the
study was boosted to some extent, but not all practices agreed to carry out a Read Code search despite
the offer of assistance from the local PCRN. An inadvertent and unexplained limitation of the current study
was selection bias, as the majority of referrals came from a single practice, which is likely to affect the
validity of the results. This practice was a particularly large one, with a large student population.
Why is the prevalence of irritable bowel syndrome so low?
Even with the use of Read Code searches, the prevalence of IBS was much lower than expected when
compared with the literature. Prevalence estimates of IBS in Western countries range from 2% to 22%.95
More specifically in the UK, a questionnaire survey estimated IBS prevalence to be 10.5%.90 However,
estimates of the prevalence of IBS are likely to be influenced by a number of factors, including the criteria
used, population studied, mode of study delivery and type of prevalence estimate.
Prevalence estimates reported in the literature vary widely depending on the diagnostic criteria (e.g. Kruis,96
Manning97 or Rome I,98 II99 or III4). A study across eight European countries with > 40,000 participants
reported that the overall prevalence of IBS was 11.5%; however, only 2.9%, 4.2% and 6.5% of participants
met the Rome II, Rome I or Manning criteria, respectively.100 The usefulness of diagnostic criteria is frequently
debated, and they tend to be of little relevance within primary care, as few GPs use them to make a
diagnosis. We adopted a symptom-based approach to identify patients consulting with IBS within primary
care and, therefore, we would have expected the prevalence of IBS to be higher than in those studies using
formal diagnostic criteria such as Rome II.99 However, there are a number of further possible explanations.
First, many studies used to estimate the prevalence of IBS have been self-reported questionnaire surveys
and are therefore likely to overestimate the proportion of patients who have been formally diagnosed with
IBS. Nevertheless, Wilson et al.90 reported that over half of patients with IBS consulted their GP within the
past 6 months. In addition, Rey and Talley95 suggest that consultation rates are higher in more recent
studies owing to increasing public awareness. They suggest that 30–70% of patients have consulted their
GP owing to their symptoms in the previous year. Furthermore, a survey of UK GPs also suggests that IBS is
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not an insignificant problem.3 Based on the Read Code searches, we were able to calculate an estimate of
IBS prevalence in a 3-month period. This was estimated at 0.2%, and it ranged from 0.03% to 0.4%
across practices. However, patients recruited via the Read Code searches had to have had the IBS Read
Code recorded in the last 10 years and to have consulted within the past 3 months for symptoms of
abdominal pain, bloating, constipation, diarrhoea or change in bowel habit. Despite this, the rate was
much lower than expected.
Second, IBS or gastrointestinal symptoms are not a part of the QOF, a scheme that incentivises practices
and rewards them according to how well they care for patients. Consequently, they are not likely to be a
priority for GPs.
Third, GPs may be reluctant to code patients for IBS or lower gastrointestinal symptoms. One reason
for this may be the uncertainty of the diagnosis. Although IBS is no longer regarded as a diagnosis of
exclusion, and NICE has produced guidelines,81 GPs may still take a ‘diagnosis of exclusion’ approach.
As a result, GPs may not use Read Codes when they first consult and use other Read Codes or free-text
fields. Consequently, if patients disengage with primary care they would not receive an IBS label.
The predictive value of the risk assessment tool
We were able to calculate sensitivity, specificity and positive predictive values for the risk assessment tool
based on the data collected. Based on a cut-off point of 4 on the risk assessment tool, it was possible to
obtain sensitivity values of > 80%. However, specificity was around 40% and the positive predictive value
was only about 20%. Therefore, the tool appeared to be quite good at predicting those who did actually
have severe IBS, but was not good at predicting those that did not actually have severe IBS. However, the
small number of patients recruited to the study meant that the study was underpowered. The sample size
calculation estimated that a sample size of 420 prevalent and 420 incident cases would be required in
order to detect an effect. Early on it became apparent that we would not be able to recruit incident cases
to the study because of the difficulties in establishing a diagnosis and the fact that many patients present
with longstanding symptoms. Indeed, of the 257 patients recruited to the study, 95% reported having
symptoms of > 3 months’ duration. As a result, the study was expanded to include prevalent cases;
however, difficulties with recruitment persisted. Despite these difficulties, it is questionable whether or
not such a tool would be useful in predicting which patients have severe disease at a later stage.
Natural history of irritable bowel syndrome
The data suggest that patients with IBS have poor HRQoL, as measured by the IBS-QOL and the EQ-5D.
These findings are comparable with those reported in the literature.101 Those patients who did not
complete the questionnaire at all three time points tended to score lower on these measures at baseline.
Data from participants who completed the baseline, and 3- and 6-month questionnaires tended to suggest
that there were small improvements in the IBS quality of life, symptom severity scores and EQ-5D over
time. Although we did not formally test these differences, this appears to contrast with previous findings of
no significant difference in the IBS-QOL subscales and overall score from baseline to follow-up 3 months
later.101 No specific intervention was administered in that study. Similarly, in our study, no specific intervention
was administered between baseline and 3 and 6 months. However, GPs were asked to recruit patients during
the consultation and it may be that treatment prescribed during the course of that consultation resulted in
improved outcomes for patients. Alternatively, these improvements may simply reflect the fluctuating nature
of the condition.
Owing to the problems with recruitment, we felt that it was important to gather the views of GPs about
the management of IBS in primary care. We therefore proceeded to the qualitative study to explore how
GPs diagnose and manage patients with IBS (study 3). We also decided to investigate further the patient
profiles of patients with gastrointestinal symptoms (IBS, AP and IBD) using data from the SIR (study 4).
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Qualitative study (study 3)
The NICE guideline for IBS81 emphasises establishing a positive diagnosis, identifying symptoms that require
prompt referral, but avoiding unnecessary investigations and referrals, and working in partnership with the
person with IBS.
There is evidence of dissatisfaction and frustration experienced and voiced by patients and doctors alike,
arising from uncertainties in aetiology and diagnosis, ineffective treatments and a mismatch between
GP and patient explanatory models.102,103 This may lead to negative stereotyping of patients with IBS by
doctors,102 and for patients it may lead to a breakdown in trust and disengagement from services.104
Patients and GPs may share similar views on aetiology and symptomology, but differ in the treatment
approaches found acceptable.105 GPs can hold hostile views about patients with IBS who are frequent
attenders and do not improve.103 There is little previous work on how a diagnosis of IBS is made in primary
care and how this label is applied. Only a small proportion of IBS cases, as recorded in medical records,
meet case definition criteria, suggesting that diagnosis in primary care may be problematic.106
Aim
The qualitative study aimed to explore how GPs currently diagnose and manage IBS and their attitudes
towards the use of a predictive, risk assessment tool within general practice.
Methods
Design
Face-to-face, in-depth, semistructured interviews were conducted with GPs in north-west England who were
participating in the study of the risk assessment tool. Data were collected between March and December 2011.
Sampling
General practitioners from practices invited to take part in the validation of the risk assessment tool were
invited to participate in a semistructured interview. Purposive sampling was used to maximise the variation
of the sample in terms of age, length of experience, ethnicity, practice size and location. Recruitment was
continued until theme saturation was reached.
Data collection
Interviews were conducted, with written consent, at GP premises by two of the researchers. Interviews
lasted between 20 and 70 minutes (mean duration 42 minutes). The topic guide was developed from
review of the existing literature and discussion within the research team. The topic guide, designed to be
used flexibly, was modified in the light of emerging themes. The main areas explored were GPs’ views on
the aetiology of IBS, how the diagnosis of IBS is made, how GPs explain IBS to patients, treatments offered
and the potential usefulness of a tool to predict chronicity.
Interviews were fully transcribed. Data coding was by constant comparison across interviews by individual
researchers and emerging themes were agreed through discussion among all authors from different
professional backgrounds (academic primary care, health services research, epidemiology). An iterative
approach to data collection and analysis was taken: coding and conceptual categories were constantly
reviewed and refined in the light of new interview data and ongoing discussion in the research team.
The topic guide was modified to allow for further exploration of emerging themes. NVivo 9 (QSR
International, Warrington, UK) was used to store and manage the data.
Results
Nineteen interviews with GPs were conducted (Table 21). Seventeen GPs had agreed to recruit patients for
the larger programme. Two GPs agreed to be interviewed but the practice declined to participate in the
main study.
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The following themes are presented: understanding IBS, making the diagnosis, explaining the label,
management strategies, frequent attenders or disengagers and the utility of a risk assessment tool.
Data are presented verbatim from transcripts and identified by a code attributed to the respondent.
Understanding irritable bowel syndrome
All GPs recognised the existence of IBS as a syndrome, a collection of symptoms, affecting different people
in different ways.
I do think it exists, I really do. I think people’s lives can be made – it’s a label isn’t? People who have
got constipation predominant IBS might – you could just call them constipated. It’s a real condition,
people get a lot of pain from it. There are people that seem to get more anxious about it. But we all
get a dodgy tummy if you’ve got an exam or something like that. So I definitely think it exists.
GP 11
General practitioners described IBS as a complex condition with a biopsychosocial aetiology, alluding to the
notion of susceptibility, triggers and precipitants, with patients often presenting symptoms related to
‘stress’ and lifestyle.
I think there’s a lot of psychology with irritable bowel, not that necessarily the psychology causes the
irritable bowel but I think for a fairly benign condition it can cause a lot more upset than you’d expect.
GP 9
TABLE 21 Details of GPs interviewed
GP demographic variable Number of GPs
Gender
Male 11
Female 8
Age group (years)
30–39 7
40–49 5
≥ 50 7
Ethnic origin
White 13
Asian/Asian British 5
Black/black British 1
Status
Principal 17
Salaried 2
Type of practice
Inner city 2
Urban 9
Suburban 8
Mean (range) years in practice 15.4 (4–28)
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General practitioners defined IBS by the lack of demonstrable organic pathology and focused on abnormal
behaviour of the bowel.
I think it is an exclusion of other pathology, but it’s often a change in bowel habit, people become
constipated, they get increased frequency of bowel motions, bloatedness, colicky abdominal pains,
sometimes I think there’s a bit of reflux associated with that, with IBS.
GP 11
So they’d be likely to have, sort of, crampy abdominal pain with bloating, sensitive to bowel disturbance
whether it be diarrhoea, constipation, erm, nausea, erm, those types of symptoms, but none of the
serious red flag-type symptoms, not usually any sign of any bleeding from the back passage, no sign of
weight loss, erm, and that type of pain, sort of, colicky pain.
GP 1
General practitioners were aware of the chronicity of IBS, with the potential for ‘flare-ups’.
. . . well irritable bowel syndrome often it just flares up, they come and they get their month of
Mebeverine, they take it and then they’re not troubled for another year.
GP 14
Some GPs alluded to their own experiences, which made symptoms in patients more real and more
understandable.
I think I’ve dealt with it so much, I’ve experienced it as well and so I think when you’ve experienced it
you know how severe some of the symptoms can be.
GP 11
Making the diagnosis
General practitioners suggested that the first step in making the diagnosis and managing people with IBS
is ensuring that the patient’s concerns are listened to.
. . . it helps just to reassure the patient that you’re taking the symptoms seriously. I think that’s probably
the biggest worry they have, because when you have some functional symptom and you’ve nothing to
show the doctor, it’s almost inevitable that you’re going to wonder whether he’ll take it seriously . . .
GP 3
Some GPs described a traditional doctor-led encounter driven almost entirely by clinical factors, but most
portrayed a two-way process in which their actions are shaped by the patient’s expectations. Most GPs
were aware of the NICE guideline81 for IBS and the suggestion that the diagnosis should be made in
a positive manner, considering the symptoms which pointed towards the diagnosis. Many GPs felt
uncomfortable with this approach and, although few described referring to secondary care unless there
were clear ‘red flag’ symptoms, they described IBS as a diagnosis of exclusion, driven by investigations and
their normality, and the diagnostic process as tentative and iterative.
So to a certain extent there’s always a degree of diagnostic uncertainty because . . . although I know
the term isn’t really favoured any more, but pretty much it’s a diagnosis of exclusion.
GP 18
The iterative process of diagnosis, by exclusion of sinister symptoms, was described as the approach taught
to them in medical school.
So now it’s very difficult, yeah, I read the NICE guidelines and it is about positive, it’s not a diagnosis
of exclusion any more, it’s about positive symptoms. I’ve read all that but it’s still very hard to go away
from something that was drummed in.
GP 11
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General practitioners suggested that they made a diagnosis based on the patient response to treatments.
. . . and, you know, their full blood count would be alright, their coeliac screen would be negative,
erm . . . and then we’d . . . you know, I’d often give them a trial of Mebeverine or something and that
quite often does help, and then they just stay on that.
GP 14
The majority of GPs reported that they did not initially add a Read Code for IBS to the patient record, but
delayed until they were more confident in the diagnosis. Thus, codes such as ‘abdominal pain’, ‘diarrhoea’
or ‘constipation’ would remain on the patient record, rather than IBS, and patients who do not return with
their gastrointestinal symptoms would not be coded as having IBS.
I’d probably put a symptom as the coding on the computer at that stage; the most predominant
symptom, but if the patient has come in with the same sorts of things over and over again and it’s
looking very much like IBS, and it responds to IBS type treatment, then I’d code it.
GP 1
Explaining the label
General practitioners described various models of IBS, including the metaphor of ‘a string of lights that are
lighting up randomly rather than in a regular pattern’ and ‘the bowel as a muscle that can be irritated like
any other muscle’. Language often emphasised lack of co-ordination or rhythm (‘higgledy-piggledy’), and
the use of analogies was common. The GPs described tailoring their explanations for the individual patient.
I try and explain that this is a, sort of, not particularly well understood problem, which can have a
variety of different causes and can cause quite dramatic symptoms, but, isn’t, sort of, generally,
sort of, serious in terms of long term, sort of, prognosis.
GP 19
General practitioners suggested that most patients are ready to accept the link between psychosocial
issues and bowel symptoms, and may even have considered this before consulting.
Whereas if I involve them throughout the process right from the beginning, er, they adhere to it.
I haven’t had a single problem with bringing up psychological issues with any of my patients, yeah.
GP 13
Management strategies
All GPs described giving lifestyle advice, particularly around diet, exercise and activity, although most
suggested that patients had already tried to modify their diet.
Some patients have already identified it – ‘My problems seem far worse when I eat such and such . . .’
so then we say hang on, why don’t you just not eat such and such and see how you do and if they
feel that their symptoms have been looked into adequately enough, and they’re reassured that it’s IBS
then they’re happy to do that.
GP 18
Some GPs suggested that a focus on the related psychological symptoms initially might lead to
improvement in gastrointestinal symptoms.
Then I tend to sort of not label them as IBS straightaway, yeah. I will manage the stress, I will manage
their anxiety, I’ll manage the depression and see what happens with the symptoms.
GP 13
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Despite acknowledging the link between psychological symptoms and IBS, GPs described a reluctance to
refer patients with IBS to mental health services, as such resources are scarce and waiting times are long,
reserving these interventions for those with more overt mental health symptoms:
We can refer to Mental Health Team for the depression, with the hope that it might help the IBS
symptoms at the same time. We couldn’t refer primarily for the IBS.
GP 1
Although CBT and hypnotherapy are recommended interventions for IBS in the NICE guideline,81 some GPs
expressed doubt about the evidence base for either intervention.
. . . the NHS does need to be careful about where it puts its money because . . . perhaps we ought to
be putting the money into more evidenced-based things.
GP 12
I need to be sort of . . . I’m not quite sure of the link between why CBT might work, the connection
between the psychological component and the patient’s IBS, and CBT. I’m assuming there are studies
to show that it does work?
GP 2
General practitioners recognised that patients may not always be satisfied with treatments offered by them
or the NHS and may seek complementary therapies, which respondents said they would not challenge if
not felt to be harmful.
Um, but yeah, like again, they’re placebos, but it’s an area where placebos do work. I certainly wouldn’t
get in the way of anyone who suggested trying something, um, provided it sounded safe. Like if they
wanted to try a homeopathic remedy or massage remedy, I’d say ‘Yeah, go for it. Why not?’
GP 3
No, I’ll say try what works for you. Some of them will be very specific things. Or they buy some seaweed
product from a health shop and that works fine. I don’t care what works, so long as it’s not going to harm
them. If they find that going for private acupuncture helps, great. Whatever, I don’t care what it is. I just
don’t want them to be suffering without anything working for them. If they find a solution that’s great.
GP 12
Frequent attenders or disengagers?
General practitioners stated that many patients do not return after an initial consultation and attributed
this to patients either being satisfied with management or ‘putting up with’ their symptoms.
But sometimes they just never come back and then you just assume they’ve got better [laughter].
GP 14
Whether it’s that they just manage it or whether it’s just that we don’t ask them about it anymore and
they just put up with it I don’t know.
GP 8
However, most GPs described the chronicity of IBS and some suggested that there were a minority of
patients who did not improve, attended frequently and were difficult to manage.
I suspect to patients it’s a complete nightmare ’cos it’s the daily thing of living with it but in general I
have to say my experience is that we can help patients but, you know, to improve their quality of life
enormously is not necessarily that easy with irritable bowel.
GP 9
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A minority of GPs felt there was little that they could offer to patients with IBS.
It’s only really if it’s . . . if there’s no obvious trigger and if it’s causing significant impact on their life.
That’s when it becomes very challenging because I think it’s relatively limited what you can do.
GP 6
General practitioners used negative language to describe such patients, suggesting that frequent attenders
were ‘complainers’ or ‘mithered’, and suggested that, in such circumstances, they might be forced to
agree to ‘un-necessary’ investigations or referrals.
Question: And if you did refer somebody, what are you expecting from the specialist?
Answer: That the patient might not keep hassling me. Usually I would refer, it sounds awful but to get
them off my back if they’re persistently coming in. I’m really worried, it’s not getting better, what can
you do? It’s not that I think the specialist will do particularly anymore. They might give some advice,
but it’s probably not going to be different to what I’ve been able to do myself.
GP 12
I think the other groups of people who find it hard to accept that their body is giving them symptoms,
and who are constantly looking for a cause which they can see on an X-ray or on an ultrasound or
something, and who are, who are . . . who don’t sort of accept the functional nature, and who are
always kind of mithering about wanting more investigations and tests, and then disappointed when
they are all normal, and I think that’s very difficult, and I do a lot of warning of people that yes, we
can do X or Y, my expectation could be normal, so how will you feel if it’s normal? Because they sort
of pin their hopes on the idea that I’ll have a coeliac screen and that will show they’ve got coeliac
disease, and then when they haven’t they kind of go, what is it then, you know, that kind of question;
so that needs quite careful handling, I think.
GP 4
It was thought that only a minority of patients, however, would become frequent attenders.
And, those with straightforward IBS, with the pattern of our consultation, it makes it easier for us to
attend to . . . and, I would say very good, indeed, only a very small percentage fall in the category that
are frequent attenders.
GP 15
I mean there are, I guess a subgroup of patients with IBS who are the real sort of somatisers I guess,
the real patients that, erm, could be termed doctors heart sink patients, erm, so patients that, that are
generally very anxious but are anxious about their health, they’re anxious about every little symptom.
There is a small group of patients with IBS who fit into that group and so that group of patients have
certain patterns, but I wouldn’t say that all patients with IBS are like that.
GP 18
Utility of a risk assessment tool in primary care
Despite the recognition that there might be a group of patients who disengaged or who became frequent
attenders, GPs did not feel that a risk assessment tool to predict which patients might become high
users of care would have any utility, particularly given the perceived lack of availability of any proven or
cost-effective treatments.
But don’t we intervene anyway? It’s not as if we sit there doing nothing unless we think someone’s
going to be a high consulter, so what actual outcome is that going to have to me and my practice?
GP 6
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Some GPs expressed concern about the practicalities of administering such a tool in a time-limited primary
care consultation.
. . . I can’t be doing with having piles of bits of paper, every specialty has got dozens of bits of paper like
this and we work across every single specialty, so having bits of paper in the room is a complete loss.
GP 4
. . . they’re a pain though, using questionnaires in consultations because you have to find it, you have
to print it off if you’ve got it on your computer, if you give it to your patient they then . . . you can
send them away to fill it in but if they fill it in there and that’s in a 10-minute consultation.
GP 11
Other GPs suggested that such tools do not fit with the realities of the consultation process, attempting to
impose an artificial structure on what ought to be a patient-centred encounter.
. . . first of all patients don’t present in this kind of neat tidy way, they come and they say oh God I
feel terrible, oh there is this and there is that and I want to tell you about my toe nails and blah blah,
so it doesn’t lend itself to that . . . what you have to do is listen to what they are saying not force, you
know, it’s not about asking a series of yes–no questions usually.
GP 4
So the value of a tool to predict which patients might benefit from early intervention for their abdominal
symptoms and direct management decisions was perceived to be limited.
Discussion
Summary of main findings
This study illustrates how the perspectives of GPs about the diagnosis and management of IBS influence
their views on the value of a risk assessment tool to predict chronicity. GPs reported that IBS is not a
difficult condition to diagnose or manage, yet most described reluctance to add the Read Code for IBS to
the record. Respondents acknowledged the link between IBS and psychological distress, but were reluctant
to refer for therapies such as CBT or hypnotherapy and did not see the value of a risk assessment tool to
predict chronicity. Most GPs suggested that patients did not return because their symptoms had settled,
rather than because they may be dissatisfied with care.
Strength and limitations of the study
Data are presented from interviews with GPs over a wide geographical area; this purposive sampling
enabled us to access a range of views. However, because we employed a theoretical, rather than a
statistical, sampling approach, the proportion of GPs holding different views cannot be inferred. Seventeen
out of 19 GPs were already taking part in an evaluation of the risk assessment tool for IBS and were possibly
more likely to feel comfortable managing IBS. The two GPs who agreed to be interviewed but not to
participate in the main study might have been expected to have more negative views about IBS; however,
this was not apparent. Data were analysed by researchers from different professional backgrounds,
increasing trustworthiness.107
Comparison with existing literature
The diagnosis of medically unexplained symptoms is often contentious;108 however, GPs in the current
study did acknowledge the existence of IBS and reported that they had no difficulty in diagnosis or
management. These findings are similar to published data reporting that compared with pelvic and back
pain, IBS was not considered difficult in terms of distinguishing functional from organic disease.109 When
GPs experienced IBS themselves, or knew someone with IBS, it helped them to understand the condition,
resonating with studies describing a similar finding in GPs who have first-hand experience of chronic
fatigue syndrome.110
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Respondents recognised the link between IBS and psychological distress;109 however, they were uncertain
of the benefit of psychological therapies in patients with IBS. It has been reported that GPs in the UK do
not refer patients with IBS for psychological treatment,109 whereas doctors in the Netherlands are more
likely to do so.102
Although the diagnosis of IBS is often made by excluding red flag indicators, in one study 72% of GPs
considered that they were usually, or often, able to diagnose IBS at the initial visit.109 This contrasts with a
previous study reporting that 19% of patients formally diagnosed with IBS had been given the diagnosis
on their first visit and 56% after a further 1–5 visits.100 These studies were conducted prior to the
introduction of the NICE guideline81 for the diagnosis and management of IBS. However, although most
GPs in our study were aware of this guideline, many were reluctant to apply a label of IBS to patients.
Read Codes were reported as being applied only if the patient reconsults and probably reflecting the
fluctuating nature of the condition.111
General practitioners emphasised the importance of self-management in patients with IBS and felt that
offering advice and reassurance was important in the first instance. Dietary advice was emphasised by
respondents, but it is not always appreciated by patients, who are likely to have already tried such
measures before consulting.105
A strong physician–patient relationship and empowering explanations given by GPs are reported to be
important to the successful management of IBS.112,113 General practitioners often give the problem back to
the patient102 and health-care professionals tend to distinguish between ‘good’ and ‘bad’ patients, with
so-called ‘bad’ patients being unaccepting of the diagnosis of IBS, recurrent attenders, demanding further
investigations, failing to cope or respond to treatment and resentful of the IBS label and psychological
explanations given.103 ‘Good patients’, on the other hand, were those who GPs suggested had a sense of
relief with the label given and were accepting of the diagnosis.103 In the current study, GPs suggested that
most patients did not return, attributing this to patients either getting better or learning to live with their
symptoms. However, there is evidence to suggest that patients with IBS disengage with services because of
dissatisfaction with GP interactions,114 a belief that there is little the NHS can offer, or attributing the onset
or worsening of symptoms to previous poor medical care.104
Of those patients who consult their GP with a FGID, approximately 30% go on to develop chronic
symptoms.82 Providing a self-help guidebook, designed with the aid of patients, reduces primary care
consultations by 60%.15 In addition, for patients with intractable symptoms resistant to conventional
medical therapy, there may be therapeutic benefit from CBT or hypnotherapy.16,17 A risk assessment tool
may aid GP decisions about the management of patients at risk of poorer outcomes and fast-track them to
therapies that are known to be effective, such as CBT or hypnotherapy, leading to lower levels of distress
and health-care utilisation in the long term. However, the majority of GPs interviewed did not feel that
a risk assessment tool would be useful to them, whereas others felt that it would be impracticable to
administer such a tool in a 10-minute consultation.
Implications for future research and clinical practice
Patients might be appreciative of such a tool within the consultation – it may demonstrate that the doctor is
taking their symptoms seriously and demonstrate patient involvement in decision-making about treatment.
There is a parallel with the use of the Patient Health Questionnaire-9, a tool to which GPs are less receptive
than patients,115 and the value of a tool based on prognostic information to determine the appropriate
intervention for patients with back pain has been shown to be effective116 but not well used by GPs.117
This study highlights tensions between research evidence identifying the potential role of a risk assessment
tool to support primary care management of IBS and GPs’ perspectives that it is not needed. The study
reinforces the need to take account of current clinical practice and practitioners’ perspectives and researchers
and clinicians should work together when developing research programmes to tackle conditions that create
challenges for clinicians.
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General practitioner database study (study 4)
As a result of the difficulties in recruiting to the risk assessment study, and in the light of earlier findings,
we decided to investigate further the profiles of patients with IBS using data from the SIR.
Aim
The aim of study 4 was to investigate profiles in patients with IBS, IBD and AP; and to explore whether or
not GPs follow NICE guidelines for patients with IBS.
Methods
Setting
The setting for this study was Salford, north-west England, with an estimated population of 228,992 in 2010.
Sampling frame
The sampling frame comprised all patients registered with the 52 practices in Salford. Patients may opt out
of the SIR; however, the proportion that do so is relatively small.
Data collection and coding
An application was made to NorthWest EHealth requesting details on a cohort of patients based on
various codes for gastrointestinal disorders.
The SIR data were obtained for the period January 2002 to December 2011. Information was supplied in
two separate files. The first file contained anonymised patient identifiers, gender and year of birth,
whereas the second file contained journal entry identifier, anonymised patient identifier, date of journal
entry, Read Code description and Read Code. These two files were matched on patient identifier. The file
was checked for duplicates and frequencies were run on all variables to check for any anomalies. Duplicate
records and patients under the age of 17 years were removed. Read Codes were then recoded into a new
variable to distinguish between symptom and/or diagnostic codes, medication codes and referral codes.
Ethics permission for this study was granted by the NorthWest EHealth Board (reference number 177) and
the individual health-care organisations.
Analysis
For this study we carried out analysis on three patient groups. These were patients with:
1. IBS (Read Codes 14CF. and J521., including any subheadings)
2. AP (Read Codes 196.., 197.. and R090., including any subheadings)
3. IBD [Read Codes J4... (without subheadings), J40.. and J41.., including any subheadings].
Patients with IBS were our primary group of interest, but we were also interested in how GPs coded patients
with similar conditions, to determine whether or not there were any differences in coding practices across
conditions. Patients with AP were chosen because it is the main feature of IBS and is required to be present in
addition to two other symptoms for a diagnosis of IBS to be given.81 In addition, we selected patients with IBD
because IBD is an organic disorder and patients present with similar symptoms to IBS.
For each group of patients we identified an index episode of IBS, AP or IBD. For each index episode, an
index date was created based on the date for that particular journal entry. For each condition we then
looked 1 year pre and post the index date to determine:
i. symptoms/diagnoses recorded pre and post IBS, AP and IBD
ii. medications prescribed pre and post IBS, AP and IBD
iii. referrals to gastrointestinal specialists pre and post IBS, AP and IBD.
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The index episode was taken as the first occurrence of IBS, AP or IBD. The date of this episode was then
used to calculate the number of days between the index episode and all corresponding journal entries for
the same patient. Where the number of days was less than or equal to ± 365, then these were recorded
as 1 year pre or post for that particular journal entry. Where the number of days was equal to 0, this was
included in the year prior to the index episode for symptoms/diagnoses and included in the year after the
index episode for medications and referrals. For the SIR, pre data were based on those with an index
episode between 2003 and 2011 (so that only those with a complete year of data available before the
index year were included), whereas post data were based on those with an index episode between 2002
and 2010 (so that only those with a complete year of data available after the index year were included).
Symptoms/diagnoses were defined as in Table 22.
Medications were defined on the basis of the NICE guidelines81 and coded as shown in Table 23.
Referrals to specialists or for further for investigation of gastrointestinal symptoms were defined as shown
in Table 24.
TABLE 22 Symptoms and diagnosis codes
Symptom/diagnoses Read Code Rubric
IBS 14CF. History of IBS
J521. IBS
AP 196.. Type of GIT pain
197.. Site of GIT pain
R090. [D] APa
Bloating 19A.. Abdominal distension symptom
19B.. Flatulence/wind
R0734 [D] Bloatinga
Constipation symptom 19C.. Constipation
Functional constipation J520. Constipation – functional
Change in bowel habit 19EA. Change in bowel habit
R078. [D] Change in bowel habita
Diarrhoea 19F.. Diarrhoea symptoms
19G.. Diarrhoea and vomiting
Functional diarrhoea J525. Functional diarrhoea
J43z. Chronic diarrhoea
J4z.. Presumed non-infectious diarrhoea
Nausea 198.. Nausea
Vomiting 199.. Vomiting
Diarrhoea and vomiting 19G.. Diarrhoea and vomiting
Tenesmus 19D.. Tenesmus symptom
Faeces/motions symptoms 19E.. Faeces/motions symptoms
Gastrointestinal infection A0... Intestinal infectious diseases
IBD J40.. Crohn’s disease
J41.. Ulcerative colitis or proctitis
a The terms in Chapter R – ‘[D]’ are defined in the Read Thesaurus as ‘symptoms, signs and ill-defined conditions’.
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TABLE 23 Medication codes
NICE medications Read Code Rubric
Bulk-forming laxatives ab2.. Ispaghula husk
ab3.. Methylcellulose
ab4.. Sterculia
Stimulant laxatives ac5.. Docusate sodium
ac7.. Senna
ac8.. Sodium picosulfate
af1.. Rectal laxatives (glycerol, bisacodyl)
ac1.. Bisacodyl
Faecal softeners ad1.. Liquid paraffin
Osmotic laxatives ae4.. Polyethylene glycols
a12.. Magnesium salts – antacid
ae2.. Magnesium hydroxide
ae3.. Magnesium sulphate
ae7.. Sodium phosphate
Antimotility agents a81.. Codeine phosphate
a82.. Diphenoxylate hydrochloride
a83.. Loperamide: single drug
a85.. Loperamide: compound preparation
a842. Kaolin and morphine mixture
Antispasmodics a41.. Atropine sulphate
a45.. Dicycloverine hydrochloride
a47.. Hyoscine butylbromide
a4c.. Propantheline bromide
a4d.. Alverine citrate
a4e.. Mebeverine hydrochloride
a4f.. Peppermint oil
Antidepressants
Tricyclics and related antidepressants d71.. Amitriptyline
d91.. Triptafen
d73.. Clomipramine hydrochloride
d75.. Dosulepin hydrochloride
d76.. Doxepin
d77.. Imipramine hydrochloride
d79.. Lofepramine
d7c.. Nortriptyline
d7f.. Trimipramine
d7b.. Mianserin hydrochloride
d7e.. Trazodone hydrochloride
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TABLE 23 Medication codes (continued )
NICE medications Read Code Rubric
SSRIs da9.. Citalopram
daC.. Escitalopram
da4.. Fluoxetine hydrochloride
da3.. Fluvoxamine maleate
da6.. Paroxetine hydrochloride
da5.. Sertraline hydrochloride
MAOIs d81.. Phenelzine
d83.. Isocarboxazid
d84.. Tranylcypromine
Reversible MAOIs d85.. Moclobemide
Other antidepressants gde.. Duloxetine
da1.. Flupentixol
daB.. Mirtazapine
daA.. Reboxetine
da2.. Tryptophan
MAOI, monoamine oxidase inhibitor; SSRI, selective serotonin reuptake inhibitor.
TABLE 24 Referral codes
Referral Read Code Rubric
Specialist referral 8h48. Gastroenterological referral
8h5J. Referral to colorectal surgeon
8H5K. Referral to upper gastrointestinal surgeon
8HL8. Gastroenterology DV done
8HM8. Listed for gastroenterology admission
8Hn4. Fast-track referral for suspected colorectal cancer
8Hn9. Fast-track referral for suspected upper gastrointestinal cancer
8HS.. Refer for gastroscopy
8HS0. Refer for sigmoidoscopy
8HU1. Referral for colonoscopy
8HU2. Referral for sigmoidoscopy
8HVc. Private referral to colorectal surgeon
8HVN. Private referral to gastroenterologist
DV, domiciliary visit.
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We also calculated prevalence estimates based on the Salford population data. Population data were
obtained from the Office for National Statistics website for Salford primary care organisation. Rates were
standardised to the Greater Manchester population for 2006. This includes the population of the
10 primary care organisations within the Greater Manchester area, which is roughly 2.5 million.
Results
Table 25 shows the number of patients with an IBS, AP or IBD diagnosis in the time period 2002–11.
AP was the most commonly reported symptom, followed by IBS and IBD.
Table 26 shows patients’ demographic details. IBS and AP were much more common in females, whereas
IBD occurred with similar frequency in males and females. IBS, AP and IBD were most likely to be found in
those aged 18–39 years and the frequency declined with age. The proportion of patients aged ≥ 60 years
was higher in the IBD group (26%) than in the IBS (16%) or AP group (22%).
Symptoms pre and post irritable bowel syndrome, abdominal pain or inflammatory
bowel disease
Table 27 shows the number of symptoms/diagnoses 1 year prior to and 1 year after the index episode of
IBS, AP and IBD. The most commonly reported symptoms in the year prior to IBS were AP (19.5%),
diarrhoea (6.1%) and bloating (3.8%). However, a large majority of patients (69.4%) did not have any
gastrointestinal symptoms recorded in the year prior to their IBS. Likewise, in the year after the index
episode of IBS, the majority of patients did not have any gastrointestinal symptoms recorded (79.1%). AP
was the most commonly recorded symptom (13.4%), and 14% of patients had a further episode of IBS
recorded in the year after their index episode. IBD showed a similar pattern to IBS with the majority of
patients (69.6%) not having any symptoms recorded in the year prior to their IBD diagnosis. The most
commonly reported symptoms were AP (15.9%) and diarrhoea (11.8%). In the year after the index
episode of IBD, AP and diarrhoea were still the most commonly reported symptoms, but the proportions
tended to be lower (10.4% and 5.4%, respectively). Almost one-third of patients had a further episode of
IBD recorded in the year after their index episode.
TABLE 25 Number of patients with IBS, AP and IBD
Condition Number of patients
IBS 8444
AP 42,490
IBD 1510
TABLE 26 Demographic information for patients with IBS, AP and IBD
Patient demographic characteristic
Condition
IBS AP IBD
n % n % n %
Female 6137 72.7 26,071 61.4 755 50.0
Age (years)
18–39 4373 51.8 19,662 46.3 629 41.7
40–59 2703 32.0 13,379 31.5 487 32.3
≥ 60 1368 16.2 9449 22.2 394 26.1
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Most patients with AP (92.5%) had no symptoms recorded in the year prior to their index episode of AP.
In the year after their index episode, 23% of patients had a further AP episode and 2.8% of patients had
an IBS diagnosis.
The proportion of patients who reported two or more symptoms in the previous year or the year after IBS,
AP or IBD was < 5% in most cases.
Medications pre and post irritable bowel syndrome, abdominal pain or inflammatory
bowel disease
Table 28 shows the number of NICE medications prescribed in the year prior to, and after, the index
episode of IBS, AP or IBD. NICE medications for IBS were prescribed for 31% of patients in the year prior
to their index episode of IBS and for 54% in the year after the index episode. The change was most
marked for antispasmodics, prescriptions for which increased from 17% in the year prior to the index
episode of IBS to 44% in the year after the index episode. IBS NICE medications were also commonly
prescribed in patients with AP and IBD, with about one-third of patients being prescribed NICE
TABLE 27 Number (%) of symptoms pre and post IBS, AP and IBD: 2002–11
Symptom/diagnosisa
Condition
IBS AP IBD
Pre
(N= 7728)
Post
(N= 7665)
Pre
(N= 39,974)
Post
(N= 37,851)
Pre
(N= 1336)
Post
(N= 1382)
n % n % n % n % n % n %
AP 1509 19.5 1028 13.4 – – 8683 22.9 212 15.9 144 10.4
Bloating 291 3.8 137 1.8 411 1.0 374 1.0 8 0.6 7 0.5
Constipation symptom 166 2.1 138 1.8 639 1.6 700 1.8 16 1.2 14 1.0
Change in bowel habit 130 1.7 45 0.6 175 0.4 174 0.5 46 3.4 5 0.4
Diarrhoea symptoms 475 6.1 256 3.3 1046 2.6 972 2.6 158 11.8 74 5.4
Nausea 104 1.3 100 1.3 483 1.2 513 1.4 6 0.4 12 0.9
Vomiting 72 0.9 67 0.9 583 1.5 583 1.5 11 0.8 19 1.4
Diarrhoea and
vomiting
47 0.6 43 0.6 202 0.5 192 0.5 12 0.9 6 0.4
Tenesmus 2 0.0 2 0.0 6 0.0 12 0.0 2 0.1 0 0.0
Faeces/motion
symptoms
31 0.4 34 0.4 72 0.2 80 0.2 8 0.6 4 0.3
None of the above
symptoms
5367 69.4 6062 79.1 36,994 92.5 27,010 71.4 930 69.6 1143 82.7
One of the above
symptoms
1950 25.2 1380 18.0 2699 6.8 9555 25.2 339 25.4 200 14.5
Two or more of the
above symptoms
411 5.3 223 2.9 281 0.7 1286 3.4 67 5.0 39 2.8
Functional constipation 151 2.0 121 1.6 511 1.3 573 1.5 20 1.5 21 1.5
Functional diarrhoea 31 0.4 31 0.4 75 0.2 118 0.3 22 1.6 15 1.1
Gastrointestinal
infection
84 1.1 63 0.8 295 0.7 295 0.8 18 1.3 8 0.6
IBS – – 1090 14.2 747 1.9 1061 2.8 42 3.1 25 1.8
IBD 33 0.4 40 0.5 128 0.3 204 0.5 – – 391 28.3
a Symptoms on the same day were coded as pre.
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medications in the year after the index episode of AP or IBD. Prescribing of antispasmodics increased
markedly in those with AP, from 5% before the index episode to 19% after. Approximately 10% of
patients with any of the three conditions were prescribed selective serotonin reuptake inhibitors (SSRIs) and
about 5% tricyclic antidepressants.
Tables 29 and 30 show the number of NICE medications prescribed in the year prior to, and the year after, the
index episodes of IBS, AP and IBD for those with and without symptoms, respectively. Where gastrointestinal
symptoms were recorded in the year prior to, or the year after, the index episode, the proportion of patients
prescribed NICE medications was much higher than in those without symptoms. However, there were still a
number of patients with no symptoms who received NICE medications in the year prior to their index episode
of IBS (22%), AP (18%) or IBD (20%). Among those with IBS, approximately 50% of those with no symptoms
recorded in the year after their index episode were prescribed NICE medications, compared with approximately
30% of those with AP or IBD.
Referrals pre and post irritable bowel syndrome, abdominal pain or inflammatory
bowel disease
About 4% of patients had a gastrointestinal referral in either the year prior to or the year after their index
episode of IBS (Table 31). This was in contrast to patients with IBD, of whom 9% had a gastrointestinal
referral in the year prior to their index episode of IBD and 22% had a gastrointestinal referral in the year
after their index episode of IBD. Few patients with AP had a gastrointestinal referral in the year prior to
their AP. The number of mental health and lifestyle referrals were low for all three conditions.
Prevalence estimates
Figures 15–17 show the age-specific rates per 100,000 population for IBS, AP and IBD, respectively, for
those coded in the SIR data. IBS was much more prevalent in females than in males and peaked in those
aged 25–29 years. In females, after this age there is a gradual decline in prevalence by age. In males,
the prevalence remains stable until age 50–54 years, after which there is a staged decline in the
prevalence rates.
TABLE 28 Number (%) of medications pre and post IBS, AP and IBD: Salford 2002–11
Medicationa
Condition
IBS AP IBD
Pre
(N= 7728)
Post
(N= 7665)
Pre
(N= 39,974)
Post
(N= 37,851)
Pre
(N= 1336)
Post
(N= 1382)
n % n % n % n % n % n %
NICE medications 2395 31.0 4099 53.5 8560 21.4 13,871 36.6 389 29.1 442 32.0
Bulking laxatives 288 3.7 629 8.2 754 1.9 1561 4.1 40 3.0 50 3.6
Stimulant laxatives 204 2.6 247 3.2 1106 2.8 1688 4.5 36 2.7 59 4.3
Faecal softeners 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Osmotic laxatives 216 2.8 289 3.8 845 2.1 1550 4.1 27 2.0 50 3.6
Antimotility drugs 246 3.2 429 5.6 727 1.8 979 2.6 132 9.9 169 12.2
Antispasmodic drugs 1328 17.2 3397 44.3 1890 4.7 7035 18.6 157 11.8 149 10.8
Tricyclic antidepressants 397 5.1 553 7.2 1924 4.8 2221 5.9 66 4.9 78 5.6
SSRI 808 10.5 957 12.5 3530 8.8 3955 10.4 101 7.6 129 9.3
Other antidepressants 124 1.6 147 1.9 554 1.4 660 1.7 12 0.9 15 1.1
a Medications on the same day were coded as post.
PROJECT 2: IDENTIFICATION AND RISK ASSESSMENT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
90
TABLE 30 Number (%) of medications pre and post in those with symptoms in the year prior to, and the year after,
IBS, AP and IBD: Salford 2002–11
Medicationa
Condition
IBS AP IBD
Pre
(N= 2361)
Post
(N= 1603)
Pre
(N= 3304)
Post
(N= 10,841)
Pre
(N= 406)
Post
(N= 239)
n % n % n % n % n % n %
NICE medications 1181 50.0 1103 68.8 1466 44.4 5314 49.0 189 46.6 135 56.5
Bulking laxatives 169 7.2 192 12.0 185 5.6 721 6.7 19 4.7 18 7.5
Stimulant laxatives 127 5.4 118 7.4 311 9.4 792 7.3 17 4.2 26 10.9
Faecal softeners 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Osmotic laxativesb 123 5.2 137 8.5 274 8.3 805 7.4 14 3.4 25 10.5
Antimotility drugs 137 5.8 145 9.0 304 9.2 529 4.9 66 16.3 50 20.9
Antispasmodic drugs 795 33.7 967 60.3 476 14.4 3165 29.2 102 25.1 64 26.8
Tricyclic antidepressants 169 7.2 181 11.3 277 8.4 857 7.9 20 4.9 26 10.9
SSRI 337 14.3 277 17.3 469 14.2 1467 13.5 42 10.3 37 15.5
Other antidepressants 69 2.9 63 3.9 82 2.5 277 2.6 4 1.0 5 2.1
a Medications on the same day were coded as post.
b Excludes lactulose which is not recommended in NICE guidelines.
TABLE 29 Number (%) of medications pre and post in those with no symptoms in the year prior to and the year
after IBS, AP and IBD: Salford 2002–11
Medicationa
Condition
IBS AP IBD
Pre
(N= 5367)
Post
(N= 6062)
Pre
(N= 36,670)
Post
(N= 27,010)
Pre
(N= 930)
Post
(N= 1143)
n % n % n % n % n % n %
NICE medications 1176 21.9 2974 49.1 6720 18.3 8018 29.7 191 19.9 300 26.2
Bulking laxatives 119 2.2 437 7.2 569 1.6 840 3.1 21 2.2 32 2.8
Stimulant laxatives 77 1.4 129 2.1 795 2.2 896 3.3 19 2.0 33 2.9
Faecal softeners 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Osmotic laxativesb 93 1.7 152 2.5 571 1.6 745 2.8 13 1.4 25 2.2
Antimotility drugs 109 2.0 284 4.7 423 1.2 450 1.7 66 6.9 119 10.4
Antispasmodic drugs 533 9.9 2430 40.1 1414 3.9 3870 14.3 55 5.7 85 7.4
Tricyclic antidepressants 228 4.2 372 6.1 1647 4.5 1364 5.0 46 4.8 52 4.5
SSRI 471 8.8 680 11.2 3061 8.3 2488 9.2 59 6.1 92 8.0
Other antidepressants 55 1.0 84 1.4 472 1.3 383 1.4 8 0.8 10 0.9
a Medications on the same day were coded as post.
b Excludes lactulose, which is not recommended in the NICE guidelines.
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FIGURE 15 Irritable bowel syndrome age-specific rates: 2002–11.
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FIGURE 16 Abdominal pain age-specific rates: 2002–11.
TABLE 31 Number (%) of referrals pre and post IBS, AP and IBD: Salford 2002–11
Referralsa
Condition
IBS AP IBD
Pre
(N= 7728)
Post
(N= 7665)
Pre
(N= 39,974)
Post
(N= 37,851)
Pre
(N= 1336)
Post
(N= 1382)
n % n % n % n % n % n %
Gastrointestinal 295 3.8 288 3.8 358 0.9 1230 3.2 123 9.2 303 21.9
Mental health 3 0.0 3 0.0 19 0.0 21 0.1 0 0.0 0 0.0
Lifestyle 24 0.3 24 0.3 79 0.2 99 0.3 6 0.4 9 0.7
a Referrals on the same day were coded as post.
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The prevalence of AP is much higher than that of IBS or IBD, and higher in females than in males. In
females, rates are highest in the youngest age groups up to the age of 30–34 years, after which rates
decline until the age of 55–59 years, where the rates gradually increase again to the age of 65–69 years
before declining in the oldest age groups. In males, there is a gradual increase in the age-specific rates up
to about 60 years, when the rates level out, until they decline in the eldest age group. The rates of IBD are
much more similar in males and females and tend to fluctuate across the age groups, with a decline in the
older age groups.
Figure 18 shows the age-standardised rates per 100,000 population for IBS, AP and IBD in Salford for the
years 2002–11. Rates have been standardised to the Greater Manchester population. The rates for IBD
remained stable across the 10-year period for both males and females. IBS shows a similar pattern in males
and females, with a slight increase in prevalence rates up to 2006 before levelling out over the second
half of the 10-year period. The rates of AP, on the other hand, increased considerably in both males and
females from 2002 to about 2009, after which they levelled out for both males and females.
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FIGURE 18 Age-standardised rates: 2002–11. F, female; M, male.
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FIGURE 17 Inflammatory bowel disease age-specific rates: 2002–11.
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Discussion
The findings from this study demonstrate that the prevalence of IBS in patients who consult, and are
recorded by, their GP is low. As highlighted earlier, this may be attributable to a number of factors.
The majority of patients who had an IBS Read Code recorded did not have any symptoms prior to,
or after, their index date. Antispasmodics were the most prescribed medications for patients with IBS.
A small number of patients with IBS were referred to gastrointestinal specialists.
Strengths and limitations
The strengths and limitations of this study are similar to those reported for study 1. This study confirms
that the recorded prevalence of IBS in patients who consult, and are recorded by, their GP is low. Several
possible explanations for this are given in the Discussion section.
This study also found that the majority of patients who were coded as having IBS did not have
gastrointestinal symptoms recorded in the year prior to, or the year after, their index episode. NICE
recommends assessment for IBS in patients having any of the following for at least 6 months: AP or
discomfort, bloating or change in bowel habit. Therefore, one might expect evidence of this in the
recording of symptom codes in the year prior to, or after, the index episode of IBS. GPs in the qualitative
study also alluded to the fact that patients may not receive a Read Code for IBS initially, but that they
would use Read Codes for AP, diarrhoea or constipation. However, this was not reflected in the data from
the SIR. Interestingly, however, IBS medications as recommended by NICE were often prescribed in those
without symptoms in the year prior to their IBS. This suggests that the use of medication codes may be an
alternative approach to identifying patients via symptom or diagnostic Read Codes. For patients to receive
a prescription, GPs must enter a description of the medication, which is then issued electronically.
However, some IBS medications (e.g. laxatives) may also be prescribed for other conditions.
The proportion of patients with IBS who were referred to a gastrointestinal specialist was relatively small
compared with the proportion of patients with a diagnosis of IBD. Few patients in all three groups had
been referred to mental health specialists or for lifestyle advice. This concurs with the findings from the
qualitative study where GPs reported being fairly comfortable in managing patients with IBS.
Project 2 overall discussion of findings from the four studies
The use of Read Codes
Read Codes were first introduced in the 1980s and their continual evolution appears to cause problems
between users and may be detrimental to the consistency of coding.118 In addition, the number of Read
Codes used to describe a concept can vary widely. For instance, a recent study on the consultation
prevalence of musculoskeletal problems in primary care identified over 100 Read Codes to classify knee
pain from several different diagnostic chapters (N – musculoskeletal; R – symptoms, signs and ill-defined
conditions; S – injury and poisoning; 1 – history/symptoms).119 About 25% of musculoskeletal consultations
were given codes outside the musculoskeletal chapter, including symptoms codes, which some GPs may
use prior to making a definite diagnosis. In addition, widespread pain was often recorded using multiple
regional pain sites rather than using codes for widespread or generalised pain. Thus, using only codes
from the musculoskeletal chapter would underestimate the consultation prevalence for musculoskeletal
problems.119 There is a lack of consistency in the use of Read Codes for diabetes mellitus: only one Read
Code was used in all practices, yet just 63% of patients were given this code and other patients were
given a diabetes-related code or a prescription code.120 This study highlights the problems associated with
using Read Codes in research for a functional condition. Using Read Codes to identify patients with IBS
brings with it further problems, as IBS is typically difficult to diagnose.
Primary care records compared with patient recall
It is apparent that the prevalence of IBS reported in surveys is an overestimate of the consultation
prevalence within primary care. Although we did not expect the consultation prevalence for IBS to be as
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high as that reported in the literature through the use of self-report surveys, we were surprised by how
low it was.95 Previous studies had reported that around 30–70% of patients consulted primary care for
their IBS.97 Furthermore, the literature suggests that GPs do not see IBS as an insignificant problem.3
One study has found large discrepancies in estimates of consultation prevalence in patients with knee pain
when comparing primary care records with patient recall. These discrepancies were a result of ‘telescoping’
on the part of the patients. Telescoping represents a form of recall bias whereby patients underestimate
the time since the consultation took place; for example patients may recall a consultation having taken
place 12 months ago when it actually occurred 18 months ago. This would lead to an overestimation
of the consultation frequency.121 Another possible reason for the discrepancy was that GPs may not record
subsequent consultations if patients have previously consulted for the same condition, in particular if
treatment is not provided or changed. Under-recording by GPs may also occur when patients present with
multiple problems at consultation.
Interestingly, studies have found that those patients who recalled consultations for knee pain and had
widespread pain or greater levels of depression were less likely to have a recorded consultation for their
knee pain.121 Like knee pain, IBS does not have a definite diagnosis and symptoms fluctuate over time;
thus, primary care records may reflect the consultation prevalence of IBS only when IBS is a major part of
the consultation or when treatment is provided or changed. In addition, Jordan et al.119 found that the
consultation rates increased when the text of the consultations was used in addition to Read Codes alone.
Of those patients who recalled having consulted their GP, only 27% had a knee-related Read Code in
their medical records, which increased to 40% when the search was extended to include knee problems
mentioned in the text.119 Others have discussed the benefit of narratives during the consultation rather
than reducing the clinical encounter to a limited number of codes.122 Findings from our qualitative study
also suggest that this may have been the approach taken by some GPs. However, although using the
text from consultations may have increased the number of patients referred to the risk assessment study,
it is still unlikely that we would have met our recruitment target.
Health care seeking for irritable bowel syndrome
The findings from the current study show that, within primary care, the consultation rate for coded IBS is
not as high as expected from the literature. However, that is not to say that patients do not suffer from
symptoms of IBS or that it is a condition that they feel comfortable in managing. There may be a number
of explanations as to why patients do not appear to consult for their IBS.
First, patients may consult their GP only when their symptoms are severe and, as a consequence, they perhaps
feel less able to cope. Indeed, data from the risk assessment study suggest that the majority of patients had
moderate or severe symptoms. However, evidence suggests that symptom severity may have an influence on
seeking health care, but that it does explain the majority of the consultation behaviour.123 Psychological and
psychosocial factors have also been implicated in health-care-seeking behaviours among patients with IBS.124
The present study suggests that a proportion of patients with IBS were prescribed antidepressants in the year
before and the year after their index episode. However, we cannot infer whether these medications were
prescribed for their gastrointestinal symptoms, for related anxiety or depression, or for unrelated anxiety and
depression. GPs in study 3 also suggested that they may focus on related psychological symptoms initially,
which may in turn lead to an improvement in gastrointestinal symptoms.
Second, patients may not consult their GP for their IBS because it is in remission, or their symptoms are
under control through the use of medication or self-management. A large proportion of patients in the
study did not have any symptoms in the year prior to their index episode of IBS but had been prescribed
IBS medications, as recommended in the NICE guidelines. However, we are not able to say whether or
not these patients had ever been recorded as having IBS prior to the year before their index episode and
whether or not they had received a repeat prescription from their GP for their symptoms. Data from
our risk assessment study suggested modest improvements in symptom severity and HRQoL over time.
However, GPs recruited patients during the consultation or through the use of Read Code searches (with a
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consultation having occurred in the last 3 months), and it may be that treatment prescribed during the
course of that consultation resulted in improved outcomes for patients. Alternatively, these improvements
may simply reflect the fluctuating nature of the condition.
Finally, patients may feel that there is little that primary care can offer and, therefore, learn to live with
their symptoms. A study reported that patients felt that doctors were unsympathetic and ignorant about
IBS and often considered IBS as ‘all being in the mind’ of the patient. Some also felt that GPs were
responsible for the worsening of their condition as a result of their ignorance of IBS or ‘through the
iatrogenic effects of treatment’.125 Another study also found that IBS patients report alienation from the
health services for similar reasons such as the poor doctor–patient relationship, belief that there is little
the NHS can offer and worsening of symptoms as a result of previous medical care.104 Others have found
that moderate to high levels of perceived stigma are significantly more common in IBS patients (27%) than
in IBD patients (8%), with the largest difference being for health-care providers.126 It is therefore perhaps
unsurprising that a proportion of those suffering from the symptoms of IBS do not consult their GP and
decide to self-medicate or seek alternative therapies. Although alternative therapies are not recommended
within the NICE guidance,81 our qualitative study showed that GPs did not discourage their use.
Would a risk assessment tool be helpful?
Despite the problems encountered during the recruitment phase of the study, we were still able to
perform some sensitivity and specificity analysis on the risk assessment tool. Even though the study was
underpowered, the analysis suggests that the risk assessment tool was sensitive in identifying those who
did have severe IBS, but it was poor in identifying those who did not have severe IBS. Whether or not
these findings would change as a result of increased study power is unclear. The fact that the reported
prevalence of patients consulting for IBS is low also limits the feasibility of such a tool within primary care.
The results should also be considered in relation to the qualitative interviews. GPs felt that the use of such
an instrument during the consultation was limited, primarily because of the lack of available resources to
provide interventions. Many also felt that it would be impracticable to administer such instruments during
a 10-minute consultation.
Similarities with other medically unexplained symptoms
Similarities can be seen with other medically unexplained symptoms such as fibromyalgia and chronic
fatigue syndrome. For example, a study found the recorded annual prevalence of fibromyalgia in primary
care to be 8 per 10,000, which is much lower than the estimated general population prevalence of 2%.
This implies that the label of fibromyalgia is rarely used within general practice.127 This study also found
that these patients are similar to those with overlapping functional syndromes or medically unexplained
symptoms. Similarly, in a review of medically unexplained symptoms in primary care, many patients
with IBS met the criteria for fibromyalgia and chronic pelvic pain.128 This overlap with other medically
unexplained symptoms, which often appear to share similar psychosocial characteristics, creates further
complexities.
Implications for future research and clinical practice
The use of symptom or diagnostic Read Codes to identify patients with IBS in primary care is questionable.
It is evident that the label IBS, through the use of the IBS diagnostic Read Code, is rarely applied in
practice. Similarities can be seen with many other medically unexplained symptoms that are difficult to
diagnose in clinical practice, but which may have a common psychological component.
The discrepancies between the self-reported prevalence rates in the literature and those for consultations
within the primary care record suggest that there may be conflicting priorities between patients and
health-care professionals and that database studies are useful in only identifying the ‘tip of the iceberg’.
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Chapter 8 General discussion of programme
findings
This general discussion section identifies messages relevant for current clinical practice and for futureresearch into self-management.
Programme organisation
The trial represents one of the largest pragmatic assessments of patient self-management ever conducted,
and the level of recruitment and follow-up represents a major logistical achievement.
Despite the achievement of goals in terms of research logistics, the impact of the intervention on
organisation of care and patient outcomes was limited. This reflected limits to the engagement with
the WISE model and the embedding of the WISE model’s principles and practices. This became evident
during the process evaluation and suggests strongly that the process of ‘internalisation’ of the
fundamental concepts underpinning the WISE model did not really take place in most practices. As a
result, the WISE model was, at best, only minimally adopted. The small number of practices that did show
greater adoption of the model could have been usefully targeted for more detailed study, but this was
difficult to predict. With regard to the step-up therapies, we again identified a major discrepancy between
uptake of therapies that might have been predicted by previous studies and actual uptake in practice.
Implementation of the WISE model: why was this not successful?
We set out to implement a practice-based training programme to enhance outcomes through enhanced
self-management, which involved a number of steps:
1. engaging a high proportion of practices with the programme
2. delivering training to a high number of clinicians and other staff
3. ensuring that training was relevant and acceptable
4. encouraging implementation of the training in routine practice
5. enhancing shared decision-making and self-management
6. improving outcomes.
Our data show that, although the study had reasonable success at some steps, we probably lost significant
‘potency’ (in terms of translating outcomes from research into routine practice) at step 4, and what was
achieved at stage 4 completely failed to generate changes to steps 5 and 6. Achieving the first three steps
may have required so many compromises in terms of time and ongoing support that it failed to translate
further. It is also possible that our judgements about impact at step 3 (in terms of the acceptability of
training) were overstated, given the limited nature of the evaluations (i.e. self-report staff evaluations).
We consider some of the reasons for the failure below.
Despite some evidence of PCT engagement (organisational ‘buy-in’ at board level, reconfiguration of its
self-management programme around the WISE model and reallocation of a sizable proportion of its
training budget to support the roll out), it is evident that the PCT was able to exert only minimal pressure
on GP behaviour.
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Although a research project, implementation of the WISE model within primary care may have been more
successful if treated like the implementation of any other service redesign, with full engagement of the
PCT commissioning staff. This may have involved consultation with practices prior to implementation and
recognition that different approaches may have been needed for different practices. As individual providers,
GP practices work in a variety of ways (including the role of practice nurses in the management of patients).
Implementation may have been improved if, as part of the study, dedicated Salford commissioning staff had
been funded. These staff would be experienced in introducing new services in Salford and working
with practices.
As suggested by the process evaluation, implementation in the context of a QOF ‘pay for performance’
climate may mean that general behaviours (such as self-management support) will continue to take second
place to those that are ‘mandatory’. GPs, as small independent providers, need to recover the cost of
providing services through income. The nature of the GP contract means that practices receive income
through a contract to provide a core service and to deliver key measures defined in the QOF. Additional
activities can be contracted via the use of direct and local enhanced services contracts. The development of
local enhanced services contracts within primary care has proved successful in embedding new ways of
working within primary care. These generate additional practice income, helping practices to invest time
and other resources to deliver the desired outcomes of the local enhanced services. Some of the difficulties
experienced with practice engagement in the training and implementation of the WISE model could have
been mitigated by the use of such a contract.
Engagement with step-up therapies was very low. A major issue to be considered further is the extent to
which patients with IBS symptoms in primary care are accepting of a psychological component of their
condition as an explanation or a route to management. Our results suggest that many patients coded as
IBS in general practice are generally happy with the label and do not request to take matters further, either
by seeking secondary care investigations or more complex therapy. It also seems evident that at least a
proportion of GPs felt that referral for psychological interventions was not in the interest of the patient,
as it took the condition beyond a simple description and into a psychiatric dimension.
It is suggested that future endeavours to both explain to and console patients with medically unexplained
abdominal symptoms in a health-care system need to recognise the spectrum of the disorder and recognise
the dimension of severity in addition to that of the nature and duration of symptoms, which is not
adequately expressed by the currently employed symptom-based criteria.
Although a proportion of patients who are genuinely distressed by their symptoms fall into the symptom-
based categorisation of IBS, it is apparent that many others who also meet the IBS ‘case definition’ have
much less debilitating symptoms.
Several strategies were used to increase referrals to the therapies. It may also have been beneficial for
communications to practices to have been incorporated into regular PCT commissioning communications.
This includes monthly key messages about new services or pathways. However, practices receive so much
information that it is difficult for it all to be effectively received.
The implementation of the WISE model and the changing primary
care context
What are the implications of the study for the WISE model? We have identified a number of potential
barriers to implementation that led to a failure to deliver the core features of the intervention in routine
practice and it is possible that the WISE model, backed by a more effective implementation programme,
could still be clinically effective and cost-effective. However, there is potential to modify the model itself.
This might include adoption of digital technologies to better support patient and practitioner behaviour
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change, targeting other conditions or patient groups and alignment with other aspects of the long-term
condition management infrastructure, such as care planning.129,130
As part of the Health and Social Care Act, PCTs were abolished.131 From 1 April 2013, the duties of PCTs
transferred to various organisations, primarily Clinical Commissioning Groups (CCGs) for the commissioning
of most hospital, community and mental health services, NHS England for the commissioning of primary
care and specialist services and local authorities in respect of public health. CCG budgets are identified at
individual practice level and practices are held to account for budget management. This creates an incentive
for GP practices to modify their working practices to make the most efficient use of their commissioning
budget. This could include embedding within general practice any activities or services that reduce
secondary care utilisation and costs, such as self-care. CCGs also have a duty to improve the quality of
primary medical care, which will involve an emphasis on GP and practice staff training and a reduction in
the variation within general practice. Should a CCG consider self-care as a strategic priority and choose to
implement the WISE model approach, this could have been identified from its strategic business planning
process and be included as a priority area of work within the strategic commissioning plan. In this way,
self-care and the WISE model would become a priority.
It is possible that, should the WISE model be identified as a strategic priority, implementation by CCGs
could be more successful than experienced in this study, as greater levers exist in CCGs than in PCTs to
implement commissioning priorities. Within CCGs, practices are able to access management and financial
resources to help them implement changes. The experience of the NIHR-funded 3D study (which uses a
similar practice-based model involving elements of self-management support) will be a potential test case
for this hypothesis.132,133
This study provides insight into implementing new ways of working in primary care, which is valuable to
CCGs in their duty of improving the quality of primary care. Lessons learnt include the importance of
incentivising practices and reimbursing them for the cost of implementation, using appropriate service
improvement and commissioning methodologies and aligning pilots and roll-outs with mainstream
commissioning processes and resources.
With regard to the issues of symptom chronicity, and the use of the assessment tool, several messages
arise. One particular issue is the ability of GPs to cope with an increasing number of such tools across all
specialties and assimilate them into daily activity. The study also showed that, with regard to IBS, the case
definition used in primary care is highly inconsistent. This remains so despite attempts for over a decade to
identify useable case definitions (in the form of ROME diagnostic criteria4,98,99).
We found that few patients who were given the term IBS had been, or were currently, attending secondary
care for the condition, leading to the suspicion that in a population such as Salford the overwhelming
proportion of patients meeting the diagnostic symptom criteria for IBS have a relatively mild condition. The
qualitative interviews with GPs about IBS suggest that a strongly pragmatic, empirical approach is utilised
by most. This almost certainly explains why the prevalence of IBS in our population was substantially lower
than that which was predicted from either previous data or case definitions obtained by direct patient
contact. In addition, our results show how difficult it is to use symptom-based clinical criteria for health
services research in the NHS. A case for tighter case definition in primary care (exemplified by the ROME
diagnostic criteria4,98,99) could be made, but it is difficult to see how and why this would provide beneficial.
The lack of uptake of aspects of the programme among patients and professionals suggests that our
assumptions about the need for improvements in management of FGID are not necessarily shared.
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Implications of the study for research
The Programme Grants for Applied Research programme provided significant financial support for a
long-term programme of implementation and evaluation, but this did not result in a clinically effective
or cost-effective intervention.
The results highlight the need for further research into large-scale change in management of long-term
conditions, given the modest results of recent interventions, including telehealth, the Expert Patients
Programme and integration of care.
There is an argument that the intervention was insufficiently piloted, given the focus placed on the use of
pilot and feasibility studies within the NIHR research programmes. A counterargument is that piloting of
some form had been done of aspects of the WISE model in other trials (see Chapter 1), and there was
some preliminary work within practices to assess likely problems, although this work lacked the specificity
and detail that would be expected of a formal pilot. Piloting would have potentially led to an earlier
indication of the likely problems, leading either to a change in the model of implementation or a change in
the research itself (including ending the RCT). However, the potential of pilots should not be overstated.
Testing models in a small number of volunteer pilots can raise important issues, but is unlikely to ever
provide a complete ‘diagnosis’ of the likely barriers to be faced in scaling up across multiple practices and
contexts. The addition of a pilot also potentially adds significantly to the cost and duration of a trial, with
that investment only potentially being recouped in a more effective intervention.
The results of the RCT might have more profound implications for large-scale implementation efforts.
A more radical alternative suggested by a reviewer of this report would be to undertake a ‘small-scale,
formative and more collaborative action–research-style pilot with a handful of practices which treated
them as active participants in shaping the intervention’. This would involve much closer working between
the research team and the local commissioners and providers, and involve practice teams much more in
the development and implementation of the intervention. ‘Working with’ primary care to implement
changes around long-term conditions and self-management support might be a preferable model to the
more standardised implementation adopted here. However, such an approach would again extend study
timelines beyond even the generous confines of the Programme Grants for Applied Research funding,
increasing cost, making studies even more vulnerable to contextual change outside the trial and putting
potentially serious limits on the ability to undertake rigorous evaluation of the type that is currently
prioritised in the UK. This reflects the ongoing debate between those who advocate a conventional
(although modified) model of evaluation, even in the context of large-scale service change, and those who
call for a different model.134–136
More research needs to be conducted exploring professional and patient attitudes and experiences of the
management of functional disorders, to ensure that assumptions about the need for improvements in
management of FGID are shared, and that interventions are seen as having utility by stakeholders.
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Appendix 2 Consolidated Standards of Reporting
Trials checklist
Section/topic Item number Checklist item
Reported on page
number
Title and abstract
1a Identification as a randomised trial in the title i
1b Structured summary of trial design, methods, results,
and conclusions (for specific guidance see CONSORT
for abstracts)
Not applicable, as trial is
subset of main report
Introduction
Background and
objectives
2a Scientific background and explanation of rationale 4–9
2b Specific objectives or hypotheses 11
Methods
Trial design 3a Description of trial design (such as parallel, factorial)
including allocation ratio
11–13
3b Important changes to methods after trial
commencement (such as eligibility criteria), with
reasons
15–16
Participants 4a Eligibility criteria for participants 11–12
4b Settings and locations where the data were collected 11
Interventions 5 The interventions for each group with sufficient details
to allow replication, including how and when they
were actually administered
See Chapter 2
Outcomes 6a Completely defined prespecified primary and
secondary outcome measures, including how and
when they were assessed
13
6b Any changes to trial outcomes after the trial
commenced, with reasons
Not applicable
Sample size 7a How sample size was determined 14
7b When applicable, explanation of any interim analyses
and stopping guidelines
Not applicable
Randomisation
Sequence
generation
8a Method used to generate the random allocation
sequence
14
8b Type of randomisation; details of any restriction (such
as blocking and block size)
14
Allocation
concealment
mechanism
9 Mechanism used to implement the random allocation
sequence (such as sequentially numbered containers),
describing any steps taken to conceal the sequence
until interventions were assigned
14
Implementation 10 Who generated the random allocation sequence, who
enrolled participants and who assigned participants to
interventions
14
Blinding 11a If done, who was blinded after assignment to
interventions (e.g. participants, care providers, those
assessing outcomes) and how
13
11b If relevant, description of the similarity of interventions Not applicable
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Section/topic Item number Checklist item
Reported on page
number
Statistical
methods
12a Statistical methods used to compare groups for
primary and secondary outcomes
14–15
12b Methods for additional analyses, such as subgroup
analyses and adjusted analyses
14–15
Results
Participant flow
(a diagram is
strongly
recommended)
13a For each group, the numbers of participants who were
randomly assigned, received intended treatment and
were analysed for the primary outcome
17
13b For each group, losses and exclusions after
randomisation, together with reasons
17
Recruitment 14a Dates defining the periods of recruitment and
follow-up
11
14b Why the trial ended or was stopped Not applicable
Baseline data 15 A table showing baseline demographic and clinical
characteristics for each group
See Tables 1 and 3
Numbers
analysed
16 For each group, number of participants (denominator)
included in each analysis and whether or not the
analysis was by original assigned groups
14, see Figure 4
Outcomes and
estimation
17a For each primary and secondary outcome, results for
each group, and the estimated effect size and its
precision (such as 95% CI)
See Table 2 and Figure 5
17b For binary outcomes, presentation of both absolute
and relative effect sizes is recommended
Not applicable
Ancillary
analyses
18 Results of any other analyses performed, including
subgroup analyses and adjusted analyses,
distinguishing prespecified from exploratory
See Table 4
Harms 19 All important harms or unintended effects in each
group (for specific guidance see CONSORT for harms)
Not applicable
Discussion
Limitations 20 Trial limitations, addressing sources of potential bias,
imprecision, and, if relevant, multiplicity of analyses
24
Generalisability 21 Generalisability (external validity, applicability) of the
trial findings
24
Interpretation 22 Interpretation consistent with results, balancing
benefits and harms, and considering other relevant
evidence
24
Other information
Registration 23 Registration number and name of trial registry viii
Protocol 24 Where the full trial protocol can be accessed, if
available
URL: https://
implementationscience.
biomedcentral.com/articles/
10.1186/1748-5908-7-7
(accessed 27 October
2017)
Funding 25 Sources of funding and other support (such as supply
of drugs), role of funders
viii
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Appendix 3 The CHEERS checklist
Section/item Item number Recommendation
Reported on page
number
Title and abstract
Title 1 Identify the study as an economic evaluation or use
more specific terms such as ‘cost-effectiveness
analysis’, and describe the interventions compared
i
Abstract 2 Provide a structured summary of objectives,
perspective, setting, methods (including study
design and inputs), results (including base case and
uncertainty analyses), and conclusions
Not applicable as
trial is subset of
main report
Introduction
Background and objectives 3 Provide an explicit statement of the broader
context for the study
4–9
Present the study question and its relevance for
health policy or practice decisions
11
Methods
Target population and
subgroups
4 Describe characteristics of the base-case population
and subgroups analysed, including why they were
chosen
11–13
Setting and location 5 State relevant aspects of the system(s) in which the
decision(s) need(s) to be made
15–16
Study perspective 6 Describe the perspective of the study and relate
this to the costs being evaluated
27
Comparators 7 Describe the interventions or strategies being
compared and state why they were chosen
See Chapter 2
Time horizon 8 State the time horizon(s) over which costs and
consequences are being evaluated and say why
appropriate
27
Discount rate 9 Report the choice of discount rate(s) used for costs
and outcomes and say why appropriate
27
Choice of health outcomes 10 Describe what outcomes were used as the
measure(s) of benefit in the evaluation and their
relevance for the type of analysis performed
25–26
Measurement of
effectiveness
11a Single study-based estimates: describe fully the
design features of the single effectiveness study
and why the single study was a sufficient source of
clinical effectiveness data
See Chapter 4 and 5
11b Synthesis-based estimates: describe fully the
methods used for identification of included studies
and synthesis of clinical effectiveness data
Not applicable
Measurement and
valuation of preference
based outcomes
12 If applicable, describe the population and methods
used to elicit preferences for outcomes
Not applicable
Estimating resources and
costs
13a Single study-based economic evaluation: describe
approaches used to estimate resource use
associated with the alternative interventions.
Describe primary or secondary research methods
for valuing each resource item in terms of its unit
cost. Describe any adjustments made to
approximate to opportunity costs
25–27
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Section/item Item number Recommendation
Reported on page
number
13b Model-based economic evaluation: describe
approaches and data sources used to estimate
resource use associated with model health states.
Describe primary or secondary research methods
for valuing each resource item in terms of its unit
cost. Describe any adjustments made to
approximate to opportunity costs
Not applicable
Currency, price date and
conversion
14 Report the dates of the estimated resource
quantities and unit costs. Describe methods for
adjusting estimated unit costs to the year of
reported costs if necessary. Describe methods
for converting costs into a common currency base
and the exchange rate
See Table 5
Choice of model 15 Describe and give reasons for the specific type of
decision-analytical model used. Providing a figure
to show model structure is strongly recommended
Not applicable
Assumptions 16 Describe all structural or other assumptions
underpinning the decision-analytical model
Not applicable
Analytical methods 17 Describe all analytical methods supporting the
evaluation. This could include methods for dealing
with skewed, missing or censored data;
extrapolation methods; methods for pooling data;
approaches to validate or make adjustments (such
as half cycle corrections) to a model; and methods
for handling population heterogeneity and
uncertainty
25–27
Results
Study parameters 18 Report the values, ranges, references and, if used,
probability distributions for all parameters. Report
reasons or sources for distributions used to
represent uncertainty where appropriate. Providing
a table to show the input values is strongly
recommended
See Tables 6 and 7
Incremental costs and
outcomes
19 For each intervention, report mean values for the
main categories of estimated costs and outcomes
of interest, as well as mean differences between
the comparator groups. If applicable, report ICERs
29 and Table 9
Characterising uncertainty 20a Single study-based economic evaluation: describe
the effects of sampling uncertainty for the
estimated incremental cost and incremental
effectiveness parameters, together with the impact
of methodological assumptions (such as discount
rate, study perspective)
See Figure 6
20b Model-based economic evaluation: describe the
effects on the results of uncertainty for all input
parameters and uncertainty related to the structure
of the model and assumptions
Not applicable
Characterising
heterogeneity
21 If applicable, report differences in costs, outcomes,
or cost-effectiveness that can be explained by
variations between subgroups of patients with
different baseline characteristics or other observed
variability in effects that are not reducible by more
information
30
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Section/item Item number Recommendation
Reported on page
number
Discussion
Study findings, limitations,
generalisability and current
knowledge
22 Summarise key study findings and describe how
they support the conclusions reached. Discuss
limitations and the generalisability of the findings
and how the findings fit with current knowledge
31
Other
Source of funding 23 Describe how the study was funded and the role of
the funder in the identification, design, conduct
and reporting of the analysis. Describe other
non-monetary sources of support
viii
Conflicts of interest 24 Describe any potential for conflict of interest of
study contributors in accordance with journal
policy. In the absence of a journal policy,
we recommend authors comply with the
recommendations of the International Committee
of Medical Journal Editors
i
Note
For consistency, the CHEERS statement checklist format is based on the format of the CONSORT statement checklist.
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Appendix 4 Project 2 patient questionnaire
 
 
 
 
 
Statement of Confidentiality 
The identification number allows us to keep track of the questionnaires as they 
are returned. Any information you provide that would permit the identification of 
an individual will be kept strictly confidential, will be used only for the purposes 
of this study, and will not be disclosed or released to any other persons or used 
for any other purpose. 
 
 
 
Better InformaTion for MAnaging stomach and bowel 
Problems (BITMAP) 
 
Initial Questionnaire 
 
 
Dear Participant 
 
We would be very grateful if you could help us by completing the enclosed 
questionnaire and returning it to us in the pre-paid envelope.  
 
It should only take about 20 to 25 minutes to complete.  
 
The information that you give us will be treated in strict confidence. 
 
If you would like any further information or have any questions about this study, 
please do not hesitate to contact: 
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We have sent you this questionnaire because your doctor or nurse completed 
a permission to contact slip when they told you about the BITMAP study at the  
The University of Manchester.  To ensure your details  are up-to-date and we 
can contact you about the follow up part of this study, we would be grateful if 
you could write your details in the box below. 
 
This page will be separated from the rest of the questionnaire and will be held 
in strictest confidence.  It will only be used for the purposes of this study and 
will not be shown or given to other persons or used for any other purpose. 
 
 
 
 
Please write your contact details here. 
 
 
Name 
 
 
Address 
 
 
 
 
 
 
 
 
 
 
Postcode 
 
 
Telephone 
 
 
Email  address 
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Participant Study Number   
 
 
 
 
 
What is today’s date?  
 
 
 
1. What is your date of birth  
     (dd/mm/yyyy)? 
 
 
 
 
2. Are you?                    Male                          Female    
 
 
 
 
3. What is your postcode?   
 
 
 
 
 
4. Please tell us what the job title is of the main earner in your household: 
  
 
______________________________________________________________________________________________  
 
 
When did your symptoms first start? 
 
                                           1 to 4 weeks ago 
     
        More than 1 month but less than 3 months ago 
 
            More than 3 months but less than 6 months ago  
 
          More than 6 months but less than 12 months ago                                                  
 
                    More than 1 year but less than 3 years ago 
 
                  More than 3 years but less than 5 years ago  
 
                                                     More than 5 years ago  
First we would like a few background details about you:  
The following questions are about your stomach or bowel 
problems: 
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Now please think about the symptoms you consulted your GP with most 
recently: 
 
 
a) When your symptoms occurred how long did they last? 
 
  
  2 hours or less                         More than 2 hours                         
 
  
 
 
b) When your symptoms occurred had you changed your diet? 
 
 
 
      Yes                                        No                              
 
 
 
 
c)  In the 14 days before you became ill, did you: 
 
 
Have gastroenteritis or food poisoning? 
 
Yes                                        No                              
 
       
 
 
Have contact with anyone with diarrhoea and vomiting (family/ other 
contact)? 
 
Yes                                         No                              
 
 
 
 
 
 
Have your activities (e.g. work or social activities) been interrupted in the 
last year because of problems with your bowels?  
 
Yes                                         No                              
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a) Which ethnic group do you belong to? 
 
White British or Irish 
 
 Other White 
 
Mixed White & Black Caribbean 
 
 White and Black African 
 
 White and Asian 
 
 Other Mixed 
 
Asian or Asian British Indian 
 
 Pakistani 
 
 Bangladeshi 
 
 Other Asian 
 
Black or Black British Black Caribbean 
 
 Black African 
 
 Other Black 
 
Another Group Chinese 
 
 Other ethnic group 
 
Please tick one box 
 
Please answer the following background questions: 
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b) Please tick one box to show which best describes the sort of work the 
main earner in your household does. (If the main earner is not working 
now, please tick a box to show what they did in their last job).  
Modern professional occupations 
such as: teacher - nurse - physiotherapist - social 
worker - welfare officer - artist - musician - police 
officer (sergeant or above) - software designer 
 
Clerical and intermediate occupations 
such as: secretary - personal assistant - clerical 
worker - office clerk - call centre agent - nursing 
auxiliary - nursery nurse 
 
Senior managers or administrators 
(usually responsible for planning, organising and co-
ordinating work and /or finance) 
such as: finance manager - chief executive 
 
Technical and craft occupations 
such as: motor mechanic - fitter - inspector - 
plumber - printer - tool maker - electrician - 
gardener - train driver 
 
Semi-routine manual and service occupations 
such as: postal worker - machine operative - security guard - 
caretaker - farm worker - catering assistant - receptionist - 
sales assistant 
 
Routine manual and service occupations 
such as: HGV driver - van driver - cleaner - porter - packer - 
sewing machinist - messenger - labourer - waiter / waitress - 
bar staff 
 
Middle or junior managers 
such as: office manager - retail manager - bank manager, 
restaurant manager - warehouse manager - publican 
 
Traditional professional occupations 
such as: accountant - solicitor - medical practitioner - scientist 
- civil / mechanical engineer 
 
Please tick one box 
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c) Last week, was the main earner in your home any of the following? 
 
 
Retired  
Student  
Looking after home/family  
Currently sick/disabled  
Unemployed  
None of the above  
d) Does (did) the main earner work as an employee or are (were) they 
self-employed? 
Employee (please go to question e)  
Self-employed with employees (please go to question f)  
Self-employed/freelance without employees  
(please skip the last few questions ) 
 
e) For employees: please indicate how many people work (worked) for 
the main earner’s employer at their place of work (worked). 
 
        
1 to 24  
25 or more  
f) For self-employed: please indicate how many people the main earner 
employs (employed).    
 
1 to 24  
25 or more  
g) Does (did) the main earner supervise any other employees? 
A supervisor or foreman is responsible for overseeing the work of other 
employees on a day-to-day basis 
   
Yes  
No  
Please tick one box. 
Please tick one box. 
Please tick one box. 
Please tick one box. 
Please tick one box. 
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If you have any comments about the survey or any other aspects of the 
research, please use the box below to tell us.  
 
 
 
 
 
 
 
 
 
Thank you very much for answering these questions. Please return your 
questionnaire and consent form in the pre-paid envelope provided. 
 
We will contact you again in 3 months time when we will send you a 
further questionnaire to complete.  If you have any questions about the 
study please contact  
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Appendix 5 Scoring for risk assessment tool
Measure Score
GHQ score
0–2 0
3–12 1
Change in diet
No 1
Yes 0
Duration of symptom episode (hours)
≥ 2 0
> 2 1
Recent gastroenteritis/food poisoning?
No 1
Yes 0
Activities interrupted as a result of bowel problems?
No 0
Yes 1
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